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SUMMARY
Investigation of a suspected case of hog cholera led to the 
isolation of bovine viral diarrhoea viruses from a
persistently infected steer and from five sibling piglets. 
The persistently infected steer was able to infect pigs by 
indirect contact under controlled laboratory conditions and 
the bovine virus was able to cause congenital porcine 
disease. Pestiviruses isolated from the steer and from the 
pigs infected on the farm were compared with one another and 
with the bovine virus after experimental pig passage.
Antigenic and genetic analyses of the gp53 proteins and
genes of these viruses revealed that the bovine virus had 
only three amino acid changes consequent upon experimental 
passage in pigs, but was distinct from the porcine field 
isolates. The initial assumption that the persistently
infected steer had infected the farm pigs was therefore not 
confirmed by experimentation.
A panel of BVDV mAbs that included some of those used to 
discriminate between the above and other pestivirus strains 
was characterised with respect to protein specificity. Most 
of the mAbs recognised either the major envelope 
glycoprotein (gp53) of BVDV or an immunodominant 
non-structural protein (p80). Competitive binding studies 
demonstrated four domains on p80 and two on gp53. 
Conservation of epitopes was much greater for p80 than for
ç|p53. Sequence comparison between mAb neutralization-escape 
mutants and parental viruses indicated the possible location 
of antibody binding sites on gp53 and suggested two domains, 
one of which was defined by relatively conserved epitopes. 
The pattern of amino acid differences comparing escape 
mutant viruses with both parental viruses and others of 
known mAb reactivity suggested that gp53 epitopes may be 
non-linear.
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1.1 INTRODUCTION
The pestivirus genus comprises bovine viral diarrhoea virus 
(BVDV), hog choiera virus (HCV) and ovine border disease 
virus (BDV), all of which cross-react serologically. 
Although each of these are significant pathogens that have 
attracted considerable study in their own right, the many 
shared biological properties of all pestiviruses make it 
difficult to review any particular subgroup in isolation. As 
well as cattle, sheep and pigs, pestiviruses may infect 
goats, many non-domesticated breeds of ruminant and wild 
boar. Pestiviruses isolated from cattle and sheep are 
generally referred to as BVDV and BDV respectively, even 
though cross-species infections make the host of immediate 
origin an uncertain basis for classification. Antigenic 
studies do, nevertheless, suggest that many ovine 
pestiviruses are distinct from BVDV (Nettleton, 1987). The 
umbrella term ”ruminant pestivirus", to denote both BVDV and 
BDV is a useful one, especially when discussing 
uncharacterised strains and field isolates. Although pigs 
may also be infected with ruminant pestiviruses, the HCV 
subgroup is clearly distinct (Carbrey, 1988).
BVDV is considered one of the most important viral pathogens 
of cattle, particularly in countries where other serious 
viral diseases such as foot and mouth and rinderpest have 
been eradicated. Disease due to BVDV is very diverse and 
often goes unrecognised. Clinical effects range from mild
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malaise, to potentiation of other infections, reproductive 
losses, congenital defects, ill-thrift and the generally 
fatal mucosal disease (Baker, 1987). In sheep, pestiviruses 
produce a rather similar spectrum of disease, of which the 
most widely recognised effects are reproductive losses and 
the birth of subsequently unthrifty lambs. HCV is also 
responsible for a wide variety of clinical syndromes, 
influenced to a considerable extent by differences in viral 
virulence (van Oirschot and Terpstra, 1989). Virulent HCV 
causes one of the most serious diseases of pigs with very 
high levels of morbidity and mortality in all ages of stock. 
In common with all pestiviruses, an important aspect of 
disease due to HCV is congenital infection.
This thesis is concerned with the transmission and 
consequences of BVDV infection to pigs and with the 
definition of genetic variability and B cell epitopes, 
particularly on the major glycoprotein of that virus. This 
review will therefore concentrate most heavily on the basis 
of pestivirus antigenicity and immunity, on the pathogenesis 
and transmission of these viruses, and on the occurrence of 
cross-species infections.
4
13  THE STRUCTURE, REPLICATION AND CLASSIFICATION OF 
PESTIVIRUSES
i) The pestivirus genome:
The molecular genetics of pestiviruses have been reviewed by 
Collett and others (1989), with an update by Collett (1992) 
and Collett and others (1992). The BVDV genome is a single 
strand of positive sense RNA, which may or may not be 
capped. It is about 12.5kbases in length and has no 3' 
poly(A) tail (Renard and others, 1985). The presence of
secondary RNA structure was indicated by a requirement for
dénaturation for efficient in vitro translation in
reticulocytes (Purchio and others, 1984b). The major part of
the genomes of the Osloss and NADL laboratory reference 
strains of BVDV have been sequenced by Renard and others 
(1987) and Collett and others (1988a) respectively. Only the 
sequences of the extreme termini at either end of the RNA 
remain uncertain. The sequence of part of the gp53 gene of 
another BVDV, the Singer strain, has also been reported 
(Dale and others, 1987). Two reference strains of HCV 
(Alfort: Meyers and others, 1989a; Brescia: Moormann and
others, 1990) have also been sequenced, and Moormann and 
others (1990) considered that they had sequenced the entire 
3' end of the genome. Taking all the data together, there is 
a 5' non—coding region of 360—385 nucleotides, followed by a 
single open reading frame (ORF) with coding capacity for 
3898-3988 amino acids or 435-449kDa of protein (Moennig and 
Plagemann, 1992). Some of the six potential AUG codons that
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precede that of the large ORF may also initiate ribosome 
entry, since oligonucleotides binding to the 5' non-coding 
region can block synthesis of the first protein of the large 
ORF (Collett and others, 1992) . The genomes of the four 
pestiviruses so far sequenced, show a nucleotide homology of 
74% between the two BVDVs, compared to 88% between the two 
HCVs. The G:A:C:T base contents of the two BVDVs are almost 
identical (Collett and others, 1989). Comparing BVDV NADL 
and HCV Alfort, the nucleotide sequence homology is 66%. 
Compared to either strain of HCV, the genomes of BVDV NADL 
and Osloss contain insertions of 270 and 228 nucleotides 
respectively. These insertions, which are in phase with the 
open reading frame, are thought to have arisen by 
recombination between cellular and viral RNA and to be 
responsible for viral cytopathogenicity (Meyers and others, 
1991a,b). No complete BDV sequence is yet available, 
although Roehe (1991) has reported the sequence of the first 
230 carboxy terminal amino-acids of the single open reading 
frame of two BDV-like viruses (87/6 and 137/4), and found 
approximately 75% amino acid homology with homologous 
regions of all four of the sequenced BVDVs and HCVs. Most of 
the gp53 gene for the BDV reference strain, Moredun, has 
been sequenced (Lowings and Paton, 1992). This showed 
greater homology to HCV Brescia and Alfort than to BVDV 
NADL, Osloss or Singer. Berry and others (1992) compared a 
290 nucleotide segment of the 5' non-coding region of 55 
distinct ruminant pestiviruses. They have suggested that 
BVDV and BDV are distinct viruses that may be isolated from
6
both sheep and cattle.
ii) The genomic expression of pestiviruses:
Pestivirus proteins can be extracted from both the cellular 
and supernatant phases of cell cultures, but a major problem 
has been the separation of viral material from contaminating 
cellular proteins (Matthaeus, 1979). Methods used to 
concentrate, and separate viral components have included 
ultrafiltration, precipitation with ammonium sulphate or 
polyethylene glycol, affinity chromatography, differential 
centrifugation, radioimmunoprecipitation (RIP) and 
polyacrylamide gel electrophoresis (PAGE). The most widely 
used methods to identify pestivirus proteins have been RIP 
followed by PAGE. All but the most recent data have been 
reviewed by Collett and others (1989). The best studied 
pestivirus in terms of genomic organization and protein 
processing is the NADL strain of BVDV. Since this strain is 
also reported upon in this thesis, it is appropriate to 
consider it in detail first. Matthaeus (1979), using 
RIP/PAGE detected three polypeptides in purified virions of 
BVDV strains NADL and Oregon C24V. Two were glycoproteins of 
57kDa and 44kDa, whilst a third was an unglycosylated 
protein of 34kDa. Purchio and others (1984a), demonstrated 
similar proteins in infected cell lysates by RIP/PAGE, with 
additional larger species of 115kDa and 8OkDa. Furthermore, 
they showed by tryptic digestion that these two larger 
molecules were related to one another. Pocock and others 
(1987), using RIP/PAGE on whole cell lysates demonstrated
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eight virus-specific proteins: pl20, p80f gp69, gp57, gp49, 
p37, p33 and gp25 (numbers refer to estimated Mz in kDa, and 
the gp prefix signifies glycosylation). Having sequenced the 
NADL genome, Collett and others (1988b) were able to use 
recombinant proteins, and later on, synthetic peptides 
(Collett and others, 1991), defined by specific subgenomic 
regions, to raise sequence-specific antisera. These were in 
turn tested for reactivity with native viral proteins by 
RIP. In this way it was possible to map specific proteins to 
the approximate regions of the genome that encoded them 
(Collett and others, 1988b; Collett and others, 1989; 
Collett and others, 1991). Pulse-chase labelling experiments 
have confirmed post-translationally derived
precursor-product relationships (Collett and others, 1991). 
Fig 1.1 shows the organization of the BVDV genome according 
to Collett and others (1991), with a modification from 
Collett and others (1992), after Thiel and others (1991). 
This has accounted for most of the BVDV-specific proteins 
described previously, with the exception of p32 and possibly 
p37 (Pocock and others, 1987). Features of the genomic 
organization include clustering of genes for structural 
proteins towards the 5' end of the genome, cotranslational 
cleavage of the primary translation product and the 
existence of transient precursors that are cleaved 
post-translationally into mature protein products. The 
proteins derived cotranslationally are presumed to be p2 0, 
Prgpl40 and Prpl75 (Pr = precursor), of which the latter two 
are post-translationally cleaved in a succession of steps to
8
Fig 1.1 Organization of the genome of the NADL strain of 
BVDV, according to Collett and others (1991) and Collett 
(1992).
The large rectangle at A, represents the open reading frame 
of BVDV NADL, with small non-coding regions at either end. 
The subdividing vertical lines indicate the approximate 
positions of proteolytic cleavage sites. The rectangles at 
B, represent the virus polypeptides, positioned according to 
their genomic organization.
Pr = precursor protein; gp = glycoprotein; p 
unglycosylated protein; ? = predicted protein not yet
demonstrated by radioimmunoprecipitation. Numbers are
approximate molecular weights in kDa.
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yield mature viral proteins. Both p20 (Wiskerchen and 
others, 1991) and p80 (Wiskerchen and Collett, 1991) are
involved in polyprotein proteolysis, as are cellular
proteases (Collett and others, 1992). Deregt and others 
(1991) , were able to show by partial proteolysis that pi25 
and p80 of the Singer strain of BVDV are related to a larger 
protein of 175kDa. However, although the 175kDa protein is a 
transient one, pulse-chase studies do not show it to be a
precursor of either pl25 or p80. The biogenesis of pl25, pBO
and p54 thus remains uncertain.
Table 1.1 shows some of the proteins demonstrated for other 
pestiviruses. Most of the proteins can be aligned to those 
of NADL by size and glycosylation. Small differences in 
apparent molecular weights may be due to strain variation or 
inter-experimental discrepancies. Comparative RIPs with 
hyperimmune sera have shown that many of the similarly sized 
proteins from different pestiviruses are indeed related
(Rumenapf and others, 1989; Akkina and Raisch, 1990).
iii) Virion structure and physical properties:
Visualization of pestiviruses by electron microscopy is 
difficult, because the virus grows to relatively low titres 
in vitro and is not easy to separate from cell culture 
constituents. The virion appears spherical, with a diameter 
of about 40nm (Horzinek and others, 1971). A fringe of 6-8nm 
projections has been described (Enzmann and Weiland, 1978). 
The nucleocapsid is non-helical and probably icosahedral
11
Table 1.1 Footnotes:
Numbers refer to estimated molecular weights in kilodaltons. 
Pr = precursor protein; gp = glycoprotein. Proteins are 
aligned by size and glycosylation to those of NADL.
iRIPs identifying proteins of other strains of BVDV, 
including non-cytopathogenic field strains have also been 
reported with similar results (Donis and Dubovi, 1987c); 
Pocock and others, 1987; Bolin and others, 1988; Bolin and
Ridpath, 1989) .
2Based on Collett and others (1991, 1992). Other reports of 
NADL proteins have been published: Pritchett and Zee (1975), 
Matthaeus (1979), Purchio and others (1984a), Moennig and 
others (1987), Magar (1988), Collett and others (1988b), 
Bolin and Ridpath (1989).
3Based on radiolabelling studies of Donis and Dubovi (1987a, 
1987b), using hypertonic initiation block and RIP. Other 
reports of Singer proteins : Coria and others (1983), Bolin 
and Ridpath (1989), Deregt and others (1990,1991).
4Based on RIP of purified virus by Matthaeus (1979), except 
for 115kDa and 80kDa proteins which were demonstrated by 
cell lysate RIPs (Bolin and Ridpath, 1990b).
5HCV strain Brescia proteins also examined by immunoaffinity 
chromatography (Wensvoort and others, 1990).
6Based on RIP and western blot studies of cell and virus 
extracts by Rumenapf and others (1989) and Thiel and others 
(1991). RIP studies of Alfort, also reported by
Grieser-Wilke and others (1990).
7Based on extrinsic and metabolic labelling of virions by 
Enzmann and Weiland (1978).
8Based on RIP studies of Akkina and Raisch (1990). An 
earlier report was by Akkina (1982) .
9Equivalent protein in BVDV strain Osloss is p41 (Meyers and 
others, 1991a).
12
Table 1.1 Virus associated proteins 
different pestiviruses.
BVDV1 HCV5
NADL2 Singer3 C24V4 Alfort6 Aid 970a7
Prpl75
Prpl65 165 
Prgpl40 
pl33
pl25 135 115 120
PrgpllG gpllS
p80 80 80 75
Prgp78 gp75 
p75 
gp62 gp65 
p58 
p549
gp53 gp57 gp57 gp55 gp55
gp48 gp48 gp44 gp44/48 gp46
p42 37 37 36
? 32 32 34
gp25 gp25 gp33
p20 19 23
pl4 14
reported for some
BDV
BDV-ll/BDV-788
220
gpl60
gpllS
gp84
gp66
gp55/53
gp45
37
gp3i
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(Horzinek, 1981). The presence of a lipid envelope is 
indicated by sensitivity of the virus to organic solvents 
(Dinter, 1963), whilst a positive stranded RNA genome is 
indicated by the infectious nature of the RNA and the 
failure of actinomycin D to inhibit viral replication in 
vitro (Diderholm and Dinter, 1966).
Pestiviruses are readily inactivated by heat treatment, many 
disinfectants, and exposure to an unprotected external 
environment (Horzinek, 1981). However, the viruses are 
relatively pH tolerant and will survive the drop in pH 
associated with rigor mortis* Thereafter they can survive 
for very prolonged periods in frozen or cured carcase 
materials (Birch, 1917).
Being glycosylated, the proteins encoded from the 5' end of 
the genome are quite likely to be part of the virus 
envelope, but not all will necessarily be found in the 
mature virion. Early reports of RIP of purified virions of 
HCV (Enzmann and Weiland, 1978) and BVDV (Matthaeus, 1979) 
gave similar results, suggesting three structural proteins 
of 55-57kDa, 44-46kDa and 34-37kDa. The first two were shown 
to be glycosylated. More recently, Thiel and others (1991) 
have demonstrated that the HCV envelope is composed of three 
glycoproteins: gp55, gp44 and gp33, whilst the virion also 
contains a nucleocapsid protein of 14kDa. Immunogold 
labelling of virions has confirmed that gp44 and gp55 are 
envelope proteins (Thiel and others, 1992). The equivalent
14
structural proteins in BVDV are gp53, gp48, gp25 and pl4
(Fig 1.1). Additional evidence for a structural role for the 
two larger glycoproteins, in both HCV and BVDV, is that both 
can mediate mAb-induced virus neutralization (Donis and 
others, 1988; Wensvoort and others, 1990, Boulanger and 
others, 1991; Weiland and others, 1992). Wensvoort (1990) 
reported that gp55 of HCV existed as both a homodimer and a 
heterodimer with gp33. Extending this work, Thiel and others 
(1991), showed that all three glycoproteins of HCV exist as 
disulphide-linked dimers in both virus infected cells and 
virions. The gp53 protein of BVDV and gp55 of HCV show an 
amino acid homology of only 76%, compared to 85.5% and 90% 
respectively between gp44/48 and gp25/33 (Weiland and 
others, 1990) . The roles of gp48 and gp25 are not 
established. Gp25, being hydrophobic, may be a transmembrane 
protein involved in anchoring gp53 (Moennig and Plagemann, 
1992) . Early reports that p!25 and p80 were structural 
proteins (Pritchett and Zee, 1975; Purchio and others, 
1984a) are now discounted (Thiel and others, 1991).
iv) Viral/cellular interactions:
Some Pestiviruses can infect a wide range of cell types in 
vitro, including cells derived from heterologous hosts 
(Horzinek, 1981). In cell cultures the virus spreads through 
the medium and via intercellular cytoplasmic bridges. 
Persistently infected cultures can be readily obtained, and 
virus spreads from mother to daughter cells during mitosis 
(van Oirschot and Terpstra, 1989). Adsorption of virus to
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cell monolayers is slow, with only 60% of BVDV attached 
after one hour (Moennig, 1971). Mechanisms whereby 
pestiviruses enter cells are largely unknown, although an 
anti-cell mAb able to block entry of some strains of BVDV 
has been described (Moennig and others, 1988), suggesting 
that specific receptors may be involved. Boulanger and 
others (1992) presented evidence demonstrating that BVDV 
enters cells by endocytosis and implicating gp53 in 
penetration.
Virus replication occurs in the cytoplasm, and under single 
growth cycle conditions, virus is detectable within 4-7 
hours with an exponential increase in titre until fifteen 
hours after infection (Horzinek, 1981). Scherrer and others 
(1970) suggested that HCV release is via budding into Golgi 
vesicles or directly at the cell membrane. Recent studies 
consider exocytosis of accumulated virus from cytoplasmic 
vesicles more likely than direct budding from the plasma 
membrane (Bielefeldt Ohmann and Bloch, 1981; Gray and 
Nettleton, 1987).
Little is known about the manner in which the genomic RNA is 
replicated and the existence of negative stranded 
replicative intermediates is not yet proven. However, both 
Schroeder and Balassu-Chan (1990) and Roehe (1991) reported 
that cDNA could be generated from infected cell lysates 
using forward primers and this would suggest that negative 
sense RNA is present. Since viral RNA production is
16
Unaffected by Actinomycin D, RNA replication must involve 
viral proteins (Collett and others, 1989). As has already
been mentioned, viral protein processing involves both host 
and viral proteases.
Cytopathogenicity for cell cultures varies between 
pestiviruses. Whereas virtually all HCVs are not 
cytopathogenic, a proportion of BVDVs and BDVs are 
(Horzinek, 1981). Even amongst cytopathogenic pestiviruses 
there is considerable difference in the type of cytopathic 
effect (CPE) observed in vitro. Fernelius and Ritchie (1966) 
distinguished between two types of CPE, exemplified by the 
NADL and Oregon C24V strains of BVDV and these differences 
can be clearly seen in Fig 1.2. The importance of 
cytopathogenicity for pathogenesis is discussed later. 
Cytopathogenicity of BVDV has been linked to the processing 
of the pl25/p80/p54 protein family. RIP of 
non-cytopathogenic strains reveals only pl25, whilst in 
cytopathogenic viruses, pBO predominates (Akkina, 1982; 
Purchio and others, 1984a; Pocock and others, 1987; Donis
and Dubovi, 1987a). Several authors have noted that the pl25 
proteins of cytopathogenic biotypes have rather heterogeneic 
electrophoretic mobilities (Pocock and others 1987; Magar 
and others, . 1988; Greiser-Wilke and others, 1992). An 
explanation for these phenomena was provided by Meyers and 
others (1989b), who showed that cytopathogenic viruses 
differ from non-cytopathogenic biotypes because of insertion 
of cellular sequences into the viral genome. In all cases
17
Fig 1.2 BVDV cytopathic effects.
Photographs of monolayers of calf testis cells:
a) = Uninfected
b) = Infected with BVDV strain NADL
c) = Infected with BVDV strain Oregon C24V
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the insertion was into p!25, close to the putative 
processing site of the protein (Meyers and others (1991a,b). 
Examination of the sequences inserted in three different 
strains of cytopathogenic BVDV revealed that two viruses 
contained a ubiquitin-like cellular sequence, whilst another 
virus (strain NADL) contained unrelated cellular RNA (Meyers 
and others, 1991a,b). However, cytopathogenic strains of 
BVDV examined by another group did not possess cellular RNA 
insertions, suggesting that these are not a prerequisite for 
the generation of p80 nor for cytopathogenicity (De 
Moerlooze and others, 1991; Desport and Brownlie, 1991). The 
functions of the non-structural virus-encoded proteins are 
not understood in detail. The p80 protein has been shown to 
possess protease and NTPase activity and to be responsible 
for many of the cleavages from the pestiviral polyprotein 
(Wiskerchen and Collett, 1991; Collett and others, 1992). 
The p54 protein has a zinc finger motif (De Moerlooze and 
others, 1990) suggesting a role in gene regulation (Thomas 
and others, 1988). The two proteins at the 3' end of the 
open reading frame: p58 and p75 may be involved in RNA
replication, p75 in particular showing similarities to other 
viral replicases (Collett and others, 1991; Collett, 1992).
v) Pestivirus taxonomy:
This was reviewed by Horzinek (1991) and the following year, 
the pestiviruses were reclassified as part of the 
Flaviviridae (Francki and others, 1992).
20
On largely physical characteristics, pestiviruses were for 
many years placed in the family Togaviridae, along with 
flaviviruses, arteriviruses and rubivirus. The main criteria 
were virion size, the presence of an outer envelope, an 
icosahedral nucleocapsid symmetry and a genome of RNA. The 
flaviviruses were given generic status in 1985 (Westaway and 
others, 1985), and once available, the molecular features of 
pestiviruses soon pointed to dissimilarities between these 
viruses and the remaining members of the Togaviridae. For 
instance, the pestiviruses lack subgenomic RNA and do not 
have a poly (A) tract at the 3 ' genomic terminus. The genome 
size and organization is similar to that of the 
flaviviruses. Although amino acid sequence comparisons show 
little homology, except with respect to two non-structural 
proteins (Collett and others, 1988c), the hydrophobicity
plots are very similar (Francki and others, 1992). This 
comparison has recently been updated and similarities of 
both pestivirus and flavivirus proteins to those predicted 
for hepatitis C virus of humans, have been demonstrated 
(Collett, 1992).
Subdivision of the pestivirus genus into one or other of 
three species-types (HCV, BVDV and BDV) is on the basis of 
host specificty and pathogenicity, antigenic differences 
detected by antibodies and more recently genomic 
comparisons. However, broad host specificity and widespread 
antigenic variation both amongst as well as between virus 
types, along with lack of sequence data, means that such
21
classification is not always straightforward. Moennig and 
Plagemann (1992) have suggested that HCV may have evolved 
from ruminant pestiviruses, since the disease appears to be 
of recent origin, and was at first characterised by extreme 
virulence, indicating poor host adaptation.
vi) Pestivirus antigens:
A serological relationship between widely different 
pestiviruses has been long recognised (Derbyshire, 1960), 
and antibodies have been shown to cross-react with all three 
pestivirus species-types (Osburn and others, 1973). Antisera 
to HCV precipitate BVDV proteins (Rumenapf and others,
1989), and there is also extensive cross-precipitation 
between antigens of BDV and BVDV (Nettleton, 1987; Akkina 
and Raisch, 1990).
Virus neutralization by antibodies is more discriminatory 
and polyclonal antisera may show a reduced or absent level 
of neutralization for heterologous pestivirus strains. This 
can be used to distinguish between certain virus isolates 
(Aynaud and others, 1974 ; Corthier and others, 1974 ; 
Neukirch and others, 1980). By cross-neutralization, HCVs
are relatively homogeneous, and can be differentiated from 
the ruminant pestiviruses (Corthier and others, 1974; Liess, 
1981; Carbrey, 1988). The diversity amongst ruminant 
pestiviruses is much greater, and although 
cross-neutralization often differentiates between strains, 
it may not be a sufficient basis for classifying them as
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BVDV or BDV (Laude & Gelfi, 1979). It does, nevertheless 
appear that by cross-neutralization, some ovine
pestiviruses are BVDV-like, whilst others are distinct 
(?BDV) (Nettleton, 1987). Wensvoort and others (1989a) and 
Dekker and Wensvoort (1992), also using cross-neutralization 
tests, divided pestiviruses into HCV-like, BVDV-like, 
BDV-like and atypical. In this classification, some ovine 
pestiviruses appeared BVDV-like, whilst others formed a 
distinct sub-group. These latter ovine viruses were 
considered the "true BDVs" and were more similar to HCVs 
than to BVDVs.
Many murine mAbs have now been produced against strains of 
HCV and BVDV (Wensvoort and others, 1986; Peters and others, 
1986; Cay and others, 1989; Edwards and others, 1991b). In 
mice, the immunodominant proteins appear to be pl25/p80, 
gp53/55 and gp44/48, since all mabs so far described are 
specific for one of these three proteins. A single bovine 
mAb prepared against BVDV (Onisk and others, 1991) reacted 
with gp53. Competition between ruminant or porcine 
polyclonal antisera and murine mAbs specific to both gp53/55 
and p80 indicates that the same epitopes may be immunogenic 
for both mice and the natural hosts (Wensvoort and others, 
1988a; Paton and others, 1991a). Most strongly neutralizing 
mAbs recognise gp53/55, although not all gp53/55 reactive 
mAbs are neutralizing (Wensvoort and others, 1986; Donis 
and others, 1988). The spectrum of viruses recognised by 
anti-gp53/55 mAbs is rather variable, but many are either
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BVDV- or HCV-specific (Hess and others, 1988; Wensvoort and 
others, 1989b). Some of the HCV-specific mAbs recognise all 
strains of this virus (Hess and others, 1988; Wensvoort and 
others, 1988). BVDV-specific mAbs able to detect all BVDVs
are uncommon (Edwards and others, 1991b) , but have been
described (Shannon and Mackintosh, 1992). The spectrum of 
viruses neutralized by individual mAbs is even narrower, and 
mAbs able to neutralize both BVDV and HCV have not been 
described. Weak neutralization of virus has also been 
described for mAbs reactive with gp44/48 of HCV/BVDV 
(Boulanger and others, 1991; Weiland and others, 1992). The 
gp48 mAbs raised against BVDV reacted with the majority of 
virus strains against which they were evaluated, including 
some strains of HCV (Moennig, 1990; Boulanger and others, 
1991) . By contrast, the gp44 mAbs prepared against HCV by 
Weiland and others (1992) discriminated between many 
isolates of HCV and some of those described by Wensvoort and 
others (1986) were specific for the HCV vaccinal "C" strain. 
A gp48 mAb has also been described which recognizes 
predominantly cytopathic biotypes of BVDV (Greiser-Wilke and 
others, 1991). MAbs reactive with the non-structural p!25/80 
protein have the broadest viral strain specificity, and some 
appear to be pan-reactive, recognising all strains of 
pestivirus (Moennig, 1990).
Wensvoort (1989) , used mAbs to map 13 epitopes on the gp55 
of HCV. He found four distinct domains, of which three were 
involved in virus neutralization. Some neutralizing mAbs
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whose epitopes clustered in a single domain recognised all 
strains of HCV and synergistic neutralization was observed 
between mAbs specific for different domains. Using mAb 
competition studies, three to four antigenic domains have 
been described for gp53 of BVDV (Moennig and others, 1989; 
Xue and others, 1990), but again, conserved, neutralizing 
epitopes were located within a single domain.
13 THE PATHOGENESIS OF PESTIVIRUS INFECTIONS
i) BVDV in cattle:
The pathogenesis of BVDV in cattle has been extensively 
reviewed (Duffel and Harkness, 1985; Brownlie and others, 
1987a; Harkness and Boeder, 1988; Radostits and Littlejohns, 
1988; Bolin, 1990a; Brownlie, 1991).
Natural infection with BVDV is common, but usually 
subclinical (Nuttall and others, 1980). Likewise, 
experimentally induced, primary postnatal infections with 
BVDV have produced little or no observable illness, in the 
vast majority of cases. However, acute infection in the 
field has occasionally been associated with outbreaks of 
disease characterised by diarrhoea, milk-drop and
oculonasal discharge and with a high level of morbidity 
(Perdrizet and others, 1987; Sol and others, 1989) and even 
mortality (Pritchard and others, 1989). Recently, acute 
infection with certain strains of BVDV has been associated
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with severe thrombocytopenia (Corapi and others, 1989 ;
Rebhun and others, 1989). In acute infections, viruses of 
either biotype multiply in many organs and in lymphoid 
tissues throughout the body, and different viruses may have 
different tissue tropisms (Wilhelmsen and others, 1990). 
Pathological changes observed include lymphoid depletion, 
lymph node haemorrhages and mild respiratory and enteric 
lesions (Carlson and others, 1957; Wilhelmsen and others,
1990). Viraemia is detectable between 5 and 14 days post 
infection (Nuttall and others, 1980). Acute BVDV infection 
may be immunosuppressive (Muscoplat and others, 1973; 
Pospisil and others, 1975; Atluru and others, 1979; Roth and 
others, 1983). It is commonly associated with other 
respiratory infections of calves (Richer and others, 1988) 
and may potentiate the effects of a variety of pathogens 
(Reggiardo and Kaeberle, 1981; Potgieter and others, 1984; 
Edwards and others, 1986; Wray and Roeder, 1987).
Acute infection of breeding animals can result in sperm 
abnormalities (Paton and others, 1989); infertility 
(Whitmore and others, 1981; Grahn and others, 1984; Carlsson 
and others, 1989) and fetal infection (Roeder and others,
1986). Fetal infection with non-cytopathogenic biotypes 
(Brownlie and others, 1989) occurs readily via the 
transplacental route, and the outcome depends largely on 
what stage of organogenesis and immunocompetence the fetus 
has attained (Duffell and Harkness, 1985). Differences 
between virus strains may also be significant. Prenatal
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death may result in resorption, mummification or abortion, 
whilst sublethal damage can lead to the birth of weak, 
growth-retarded animals with a variety of congenital 
abnormalities (Harkness and Roeder, 1988). Apparently normal 
animals may also be born that are either viraemic and 
seronegative or virus-negative and seropositive. Animals in 
the former category that have been infected in early 
gestation are immunotolerant to the infecting virus strain 
(McClurkin and others, 1984) and remain persistently
infected for the rest of their lives (Casaro and others, 
1971; Kahrs, 1973). They may grow normally, or become 
stunted, and they may show a wide range of abnormalities, as 
well as general unthriftiness and susceptibility to 
secondary infections. In addition, persistently infected 
animals may subsequently develop a fatal condition known as 
mucosal disease (Liess and others, 1974 ; Roeder and Drew,
1984). This is characterised by ulceration of mucosal 
surfaces and lymphoid depletion, and is caused by 
superinfection with a cytopathogenic biotype of BVDV 
(Brownlie and others, 1984; Bolin and others, 1985), that is 
antigenically similar to the persisting non-cytopathogenic 
virus (Brownlie and others, 1987b; Howard and others, 1987). 
It is proposed that the cytopathogenic virus arises by 
mutation from the persistently infecting non-cytopathogenic 
strain through recombination with cellular RNA (Meyers and 
others, 1989b). Superinfection of persistently infected 
cattle with heterologous cytopathogenic strains may induce a 
chronic wasting disease (Brownlie and others, 1987a).
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ii) BDV in sheep:
Reviews of the pathogenesis of BDV in sheep include those by 
Barlow and Patterson (1982), Terpstra (1985), Nettleton
(1987) and Harkness and Roeder (1988). Both mild (Vantsis 
and others, 1979 ; Roeder and others, 1983) and severe 
(Chappuis and others, 1986) forms of clinically apparent
postnatal disease have been reported. Nevertheless, 
postnatal infection is usually transient and generally 
asymptomatic and clinical border disease is mainly a feature 
of congenital infection. As with BVDV in cattle, fetal 
infection is most likely to be transplacentally derived and 
the outcome is influenced by fetal development (Nettleton, 
1987) and by viral virulence (Nettleton and others, 1992). 
Infection after fetal immunocompetence may result in virus 
elimination, although fetal damage may still occur, and 
indeed may be enhanced by the immune response (Barlow and 
Patterson, 1982). Fetal resorption, mummification, abortion 
and stillbirth are all possible outcomes, as is survival to 
term, with or without persistent virus infection. The almost 
pathognomonic, "hairy shaker'? lamb has a myelin deficiency 
of the central nervous system (Clarke and Osburn, 1978), 
abnormal hair follicles (Derbyshire and Barlow, 1976) and an 
abnormal conformation. Such disease is readily reproduced by 
experimentally induced infections in mid-gestation 
(Terpstra, 1978). As with BVDV in cattle, persistent 
infection is associated with a specific immune tolerance to 
the persisting strain of virus, and is usually lifelong. 
However, a case of spontaneous recovery from viraemia has
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been described (Nettleton and others, 1992). Although
persistently infected lambs often show illthrift and a range 
of abnormalities, especially chronic wasting (Nettleton and 
others, 1992), long term survival and apparent normality are 
possible (Terpstra, 1981). A fatal, late onset disease 
associated with superinfection of persistently infected 
animals with a cytopathogenic biotype of BDV does occur, 
although the syndrome is less well defined than that of 
mucosal disease of cattle (Barlow and others, 1983; 
Nettleton and others, 1992).
iii) HCV in pigs:
Pigs most commonly become infected oronasally, in which case 
the tonsil is the primary site of viral replication (Dunne 
and others, 1959). After the first phase of viraemia, there 
is widespread infection of immunological tissues, further 
viraemia, and finally invasion of parenchymatous organs 
(Ressang, 1973a,b). As with the non-cytopathogenic ruminant 
pestiviruses, the basis of cellular destruction is not 
known. Damage to endothelial cells combined with 
thrombocytopenia and other induced clotting abnormalities 
can result in infarction and haemorrhage (Trautwein, 1988). 
The virus readily crosses the placenta to establish fetal 
infections (Emerson and Delez, 1965b).
The severity of the lesions and their speed of onset, 
depends upon the virulence of the infecting strain of virus 
and postnatal disease ranges from peracute to subclinical.
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The disease caused by highly virulent strains is 
characterised by rapid virus replication to high titre, 
early onset of clinical signs, and a frequently fatal 
outcome. With less virulent viruses, virus replication is 
more restricted and complete recovery can occur, or else 
chronic infections may establish (Mengeling and Cheville, 
1968). In the latter cases, there may be a temporary 
remission of illness, associated with the appearance of HCV 
neutralizing antibodies. However, virus usually persists, 
and the pigs eventually die.
As with all the pestiviruses, the outcome of prenatal 
infection is extremely variable, depending on the stage of 
gestation at which infection occurs, and particularly for 
HCV, on the virulence of the infecting virus (van Oirschot 
and Terpstra, 1989). Nevertheless, low virulent strains and 
even some attenuated live vaccines may still be fetopathic 
(Meyer and others, 1981; Dunne and Clarke, 1968). Virus may 
cross the placenta at one or more sites and subsequently 
spread between fetuses (van Oirschot and Terpstra, 1989). 
Prenatal death is most likely with virulent virus strains or 
where low virulent viruses infect the embryo in early 
gestation. Teratogenic effects also tend to be most severe 
when infection is early in gestation, during organogenesis 
(Wrathall, 1975) . An example of this type of defect is 
cerebellar hypoplasia and hypomyelinogenesis leading to 
congenital tremor (Emerson and Delez, 1965a). Infection with 
viruses of low virulence before immunocompetence can result
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in the birth of persistently infected animals, that are 
immunotolerant to the infecting strain of virus (van 
Oirschot, 1977) and do not produce specific antibodies. The 
basis of this immunotolérance has not been established,
although virus induced damage to lymphoid cells and/or 
non-expression of viral antigens in infected cells have been 
postulated as possible mechanisms (van Oirschot, 1980). 
Despite viraemia, these animals often appear healthy at 
birth. However, they invariably die, even though illness may 
be delayed until many months into postnatal life (van 
Oirschot, 1979). The trigger for this late-onset disease is 
not known, but it has not been shown to be asociated with 
superinfection with cytopathogenic viruses. These pigs
commonly become stunted and often develop posterior paresis, 
but haemorrhages characteristic of acute infection are not 
observed. Postmortem lesions are few, but include thymic 
atrophy and swollen lymph nodes.
1.4 THE EPIDEMIOLOGY OF PESTIVIRUS INFECTIONS
i) Geographical distribution:
Pestivirus infections of domestic ruminants, particularly 
cattle, appear to be common throughout the world (Phillips, 
1983; Barlow, 1983), and eradication of BVDV/BDV on a 
nationwide scale has not been reported. In Britain, the 
seroprevalence of bovine infection has been estimated at
about 65% on an animal basis and 95% on a herd basis, whilst
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1.8% of cattle have been found to be persistently infected 
(Edwards and others, 1987). Ovine infection is somewhat less
common (Barlow and others, 1982). HCV has been eradicated
from Britain and many other countries by national
stamping-out policies based on the tracing and slaughter of
affected pig herds. However, complete eradication of the 
disease from Western Europe has not yet been achieved 
(Westergaard, 1992), whilst the virus is still endemic in 
parts of Asia, and Central and Southern America (Welte, 
1991).
ii) Ruminant Infections:
The major reservoirs of infection for healthy stock are 
acutely or persistently infected animals, particularly the 
latter, which shed virus continuously and to higher titre 
(Duffel and Harkness, 1985; Nettleton, 1987). Virus is 
present in all body secretions, especially oronasal fluids, 
but also in milk, faeces, urine, tears, semen and uterine 
flushings (Baker, 1987). Virus transmission by inhalation or 
ingestion may follow direct contact between animals or occur 
indirectly, such as via contaminated bedding or food. 
Parenteral transmission by contaminated flies and needles 
may also occur (Edwards and others, 1990b; Roeder and 
Harkness, 1986). The virus will not survive for prolonged 
periods in the external environment (Baker, 1987), however, 
conditions for storage of semen and embryos also preserve 
virus infectivity and artificial insemination can spread 
infection to the recipient animal (McClurkin and others,
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1979 ; Paton and others, 1990). Pestivirus contaminated fetal 
calf serum has the potential to spread infection through its 
use in embryo transfer (Bolin, 1990b) and vaccine 
manufacture (Spais and others, 1975; Loken and others,
1991). Airborne transmission between herds is probably not 
significant. Vertical transmission via the transplacental 
route readily occurs from both acutely and persistently 
infected dams (Westbury and others, 1979; Terpstra, 1981; 
Radostits and Littlejohns, 1988). Persistent infections are 
always with non-cytopathogenic biotypes and these are the 
most important in transmission between animals (Bolin, 
1990a). Cytopathogenic viruses arise mainly de novo, in 
individual persistently infected animals (Brownlie and 
others, 1987a; Meyers and others, 1989b). However, in groups 
of animals that are all persistently infected with the same 
non-cytopathogenic virus, a cytopathogenic virus that has 
appeared in one animal can spread to the others, leading to 
a mucosal disease outbreak.
iii) Porcine infections:
Infected pigs can shed virus in a wide range of body fluids, 
even before the onset of clinical disease. Both the level 
and duration of shedding depends on viral virulence and the 
age and immune status of the pig. Other pigs may become 
infected via the oral, nasal, aerogenic, conjunctival, 
genital and various parenteral routes (Terpstra, 1987). Many 
of the same routes of pestivirus transmission apply for pigs 
as for ruminants, although transmission between pigs is
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likely to be facilitated by their generally more intensive 
management. In addition, feeding pigs infected meat that has 
not been adequately cooked is a very important means of 
spreading HCV (Doyle, 1933). The so called "carrier sow" is 
an animal that has recovered from disease, but will 
nevertheless give birth to virus-shedding piglets because of 
earlier in utero infection (Huck & Aston, 1964). In high pig 
density regions, man is an important cause of mechanical 
spread between farms (Terpstra, 1987).
1.5 CROSS-SPECIES INFECTIONS
This subject has been reviewed by Harkness and Boeder 
(1988). Since many ruminant pestivirus isolates are 
pathogenic for both cattle and sheep (Snowdon and others, 
1975; Parsonson and others, 1979; Jewett and others, 1990), 
virus exchange between the two species under field 
conditions is very likely (Duffel and Harkness, 1985), 
although rarely documented (Nettleton, 1987; Carlsson, 
1991a; Loken and others, 1991). Antigenic and genomic 
comparisons of ruminant pestiviruses support this view, 
suggesting that a proportion of bovine isolates are 
BDV-like, whilst a proportion of ovine isolates are 
BVDV-like (Vantsis and others, 1979 & 1980; Nettleton, 1987; 
Edwards and others, 1988; Wensvoort and others, 1989a; Berry 
and others, 1992; Dekker and Wensvoort, 1992). Serological 
evidence shows that pestiviruses infect goats in the field
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(Taylor and others, 1977), and goats have been
experimentally infected with pestiviruses isolated from 
cattle, sheep and pigs. In each case this may result in 
prenatal disease (Barlow and others, 1975; Shimuzu and
Kumagai^ 1989 ; Depner and others, 1990, Loken, 1987).
Experimentally induced infections of ruminants with HCV have 
been subclinical, (Loan and Storm, 1968 ; Dahle and others, 
1987; Harkness and Roeder, 1988), whilst field cases have 
not been reported.
Naturally occurring infection of pigs with ruminant-type 
pestiviruses has been documented by serology (Table 1.2) and 
virus isolation (Fernelius and others, 1973; Carbrey and
others, 1976; Terpstra and Wensvoort, 1988; Roehe, 1991).
Ruminant contact probably accounts for many of these 
infections and pigs kept on the same premises as cattle have 
been shown to have a significantly higher BVDV 
ser©prevalence than pigs kept on their own (Terpstra and 
Wensvoort, 1992). Field cases of ruminant-type pestivirus 
infection in pigs have also been associated with the use of 
live vaccines contaminated with BVDV/BDV (Vannier and 
others, 1988; Wensvoort and Terpstra, 1988b). Available
evidence from both naturally occurring and experimentally 
induced ruminant-type pestivirus infections of pigs suggests 
that postnatal infections are transient and subclinical, 
even after repeated virus passage through pigs (Chen and 
others, 1976). Prenatal porcine infection with ruminant-type
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Table 1.2 Serological prevalence of ruminant-type pestivirus 
infections in pigs from different countries.
Country % Seroprevalence Authors
Australia 53 Snowdon & French (1976)
Denmark 6.4 Holm Jensen (1985)
England 1.1 Sands and Harkness
(personal communication)
6.5 Paton and others (1991a)
Germany 20-40 Liess and others (1976)
Ireland 26 Lenihan & Collery (1977)
19 O'Connor and others (1991)
Netherlands 19.3 (boars) Terpstra and Wensvoort
21.3 (sows) (1992)
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pestiviruses can also occur, although not all such viruses 
readily cross the placenta (Stewart and others, 1971; Dahle 
and others, 1987). The effects of in utero infection are
variable (Leforban and others, 1990a), but rather similar to 
the consequences of prenatal infection with low virulent 
strains of hog cholera (van Oirschot, 1979; Plateau and 
others, 1980). The range of outcomes include prenatal
damage, death or recovery and either immediate or delayed 
postnatal illness. Occasional pigs will remain persistently 
infected for prolonged periods (Terpstra and Wensvoort,
1992). Pigs that have recovered from infection with ruminant 
pestiviruses are often protected against challenge with 
virulent strains of hog cholera (Beckenbauer and others, 
1961).
Whether or not pestiviruses circulate between domestic and 
free-living ruminants is not established, but the latter can 
certainly become infected (Nettleton, 1987 & 1990). The
relationship of these viruses to domestic ruminant strains 
has not been well studied but two viruses isolated 
respectively from a deer (Edwards and others, 1988) and a 
giraffe (Plowright, 1969) appeared to be antigenically 
distinct from strains of BVDV and BDV (Dekker and Wensvoort, 
1992; Cay and others, 1989) . Wild boar (Sus scrofa ferus) 
can be important reservoir hosts for hog cholera infection 
of domestic pigs (Westergaard, 1992).
The possibility of human infection with pestiviruses has
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been considered, but such evidence as has been found is not 
yet convincing (Giangaspero and others, 1988; Yolken and
others, 1989).
1.6 THE IMMUNE RESPONSE TO PESTIVIRUSES
i) Humoral immunity:
Specific antibodies are produced by ruminants and pigs 
following acute infections with pestiviruses, and these 
antibodies can be virus neutralizing in vitro and protective 
in vivo (Benner, 1928; Shope and others, 1976; Howard and
others, 1989). The development of systemic antibody is 
sometimes rather slow, with first detection not until two to 
three weeks post-infection and with levels continuing to 
rise for many weeks thereafter (Liess, 1988 ; Brownlie,
1991). In pigs, it has been suggested that more virulent 
strains of HCV induce antibody more rapidly and to higher 
titre compared to low virulent strains (Loan and Rodabaugh, 
1966). Pestivirus antisera . cross-neutralize heterologous 
strains of the virus to variable extents, depending on the 
antigenic relationship between the different virus strains 
(Snowdon and French, 1968). Furthermore, pestivirus
challenge after prior infection with a different strain, 
leads to an anamnestic antibody response (Horzinek, 1981). 
Serum antibody persists for a long time after pestivirus 
infections, and probably indefinitely (Kahrs and others, 
1966; Ehrensperger, 1987).
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Prenatal pestivirus infections before immunocompetence can 
lead to a specific immunotolérance, whereby antibodies to 
the persisting strain are usually not produced (McClurkin 
and others, 1984), even in later life when antibody
responses to other antigens (van Oirschot, 1977), including 
heterologous pestiviruses (Brownlie and others, 1987b) may 
be relatively normal. Some non-specific abnormalities in the 
immunological responsiveness of lymphocytes from 
persistently infected cattle have however been noted 
(Muscoplat and others, 1973). Immunocompetence of the
porcine fetus to HCV seems to develop later than for other
porcine viruses, and may not be complete even at birth
(Ehrensperger, 1987). Occasionally this immunotolérance
breaks down leading to the production of antibody to the 
persisting strain (Edwards and others, 1991a), and sometimes 
to clearance of virus (Nettleton and others, 1992; Terpstra 
and Wensvoort, 1992). Pigs may also become chronically 
infected with HCV following postnatal infection and in these 
cases antibody may or may not be produced (Mengeling and 
Cheville, 1968). Colostral antibody can protect pigs from 
virulent HCV for the first 5 weeks of life (van Oirschot and 
Terpstra, 1989), although virus replication can still occur. 
In both ruminants and pigs, colostral antibody will 
temporarily mask the viraemia in persistently infected 
animals (van Oirschot and Terpstra, 1977; Meyling and
Jensen, 1987).
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ii) Cell mediated immunity:
The role of cell mediated immunity in pestivirus infections 
has not been established. However, in acute BVDV infections, 
virus clearance from the blood precedes the development of 
detectable antibodies (Howard and others, 1992).
Furthermore, Rumenapf and others (1991) have shown that for 
HCV, it is possible to induce protective immunity in the 
absence of a detectable neutralizing antibody response.
1.7 THE LABORATORY DIAGNOSIS OF PESTIVIRUS INFECTIONS
The diversity of disease that can be induced by pestiviruses 
in both ruminants and pigs is such as to make clinical 
diagnosis uncertain in many situations. Failure to recognise 
pestivirus involvement in disease can be very damaging, and 
a particularly important instance of this would be failure 
to diagnose hog cholera at an early stage, if it appeared in 
a disease-free country such as Britain. Laboratory diagnosis 
is also the only means of recognising virus carrier animals 
that are not showing illness or of identifying stock that 
are already immune.
As with many other infectious diseases, laboratory 
techniques fall into two categories: detection of the agent, 
or detection of agent-specific antibodies.
\
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I) Virus detection:
Pestiviruses can be grown fairly readily in vitro and the 
susceptibility of different primary and continuous cell 
cultures has been reviewed by Horzinek (1981). Immunological 
staining of cytoplasmic antigens with pestivirus-specific 
antibodies is the most widely used method of identifying 
virus thereafter (McNulty and Allan, 1984; Katz and others,
1987). It is vital that fetal calf serum used as a cell 
culture supplement is screened to eliminate batches that are 
contaminated with traces of either BVDV (Nuttall and others, 
1977) or anti-BVDV antibodies (Edwards, 1990b). In vitro
characterization of viruses isolated in culture involves 
testing for neutralization by reference antisera and for 
recognition by discriminatory mAbs. This will distinguish 
HCV from ruminant pestiviruses, and allows the ruminant ones 
to be compared with reference strains of BVDV and BDV. A 
more rapid method of virus detection is indirect fluorescent 
antibody (IFA) labelling of tissue cryostat sections (Stair 
and others, 1963 ; Meyling, 1970). A polyclonal antibody is 
usually used for primary diagnosis, which may be followed up 
by typing with discriminatory mAbs (Anon, 1991). Recently, 
ELISAs have been developed for the detection of pestivirus 
antigens in tissue or blood samples (Fenton and others, 
1990; Mignon and others, 1991; Shannon and others, 1991).
These tests rely on broadly reactive (anti-pl25/80) 
monoclonal antibodies and are less labour intensive than 
IFA.
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An alternative to testing for virus antigen is to look for 
viral RNA, using either DNA probes (Brock and others, 1988); 
or reverse transcription, followed by the polymerase chain 
reaction (Schroeder and Balassu-Chan, 1990; Roehe and 
Woodward, 1991). These methods are potentially very
sensitive and should be able to offer a variety of strain 
specificities. Although there have been many reports of the 
laboratory development of such tests, they are not yet 
widely used in routine diagnosis.
The applications of virus detection tests include 
investigative diagnosis of disease, screening for persistent 
infection and screening for pestivirus contamination of 
semen, embryos, fetal calf serum, cell cultures, vaccines 
and other biological reagents.
ii) Serology:
Serological techniques have been continuously adapted and 
improved, and reviews of early methods can be found in Liess
(1988) and Edwards (1990b). Currently, tests are mainly of 
two types: virus neutralization tests (VNT) and enzyme
linked immunosorbent assays (ELISA). VNTs measure the 
ability of sera to neutralize cell culture infectivity of 
given pestiviruses at a range of serum dilutions. They are 
the most widely used and accepted reference tests for 
pestivirus serology. The tests take 3-5 days to perform and 
virus growth is assessed by either cytopathic effects or by 
immunological staining with fluorescein or peroxidase
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conjugated antibodies (Holm Jensen, 1981). Neutralization 
will be maximal when the virus used in the test is the same 
as that which elicited the antibody response. When the two 
viruses are very dissimilar, cross-neutralization may be 
minimal or absent (Horzinek, 1981), depending in part on the 
level of antibody present. This has both diagnostic 
advantages and disadvantages. It means that differentiation 
between heterologous pestiviruses such as HCV and ruminant 
strains is possible using comparative VNTs (Corthier and 
others, 1974). However, where a single reference strain of
virus is used, for instance in ruminant serology, there is 
the danger that low level antibody elicited by a 
heterologous pestivirus may be overlooked (Brockman and 
others, 1988).
ELISAs offer automation, more rapid testing, and a range of 
specificities. They are mostly based on the binding of serum 
antibody to cell lysate antigens, detected by anti-species 
immunoconjugates or by displacement of specific pestivirus 
antibody reagents. Recently, genetically engineered antigens 
have also become available (Lecomte and others, 1990; Kwang 
and others, 1992; Petrie and others, 1992). ELISAs can be 
divided into those that detect antibodies to a broad 
spectrum of pestiviruses and those that are more strain 
specific. The former are mainly indirect ELISAs that measure 
serum antibody binding to all available epitopes of a given 
cell lysate virus antigen (Howard and others, 1985), or to 
specific, conserved epitopes (Fenton and others, 1991).
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Competitive tests using broadly reactive mAbs also recognise 
a broad spectrum of antibodies (Paton and others, 1991a).
Strain-specific tests have been based on competitive assays 
using polyclonal antibodies (Leforban and others, 1990b) or 
discriminatory mAbs (Wensvoort and others, 1988).
Serology is used to diagnose a previous pestivirus 
infection. Since antibodies to pestiviruses persist long 
after infection, proof of recent infection requires 
demonstration of a rising antibody titre. This is most 
important in attributing disease to common infections, such 
as BVDV and BDV. By contrast, in Britain, where HCV does not 
occur, any seroreaction specific to this virus would be 
considered significant. Since transplacental antibody 
transfer does not occur in pigs or ruminants, specific 
antibody in precolostral samples from unborn or newborn 
animals is diagnostic for prenatal infection. The effect of 
colostrally derived antibody on both virus isolation and 
serology must always be considered in young animals.
1.8 THE CONTROL OF PESTIVIRUS INFECTIONS
Control of livestock diseases is usually attempted at either 
a herd or area level. Prerequisites for control of a 
contagious infection are: 1) recognition of the disease in 
question; 2) an understanding of the major risk factors 
contributing to disease transmission and 3) a policy of
44
intervention to eliminate existing infections and/or reduce 
transmission.
I) Management procedures/slaughter policies:
In Britain, as in a number of other countries, HCV has been 
eradicated by the detection and slaughtering of all infected 
pig herds. Adeguate laboratory diagnostic tests are 
essential, especially for the detection of low virulence 
strains. In addition, the capacity to trace animal movements 
on and off affected premises, and to establish other common 
spread factors is vital in the identification of all farms 
linked to a particular outbreak. Once a disease-free status 
has been obtained, a monitoring programme must be 
established to ensure that newly introduced infection would 
be rapidly recognised. Steps must also be taken to reduce 
the risk of réintroduction through importation of pigs and 
pig products.
The eradication of pestiviruses from sheep or cattle on a 
national scale has not been reported and cross-species 
transmission between sheep, cattle and wild ruminants makes 
the proposition rather challenging. Nevertheless, in Norway 
BVDV is already notifiable and a national programme for 
eradication has been prepared (Loken and Krogsrud, 1992). At 
a herd level, freedom from infection may be sought by 
elimination of persistently infected animals, screening of 
new stock and use of semen from certified BVDV-free bulls
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(Harkness, 1987). There is still the possibility that 
infection may continue to be transmitted between acutely 
infected animals, even after persistently infected carriers 
have been removed (Moerman and others, 1992). An alternative 
that has been occasionally advocated is retention of a 
persistently infected animal in the herd and controlled 
exposure of other cattle. The idea is that all stock will 
become infected and immune, before the onset of breeding age 
(Duffel and Harkness, 1985; Cook and others, 1990).
ii) Vaccines:
Modern HCV vaccines are mainly live ones, attenuated by 
passage in cell cultures or rabbits (Biront and Leunen,
1988). They are stable and avirulent, even for pregnant 
animals (Overby and Eskildsen, 1977) and confer long-lasting 
immunity. Given at high doses, they can prevent the 
replication of virulent virus as well as protecting against 
disease (Leunen and Strobbe, 1977). Their systematic use in 
conjunction with suitably enforced management procedures can 
significantly contribute to HCV eradication (van Oirschot 
and Terpstra, 1989). One problem with their usage, is that 
piglets born to vaccinated sows may not respond to 
vaccination until colostral immunity wanes after a variable 
period (Sasahara, 1970). Although the widely used ”Chinese" 
strain of vaccine can be differentiated from field viruses 
using mAbs (Wensvoort and others, 1986), no serological
differentiation is available. Recently, two potential 
recombinant HCV vaccines involving insertion of glycoprotein
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genes into either Aujeszky's disease virus (van Zijl and 
others, 1991) or vaccinia (Rumenapf and others, 1991), have 
both been shown to protect pigs against HCV challenge. A 
baculovirus-based recombinant protein has also been shown to 
be protective (Moormann and others, 1992). It is to be hoped 
that with new vaccines, it will be possible to distinguish 
serologically between vaccinated and naturally infected 
animals.
Live attenuated and inactivated BVDV vaccines have been 
widely used in some countries, but their ability to protect 
against fetal infection following heterologous viral 
challenge is in doubt (Harkness and others, 1987; Bolin and 
others, 1991). The extent of antigenic diversity amongst 
pestiviruses is still not fully established, let alone the 
degree to which immunity to particular strains or strain 
combinations would be cross-protective. Further doubts have 
arisen as to the safety of modified live vaccines, some of 
which have proved to be fetopathic (Kahrs, 1968), 
immunosuppressive (Roth and .Kaeberle, 1983) and possibly 
even able to induce mucosal disease if given to persistently 
infected animals (Peter and others, 1967). Temperature
sensitive vaccine strains of low pathogenicity have been 
developed (Lobmann and others, 1984) that do not cause fetal 
infection (Lobmann and others, 1986). Novel approaches to
the development of improved vaccines have included the use 
of an immunostimulating complex (ISCOM) subunit vaccine 
(Carlsson and others, 1991b) and vaccinia/BVDV recombinant
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vaccines incorporating BVDV glycoproteins (Dale and others, 
1987; Lecomte and others, 1992). Baculovirus recombinants
are also being examined (Lecomte and others, 1992).
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2.1 INTRODUCTION
This chapter describes some of the more routine materials 
and methods that were applied to this study. Applications 
specific to a particular piece of work are mostly dealt with 
alongside the appropriate experiments.. Reagent formulae 
are to be found in the Appendix. Reagents for molecular 
biology were as described by Sambrook and others (1989a,b,c) 
or as recommended by cited manufacturers/suppliers.
2.2 CELL CULTURES 
I) Growth and maintenance of cell cultures:
Three different cell culture types were used:
1) A semi-continuous pig kidney cell line (PK15)
2) A semi-continuous bovine turbinate cell line (BT)
3) A non-continuous culture of calf testis cells (CT) 
All three cell types were grown in minimal essential medium 
(MEM) with 10% bovine fetal. calf serum (PCS) . PK15 cells 
were split twice weekly at a ratio of 1:4, whilst BT cells 
were split once weekly at a ratio of 1:2. CT cells were 
prepared by trypsinization of calf testes as described by 
Paul (1970). A stock of second passage cells was frozen in 
multiple aliquots in liquid nitrogen. These cells were 
thawed and passaged every 4-5 days with a 1:4 split ratio. 
They were not kept beyond passage 10.
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Passage of cell cultures. Trypsin was used to disperse 
monolayers into cell suspensions for seeding new cultures in 
flasks, tube cultures or microtitre plates. The growth 
medium was discarded and the cell monolayer was washed twice 
with prewarmed (37°C) antibiotic-trypsin-versene solution 
(ATV). A third volume of ATV was added in sufficient 
quantity to just cover the monolayer and the culture vessel
was returned to the 37°C incubator for 10 minutes. Cells
were dispersed by repeated pipetting and then diluted with 
an appropriate volume of MEM containing 10% PCS.
Checks for pestivirus contamination. Because of the danger 
of inapparent contamination of cell cultures with
non-cytopathogenic pestiviruses, all batches of PCS used at 
the Central Veterinary Laboratory (CVL) were routinely
screened for pestivirus contamination. In addition whenever 
cultures were used to isolate or multiply viruses, negative 
and positive control cultures were always processed 
concomitantly. Before acceptance for use in pestivirus work, 
all batches of PCS were also screened routinely for the 
presence of pestivirus growth inhibitors.
2 3  VIRUS PROPAGATION AND DETECTION
i) Reference strains of virus:
Viruses were stored as clarified culture fluids at -70°C.
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The Oregon C24V strain of BVDV (Gillespie and others, 1960) 
was cloned by three cycles of limiting dilution and then 
passaged once more prior to use (a total of 67 in vitro
passages). The NADL strain of BVDV (Gutekunst and Malmquist,
1963) had been twice plaque purified and then passaged 7 
times before use (a total of 12 in vitro passages). Both 
these strains of BVDV are cytopathogenic (Fig 1.2). A 
non-cytopathogenic BVDV (ncpl44800) used in Chapter 5 for 
rad io immunoprec ip itat ion was a field isolate obtained from 
the serum of a cow that died of mucosal disease. Primary 
isolation and subsequent replication (up to passage 7) was 
on BT cells and included biological cloning by three cycles 
of limiting dilution.
ii) Virus isolation:
Samples for virus isolation (tissues or sera) were either 
processed on arrival at the laboratory, or after storage at 
-70°C. Tissues were homogenised by grinding with sterile 
sand in Griffith's tubes, so as to yield approximate 10%
suspensions in sterile PBS pH 7.2, with 10X antibiotics. The
suspensions were clarified by centrifugation at 2000g for 10 
minutes. Samples were then added to nearly confluent cell 
monolayers grown in 25cm2 plastic flasks (inoculated with 
1ml of sample) or on flying coverslips in tube cultures 
(inoculated with 0.2ml of sample). After incubation at 37°C 
for one hour, the monolayers were washed with PBS pH7.2 and 
then overlaid with growth medium. The cultures were 
incubated for 4 days at 37°C, whereupon coverslips were
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fixed in acetone, whilst flask contents were frozen and 
thawed prior to subpassage. Untreated sera were used as 
inocula as above, or else were added to cell suspensions at 
the time of seeding new cultures.
iii) Microtitre virus detection by peroxidase-linked assay:
The method is based on the peroxidase-linked assay (PLA) of 
Holm Jensen (1981).
Growth of virus. Ninety-six well, plastic, tissue culture 
grade, microtitre plates (Nunc) were used. Since viral 
inocula must be non-cytotoxic, the method was used for 
primary isolation from sera but not from tissue homogenates. 
The technique was also used for immunocharacterization of 
viruses prepared in previous cultures. Samples of serum or 
tissue supernatant were either added to the wells before the 
addition of a cell suspension, or else were inoculated 
directly into the cell suspension before this was dispensed 
into the wells. For virus isolation, IOjjI of undiluted serum 
or tissue culture supernatant was added into each of 4 wells 
in a microplate. Alternatively, serial dilutions of the 
sample were dispensed in quadruplicate if an estimation of 
viral titre was required. Negative and positive virus 
control samples were included on each plate with the 
positive control wells being set out last. BTs, CTs and 
PKISs all gave good results with this method and 50-100pl 
of cell suspension was added to each well at a 
concentration of between 1.0 and 3.0 X 105 cells per ml. The
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plates were sealed with a self-adhesive plastic film and 
were incubated in a moist, 5% C02 atmosphere at 37°C. The 
plates were examined microscopically to determine cell 
morphology and after 2-4 days, they were processed for 
detection of virus-specific antigens. The medium was 
discarded and the cells were fixed in, situ by 10 minutes 
incubation at room temperature with PLA fixation fluid. The 
plates were blotted and further dried under a bench lamp for 
three hours, at approximately 25°C. If not to be stained 
immediately, plates were stored in sealed plastic bags at 
-20°C.
Immunostaining procedure. All reagents were dispensed into 
the plates with a multichannel pipette and other than PLA 
wash fluid all volumes were 50pl/well. Wash fluid was 
dispensed at 0.2ml/well/wash. All incubations were at 37°C 
for 15 minutes. After washing, plates were blotted dry 
before addition of further reagents. Plates were first 
rehydrated with 0.01M PBS pH7.6 and then incubated with mAb 
at a predetermined concentration in PLA diluent. For 
non-discriminatory staining of all pestiviruses, a 
pan-pestivirus reactive mAb was used (WB105c, see Chapter 
5). After three washes, plates were incubated with a rabbit 
anti-mouse-IgG antibody conjugated to horse-radish 
peroxidase (Dako) at a 1 in 150 dilution in PLA diluent. 
After three washes with wash fluid and a fourth with 
distilled water, the plates were incubated with substrate. 
Finally, the substrate was shaken out and replaced with wash
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fluid. The plates were read either immediately or after 
overnight storage at 4°C. Microscopically, virus positive 
cells recognised by mAbs have a red-brown stained cytoplasm, 
with virtually no background staining.
Iv) Direct fluorescent antibody test for HCV:
This was performed on either 5 micron thick cryostat 
sections of tissues or on cell monolayers. These were 
mounted or grown on glass coverslips, which were then fixed 
in acetone for 10 minutes. The coverslips were rehydrated 
with 0.01M PBS pH 7.6 and then overlaid with a fluorescein 
isothiocyanate (FITC) conjugated hog cholera-specific 
antiserum, diluted 1/20 in PBS. After incubation and 
washing, the coverslips were counterstained with Evan's 
Blue, before mounting for UV microscopy.
v) Biological cloning of viruses:
This was achieved by three cycles of limiting dilution, 
using the PLA and 96 well microtitre plates. Each virus was 
titrated on a single plate in. tenfold steps, in 12 replicate 
columns, before addition of an appropriate cell suspension 
and incubation for four days at 37°C. Supernatant fluids 
from each well were retained, whilst the cells were 
immunostained with a pan-pestivirus reactive mAb (WBlOSc). 
The twelve supernatants from the wells showing 
virus-specific staining at the highest dilution, were used 
to start a new cycle of titrations and virus growth. After 
the third cycle, end-point supernatants were used to grow a
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stock of cloned virus in 25cm2 cell culture flasks. 
Production of a biologically cloned stock therefore required 
an additional four cell culture passages.
2.4 SERUM-VIRUS NEUTRALIZATION TESTS (VNTs)
i) Test procedure:
The method was based on the neutralizing peroxidase-linked 
assay (NPLA) of Holm Jensen (1981). All sera tested had been 
heat treated at 56°C for 30 minutes and were stored at -20°C 
prior to testing. Fifty microlitre volumes of sera at 
various dilutions were incubated in 96 well microplates 
(Nunc) for one hour at 37°C with an equal volume of medium 
containing approximately IOOTCID50 of virus. The addition of 
cell suspension, and the incubation, fixation and staining 
of the plates were as described for the PLA. Antibody titres 
were calculated by the Spearman-Karber method (Lorenz and 
Bogel, 1973) and expressed as the reciprocal of the dilution 
of serum (prior to admixture with virus) able to neutralize 
50% of virus replicates. For graphical displays of 
seroconversion, logarithmic (log10) values were used.
Ii) Reference antisera:
A panel of ten reference antisera against ruminant-type 
pestiviruses were used for cross-neutralization tests. Nine 
of these sera were from sheep, and one was from a pig. Each 
was raised against a different virus, the viruses having
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been selected from mAb studies as being representative of a 
range of different antigenic types (Table 2.1). The 
hyperimmune BDV antisera (pAb 7145) used for 
rad i o immunoprec ip itat ion had been raised in a gnotobiotic 
calf by repeated inoculation with a pool of five virus 
strains. The hyperimmune HCV anti serum used in the direct 
fluorescent antibody test had been raised by repeated 
inoculation of specific pathogen free pigs with a low 
virulent strain of HCV.
2.5 MONOCLONAL ANTIBODIES
Monoclonal antibodies used in this study were mainly raised 
against BVDV strains Oregon C24V and NADL at CVL (Edwards 
and others, 1988). Their production involved inoculation of 
mice with concentrated infectious virus. Following spleen 
cell fusions, hybridoma supernatants were screened for 
anti-pestivirus activity by an indirect immunoperoxidase 
assay, using infected and uninfected cell monolayers fixed 
with 20% acetone (peroxidase-linked assay: PLA, Holm Jensen, 
1981). Seventeen hybridomas giving virus-specific reactions 
were cloned by two cycles of limiting dilution. Further 
supplies of the mAbs were prepared either in mice or from 
tissue cultures. For the former, pristane primed mice were 
inoculated intraperitonea1ly with hybridoma cells and were 
killed in order to harvest ascitic fluids after 
approximately 2 weeks. Ascitic fluids were clarified by
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Centrifugation and then stored in aliquots at -20°C. Tissue 
culture supernatants from hybridoma cultures were 
concentrated by ammonium sulphate precipitation and then 
also stored at -20°C. The immunoglobulin class and subclass 
of each mAb as determined by agar gel immunodiffusion 
against reference antisera is shown in Table 2.2, which also 
shows the neutralizing titre of each mAb for the two 
parental strains of BVDV: NADL and Oregon C24V (Sands,
personal communication). There was no enhancement of 
mAb-induced neutralization of these viruses in the presence 
of guinea-pig complement (Sands, personal communication). 
CVL mAbs raised against HCV and used in Chapter 3 to type 
field isolates have also been described (Edwards and Sands, 
1990a) . All CVL mAbs have the prefix WB (Weybridge BVDV) or 
WH (Weybridge HCV). Some additional mAbs raised against BVDV 
and known to be gp53-specific (Bolin and others, 1988) were 
supplied by Prof Moennig from Hannover University. These 
have a CA prefix (Table 2.3).
2.6 MOLECULAR BIOLOGY
i) Agarose gel electrophoresis:
Complementary DNA was analysed and extracted using 
horizontal, agarose gel electrophoresis. Gels were of 1% 
agarose (Sigma) or 2% low melting point agarose (Sigma). A 1 
Kb DNA ladder (BRL) was used as molecular weight markers. 
Samples were diluted in loading buffer prior to
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electrophoresis at a constant potential difference of 100 
volts. After approximately 45 minutes, the power was 
switched off and the gels were stained by immersion in 
ethidium bromide (O.Spgml-1) . Gels were examined under UV 
light and photographed with a C.U.5 camera (Polaroid). DNA 
was extracted from low melting point gels by cutting out 
specific bands. Subsequent DNA elution and purification used 
a silica matrix supplied in kit form (Prepagene ™, Biorad).
ii) Sequencing gel electrophoresis:
Sequencing reactions were analysed by separation on 6% 
polyacrylamide-urea gels. Wedge gels were cast which tapered 
in thickness from 1.0mm - 0.4mm. Using sharks-tooth combs 
and loading 1 .5pl of sample per lane, up to 18 sequencing 
reactions could be loaded per gel. Gels were prerun for 30 
minutes at 1000 volts before sample application. Thereafter 
voltage was stepped down gradually until the current had 
fallen to 45mA. At this point, a constant current was 
employed until the end of electrophoresis.
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Table 2.1 Experimental reference sera used for
cross-neutralization tests.
Antiserum Challenge Species Virus Homologous
reference virus origin mAb neutralizing
number of virus type antibody
2149 166312 Bovine B7 1280
2148 144800 Bovine A3 160
2185 A1050 Bovine A1 2560
2186 168485 Bovine A5 480
2187 150022 Bovine A2 ^10240
2188 156672 Bovine B6 640
2189 153735 Bovine A4 3840
6130 BDV 87/6 Pig U/C 320
2147 Deer Deer U/C 3840
2154 Giraffe Giraffe U/C 960
All sera were raised in sheep, except 6130, raised in a pig. 
Virus mAb type is from a classification of British ruminant 
pestiviruses on the basis of reactivity with a panel of 22 
mAbs (Edwards and others, 1988). U/C = unclassified. Al-5 = 
viruses that reacted with nine or more mAbs. B6-7 = viruses 
that reacted with 8 or less mAbs. Homologous neutralizing 
antibody expressed as reciprocal of titres able to 
neutralize 50% of viral replicates at IOOTCID50.
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Table 2.2 IgG subclass and neutralizing titre of monoclonal 
antibodies.
IgG Neutralizing titre for
Subclass NADL Oregon C24V
NADL mAbs
WB158n 1 3200 , <50
WB160n 1 <50 <50
WB166n 1 6400 <50
WB170n 1 <50 <50
WB212n 1 <50 <50
WB214n 1 £6400 £6400
Oreaon
C24V mAbs
WB103C 1 <50 <50
WB105C 2a <50 <50
WB106C 2a <50 <50
WB109C 1 <50 <50
WB112C 2a <50 <50
WB115C 1 <50 <50
WB162C 1 <50 1600
WB163C 2a <50 3200
WB165C 2a <50 <50
WB210C 1 <50 <50
WB215C 2b <50 1200
Data courtesy of J. Sands. All BVDV mAbs produced at 
Weybridge have been given the prefix WB followed by a unique 
number. MAbs raised against BVDV NADL end in the letter "n", 
whilst those raised against BVDV Oregon C24V end in "c". 
Neutralization titres are expressed as the reciprocal of the 
logio dilution able to neutralize 50% of replicate wells 
containing approximately IOOTCID50 of virus. MAbs were in 
the form of ammonium sulphate precipitated, 10X concentrated 
tissue culture supernatants.
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Table 23 MAbs from Hannover
MAb Parental virus Protein specificty Neutralization
CA1 NADL gpss yes
CA36 7443 gp53 yes
CA39 7443 gp53 yes
CA82 Singer gp53 yes
Data taken from Mateo (1988) . Parental viruses were the
cytopathogenic BVDVs: NADL and Singer and the
non-cytopathogenic BVDV: 7443. Neutralization = able to 
neutralize parental virus.
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3.1 INTRODUCTION
Natural infection of pigs with ruminant pestiviruses (bovine 
viral diarrhoea virus: BVDV and ovine border disease virus: 
BDV) has been documented by serological surveys (Snowdon and 
French, 1968) and by occasional virus isolations (Fernelius 
and others, 1973). In the majority of cases such infections 
appear to be subclinical, but they have sometimes been 
associated with reproductive or neonatal illness, consistent 
with congenital infection (Terpstra and Wensvoort, 1988). 
They have generally been attributed to either the use of 
pestivirus contaminated vaccines (Vannier and others, 1988; 
Wensvoort and Terpstra, 1988) or to contact between pigs and 
ruminants (Terpstra and Wensvoort, 1992). Such cases can 
readily lead to suspicion of hog cholera, as occurred in 
Britain in 1987 (Roehe, 1991). In the laboratory, 
discrimination between ruminant pestiviruses and hog cholera 
is most often attempted by the use of type-specific mAbs 
(Edwards and others, 1991b), cross-neutralization tests with 
reference virus strains and antisera (Wensvoort and others, 
1989a) and HCV-specific ELISAs (Wensvoort and others, 1988).
Experimental studies have tended to confirm that postnatal 
infection of pigs with ruminant pestiviruses is asymptomatic 
but that congenital infection can produce illness and 
persistently infected piglets (Leforban and others, 1990a;
Terpstra and others, 1992).
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This chapter describes the investigation of an outbreak of 
disease that occurred on a mixed farm (Farm "X") where both 
pigs and cattle were kept. Postmortem examinations, 
following sudden deaths amongst a litter of sucking pigs, 
revealed haemorrhagic lesions suspicious of hog cholera or 
African swine fever. Movement restrictions were therefore 
placed on the farm, whilst postmortem tissues were tested 
for the presence of these two viruses. Although, 
pestiviruses were isolated from some of these tissues, 
preliminary typing with mAbs suggested that they were 
BVDV-like, and not HCV. The movement restriction order was 
therefore relaxed, whilst the farm was revisited in order to 
collect further specimens from cattle and pigs and to 
establish a detailed farm history. There was evidence of 
infection of both cattle and pigs with BVDV-like viruses, 
leading to the hypothesis that cattle to pig transmission 
had occurred. In order to test this theory, viruses isolated 
from pigs and a calf were subjected to in vitro antigenic 
comparison, using both monoclonal and polyclonal antibodies.
3.2 FARM HISTORY 
I) Animal accomodation:
Both pigs and cattle were kept on Farm "X". At the outset of 
the investigation the pigs comprised six breeding sows, one 
boar, thirty weaners and a single unweaned litter. There 
were eight suckler cows, thirty-six housed calves and
65
thirty-five steers at grass. Apart from the older steers 
kept at pasture the rest of the animals were housed in pens 
arranged around a large open yard (Fig 3.1). Most of the 
animals crossed this yard on a daily basis, although pigs 
and cattle never actually mixed. The sows and cows were in 
separate pastures during the day, but were brought back in 
across the yard at night. The in-housed calves were let out 
onto the yard on a daily basis to drink from a pond. One 
calf pen was open-fronted, so that nose to nose contact 
between cattle and pigs could have taken place.
Ii) Animal purchase and sale:
Other than the boar, no new pig purchases had been made for 
many years. Most pigs were sold after weaning apart from a 
small number of gilts retained for breeding purposes. The 
affected litter was sired by the previous boar, which was 
culled soon after because of oversize and inbreeding risk. 
Artificial insemination was never used for the pigs. Calves 
were bought in regularly via markets to supplement farm-bred 
animals so as to achieve a multi-suckling system. All the 
cows were served by artificial insemination. Heifers were 
occasionally retained to maintain the breeding herd.
iii) Previous disease and medication:
No problems were reported for the previous year from either 
pigs or cattle, other than a single bovine stillbirth. The 
pigs received no vaccines other than for erysipelas at 
weaning. No injectables had been given during pregnancy to
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Fig 3.1 Aniiâal accomodation around central yard of Farm "X".
Open-fronted pen housing persistently infected calf is 
marked with an asterisk (*). Sows and cows had alternate 
access to fields 1 and 2 .
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the sow that farrowed the affected litter. The pigs were 
never fed on household scraps.
3 3  MATERIALS AND METHODS
1) Pathological investigations and sample collection:
The chronology of events is listed in Table 3.1.
Piglets 4 to 8 were examined postmortem at the local 
Veterinary Investigation Centre and a variety of samples 
were collected for virological and histopathological 
examination. Tissues for virus isolation were sent to CVL on 
ice, whilst histopathological specimens were sent in 10% 
buffered formal saline. The farm was visited twice (Table 
3.1) to collect clotted blood samples from which serum was 
harvested for virus isolation and serology. At the visit on 
10/01/91, several piglets appeared very pale and 
anticoagulated blood samples were therefore collected from 
piglets 7-10, for haematological examination.
ii) Virus detection:
A fluorescent antibody test for HCV was carried out on 
cryostat sections of submandibular lymph nodes, spleens and 
kidneys from piglets 4 and 5 using a fluorescein conjugated 
swine antiserum to HCV. Samples from these two piglets were 
also tested for African swine fever at the Pirbright 
laboratory of the Institute for Animal Health.
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Table3.1 Chronology of events on a farm affected by BVDV.
Date Event
07/12/90 12 apparently normal pigs* born of which 2 were 
overlain.
28/12/90 Sudden death of piglet 1*.
29/12/90 Sudden death of piglet 2*.
30/12/90 Sudden death of piglet 3*.
01/01/91 Sudden death of piglets 4* & 5*.
Postmortems showed extensive petechial 
haemorrhages, leading to suspicion of hog 
cholera/African swine fever. Tissues submitted 
to CVL.
10/01/91 Bloods collected from adult pigs, surviving 
littermates (6-10*) and all the housed 
cattle apart from the cows.
15/01/91 Death of piglet 6*.
24/01/91 Death of piglet 7*.
26/01/91 Death of piglet 8*.
25/02/91 Bloods collected from cows, previously virus 
positive calf and two surviving piglets 
(9* & 10*).
* indicates piglets from affected litter.
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Cell cultures used for pestivirus isolation were calf testis 
cells at passage 4-10 (CT) and a porcine kidney cell line 
(PK15). Sera were added to microtitre plates or flasks 
immediately before seeding with cell suspensions. 
Homogenised tissues were inoculated onto nearly confluent 
cell monolayers in flasks or in tube cultures containing 
flying coverslips. Flasks were frozen and thawed prior to 
harvesting of culture fluids for further passage. Microtitre 
plates and coverslips were immunosta ined using either a 
fluorescein conjugated swine antiserum to HCV or 
anti-pestivirus mAbs and a rabbit anti-mouse IgG peroxidase 
conjugate (Dako).
iii) Comparison of virus isolates by cell culture specificity and recognition by mAbs:
Four virus isolates were serially passaged six times, in 
both PK15 and CT cells. The cells were grown in 25cm2 
culture flasks which were inoculated with virus at the time 
of seeding and then incubated at 37 °C for 4 days. The 
inocula for the first passages were 0.05ml samples of 
infected serum from a calf and three pigs (numbers 6, 7 and 
8). Subpassages were made with fresh cells and 0.2ml of 
clarified medium collected from a previous culture after a 
freeze/thaw cycle. The virus titre at the end of each 
subpassage was determined by PLA.
Comparative mAb binding assays were performed by PLA on 
viruses titrated in tenfold steps. A panel of 18 mAbs was 
used to type viruses at their second passage in CT cells.
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whilst a smaller panel of 12 mAbs was later tested against 
viruses at passage levels two and six in both PK15s and CTs. 
The intensity of staining was scored and the proportion of 
each monolayer stained was noted for each virus dilution. 
Production, characterization and assay optimization of the 
mAbs used has been described (Edwards and others, 1988; 
Mateo, 1988; Paton and others, 1991b; Chapters 5 and 7). A 
peroxidase conjugated hog cholera-specific mAb (HC34) was 
provided by V. Moennig.
iv) Serology:
Sera from Farm "X" were tested for the presence of 
neutralizing antibodies to a variety of pestiviruses. Tests 
were performed in microtitre plates according to standard 
procedures (Chapter 2 and Holm Jensen, 1981). Viruses used 
were the Oregon C24V laboratory strain of BVDV, the Alfort 
187 strain of HCV, a border disease-like isolate (87/6) made 
from a British pig in 1987 and a number of the isolates from 
the present outbreak. Titres were expressed as reciprocals 
of serum dilutions able completely to inhibit the growth of 
approximately 100TCID5o of virus.
The ability of different sera to neutralize porcine and 
bovine pestiviruses isolated from the affected farm was 
compared. These tests were performed concomitantly, with 
each serum dilution being prepared in one batch, before 
division amongst the different tests. The sera came from 
animals on the affected farm (8 from cattle and 7 from pigs)
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plus 10 reference sera previously raised in sheep or pigs 
against a diverse panel of ruminant-type pestiviruses 
(Edwards and Ibata, personal communication; Chapter 2.).
3.4 RESULTS
i) Pathological findings:
Piglets 1-5 died without showing premonitory signs and 
numbers 4 and 5 were the first to be examined. They were 
small for their age (25 days) weighing only 3.5 and 4.5 kg 
respectively, but were not in poor condition. There were no 
external lesions. The carcases were pale and oedematous with 
prominent pinkish-red lymph nodes. In both cases there was 
extensive petechiation on the serosal surface of the 
intestines, particularly the ileum. There were also numerous 
petechiae in the renal cortex. In one piglet only, large 
numbers of petechiae were present in the lungs. There was 
haemorrhage into the pericardial sac and there were a few 
petechiae on the epiglottis. .
Piglet 6 was submitted alive 14 days later. It was conscious 
but incoordinate and was euthanased with barbiturate. The 
animal was in reasonable condition but weighed only 5.5kg. 
As with piglets 4 and 5, the carcase was pale and 
oedematous, with large, pinkish-red lymph nodes. However, 
petechiation was not a feature, with small numbers only in 
the epiglottis. The liver and kidneys were pale and the
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chain of mesenteric lymph nodes all had multiple small cysts 
containing yellowish watery fluid.
Piglets 7 and 8 died at 49 and 51 days old. They had fallen 
behind their two remaining litter mates, one weighing 5.5kg 
and the other 7kg. Despite their small size, they were not 
emaciated. The carcases were strikingly anaemic, again with 
pinkish-red, enlarged lymph nodes. There were a few discrete 
subserosal haemorrhages on the colon of the larger piglet 
but none elsewhere. The smaller piglet, which was the last 
to die, had small numbers of petechiae on the epiglottis, 
renal cortex and serosa of the ileum and colon. There was a 
striking pattern of lobular necrosis affecting the liver of 
both piglets, the affected areas coalescing in the smaller 
piglet.
Microscopically, lesions in piglets 4-8 included widespread 
haemorrhages, meningitis, myocarditis, hepatic necrosis and 
nephritis. Haemorrhage was most prominent in the animals 
that died youngest.
Haematological examinations were conducted on two viraemic 
piglets (7 and 8) and on their two virus 
negative/seropositive littermates (9 and 10). The viraemic 
animals were profoundly anaemic, with erythrocyte counts of 
1.64 and 2.49 x 1012L"1, haemoglobin concentrations of 4.0 
and 4.3gdl‘1 and packed cell volumes of 13% and 15% 
respectively. The same two animals also showed leucopenia
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with relative neutropenia and lymphocytosis. The values of 
these indices for the other two animals (piglets 9 and 10) 
were within normal ranges.
ii) Virus detection:
Piglets 4 and 5 were the first to be examined. A fluorescent 
antibody test for HCV performed on cryostat sections of 
tissues collected from these piglets gave negative results 
and tests for African swine fever virus were also negative. 
However, pestiviruses were isolated from some tissues of 
both these pigs using PK15 cells grown on flying cover 
slips. They were identified by immunostaining with a 
fluorescein conjugated HCV antiserum. They were also 
recognised by BVDV specific mAbs, but not by ones specific 
for HCV. (Table 3.2).
Sera collected from cattle and pigs on 10/01/91 (Table 3.1) 
were all inoculated into cell cultures (PK15 cells for 
porcine samples and CT cells for bovine samples). These 
cultures were immunostained with a pan-pestivirus reactive 
mAb: WB105c. Results for the pigs are shown in Table 3.3. 
All of the adult pigs were virus negative, whilst three out 
of the five remaining sucking piglets were virus positive 
(isolates FP1 91/1, FP2 91/1 and FP3 91/1, from piglets 6, 7 
and 8 respectively). Of the cattle, a single, apparently 
healthy calf from the open fronted pen was identified as 
virus positive (isolate FBI 91/1).
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Table3.2 Pestivirus isolations from tissues of piglets 4/5.
Source of virus HCV-pAb HCV-mAb BVDV-mAb
Tissue pool 1 +/+ -/- +/+
Tissue pool 2 +/+ nt nt
Tissue pool 3 -/+ nt nt
Negative control - - -
HCV control + + -
BVDV control nt — +
HCV-pAb was a fluorescein conjugated HCV polyclonal 
antibody. HCV-mAb was a peroxidase conjugated HCV specific 
mAb (HC34: anti-gp55). BVDV-mAb was a peroxidase conjugated 
BVDV specific mAb (CT6: anti-gp53). Tissue pool 1 was
submandibular lymph node. Tissue pool 2 was mesenteric lymph 
node plus spleen. Tissue pool 3 was kidney plus ileum. 
Negative control was uninoculated PK15 cells. HCV control 
was PK15 cells infected with HCV strain Alfort. BVDV control 
was bovine turbinate cells infected with BVDV strain Oregon 
C24V. + = positive staining, - = negative staining, nt = not 
tested. +/- = positive staining for tissue from piglet 4, 
but negative staining for tissue from piglet 5.
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Table 33  Virus isolation and serology for pig sera collected 
10/01/91.
Virus BVDV HCV
Isoltn. VNT VNT
sow 1 — <5 <5
sow 2 * - 1280 30
sow 3 - <5 <5
sow 4 - 120 5
sow 5 - <5 <5
boar - <5 <5
piglet 6 + <5 <5
piglet 7 + <5 <5
piglet 8 + <5 <5
piglet 9 - 160 <5
piglet 10 - ^2560 15
*sow 2 was the dam of the piglets. Virus isolation in PK15 
cells: +/- indicates positive/negative staining pattern with 
pan-pestivirus reactive mAb WBlOSc. VNT titres expressed as 
reciprocals of dilutions able to neutralise 50% of viral 
replicates, using the Oregon C24V strain of BVDV and the 
Alfort 187 strain of HCV
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Piglets 6, 7 and 8 died, five, fourteen and sixteen days
after they had been blood sampled. Postmortem tissue 
homogenates from all three pigs were inoculated into CT cell 
cultures and pestiviruses were isolated from each pig (Table 
3.4).
On 25/02/91, sera were collected from the previously 
unsampled cattle on the farm, from the previously virus 
positive calf and from the two surviving piglets (9 and 10). 
These were examined for pestiviruses by inoculation of CT 
cell cultures. All samples gave negative results, except for 
the previously virus-positive calf, which was still 
viraemic. At a third blood collection, two months later, the 
calf was still viraemic, with a serum BVDV titre of 
105 • 5TCID5oml"1.
iii) Comparison of virus isolates by cell culture specificity and recognition by mAbs:
Three of the porcine virus isolates (FP1 91/1, FP2 91/1 and 
FP3 91/1) and the bovine isolate (FBI 91/1), all recovered 
from sera, were compared for growth in bovine and porcine 
cell cultures and for recognition by pestivirus mAbs. The 
porcine isolates maintained good growth in both CT and PK15 
cells. However, the bovine isolate continued to grow well in 
CT cells, but failed to replicate in PK15s, being lost 
altogether by passage two (Table 3.5). All of the isolates 
were non-cytopathogenic.
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Table 3.4 Virus isolation from postmortem tissues of piglets 
6, 7 and 8.
Pig 6
Virus positive 
Virus negative
ileum, tonsil/submandibular lymph node,
kidney/spleen/liver, serum
none
Pia 7
Virus positive 
Virus negative
tonsil/submandibular lymph node/thymus,
liver/spleen, serum
ileum
Pig 8
Virus positive 
Virus negative
kidney/liver/lung/submandibular lymph node, 
brain
tonsil/ileum
Tissues were tested as pools (eg tonsil/ileum) if received 
in a single container. Virus positive = virus detected after 
two passages in CT cells using immunoperoxidase staining 
with a pan-pestivirus reactive mAb (WBlOSc).
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Table 3.5 Multiplication of virus isolates following serial 
passage in bovine and porcine cell cultures.
Virus Titres
Cell passage no. FP1 91/1 FP2 91/1 FP3 91/1 FBI 91/1
CT Cells:
1 nt nt nt nt
2 4.7 4.7 4.4 5.2
3 5.9 6.7 5.2 7.2
4 5.2 5.2 6.2 6.5
5 6.5 6.2 6.9 7.2
6 7.2 6.2 6.9 6.2
PK15 Cells:
1 3.5 3,5 4.0 0.8
2 6.2 6.2 5.9 -
3 5.9 . 6.7 5.9 -
4 4.5 4.7 4.7 -
5 5.5 5.5 5.2 -
6 7.2 to 6.9 —
Virus titres are shown as log10 TCID5o/50/l/1. nt = not 
titrated, - = no virus detected in undiluted stock.
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The reactivity of second CT passage virus isolates with a 
panel of 18 pestivirus mAbs is shown in Table 3.6, whilst 
Fig 3.2 shows the gross visual appearance of two PLA plates 
after staining (NB microscopical examination is necesary for 
the full interpretation) . None of the isolates were 
recognised by HCV-specific mAbs, but all reacted with a 
pan-pestivirus-specific mAb (WBlOSc). Some discrimination 
between isolates was found with anti-gp53 mAbs raised 
against BVDV. Certain virus/anti-gp53 mAb combinations 
produced mixed reactions whereby only a proportion of 
infected cells were stained. Two anti-gp53 mAbs (WBllSc, 
CA36) reacted only with the bovine isolate, whilst another 
six reacted with the bovine isolate and a proportion of 
cells infected with some porcine isolates.
The reactivity of the above four virus isolates with a 
smaller panel of mAbs was also tested after two and six 
serial passages in CT or PK15 cells (FBI 91/1 only tested in 
CT cells because of poor replication in PK15 cells). The 
twelve mAbs chosen were a subset of the larger panel, 
excluding some that had not discriminated between the 
isolates. An HCV-specific mAb still failed to bind any of 
the isolates, whilst the BVDV mAbs WBllSc and CA36 which had 
clearly discriminated between the bovine and porcine 
isolates after two CT cell passages still gave the same 
results.
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Table 3.6 Recognition of bovine and porcine virus isolates 
by a panel of 18 mAbs after two passages in CT cells.
Virus strain
Monoclonal FBI FP1 FP2 FP3 BVDV HCV BDV
antibody 91/1 91/1 91/1 91/1 C24V Alfort Moredun
Anti-qp53
(BVDV)
WBllSc + - - - ++ - -
WB158n - - - - - - -
WB162C + + + + ++ - -
WB163C ++ + + (+) ++ - 4-
WB165C - - - ++ - -
WB166n + + + + +.+ - 4-4-
WB170n - - - - — —• -
WB214 ++ ++ (++) (++) ++ - -
WB215 ++ (++)* (++) - ++ - -
CA1 + (++) (++) (++) ++ - —
CA36 ++ - - - + - -
CA39 + (++) (++) (++) ++ - -
CA82 + — (+)* — 4-4- — —
Anti-oBO
(BVDV)
WBlOSc ++ ++ ++ ++ 4-4- 4-4- 4-4-
WBlGOn ++ ++ ++ ++ 4-4- — +
WB212n
Anti-croSS
++ ++ ++ ++ 4-4- 4- 4-4-
(HCV)
WH303 - - - - - 4-4" -
WH308 — — —
FBI 91/1 = bovine isolate. FP1-3 91/1 = porcine isolates 
from pigs 6, 7 and 8. The proportion of cells stained was 
the same at all virus dilutions except for those marked with 
an asterix (*), where only wells infected with virus stock 
at 1 in 10 showed any staining. - = no staining; () = <50% 
of infected cells stained; + = positive staining; ++ = 
strong staining; nt = not tested
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Pig 3.2 Macroscopic appearance of stained PLA plates 
showing reactivity of some mAbs to virus isolates FBI 91/1 
and FP3 91/1.
a) FBI 91/1 virus isolated from serum of persistently 
infected calf and stained at second CT passage
b) FP3 91/1 virus isolated from serum of pig 8 and stained 
at second CT passage. .
MAbs used for staining: columns 1-4 = WBlOSc, column 5 =
WH303, column 6 = WH308, column 7 = WB162c, column 8 =
WB163C, column 9 = WB214n, column 10 = WB215C, column 11 =
WB166n, column 12 = WB210C.
Virus dilutions: virus diluted in tenfold steps from 10°-106 
(rows A-G). Row H = uninfected CT monolayer.
Scoring of staining for each column (mAbï: 1-4 = +/+, 5-6 =
-/-, 7 = +/+, 8 = +/(+), 9 = +/+, 10 = +/-, 11 = +/+, 12 =
+/+. Where + = specific staining, (+) = specific staining of
only part of monolayer, - = no specific staining. +/- = 
specific staining of FBI 91/1 / no specific staining of FP3 
91/1.
MAb characteristics:
WBlOSc - pan-pestivirus specific anti-pBO mAb (recognises 
all pestiviruses). WH303 = pan-HCV specific anti-gp55 mAb
(recognises all HCVs and no other pestiviruses). WH308 =
HCV-specific anti-gp55 mAb (recognises many HCVs and no 
other pestiviruses). WB162C, WB163c, WB214n, WB215C =
anti-gp53 mAbs raised against BVDV and recognising many 
ruminant pestiviruses, but not HCVs (Chapter 5). WB166n = 
Anti-gp53 mAb raised against BVDV and recognising many 
ruminant pestiviruses, and some HCVs (Chapter 5). WB210c = 
Anti-gp48 mAb raised against BVDV and recognising many 
ruminant pestiviruses, but not HCVs (Chapter 5) .
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iv) Serology:
Of forty-one cattle sera, thirty-nine were seropositive 
(titres ^1/10) in a virus neutralization test (VNT) using 
BVDV strain Oregon C24V. Seven seropositive sera that were 
titrated to an endpoint, had titres of between 1/160 and 
1/640. One of the two seronegative animals was the 
persistently infected calf. By the same test, two piglets 
and two sows were seropositive, one of the sows being the 
dam of the piglets. When tested by VNT, using the Alfort 187 
strain of HCV, only three pigs were seropositive and to much 
lower titre compared to the BVDV result (Table 3.3).
A comparison of the ability of different sera to neutralize 
porcine and bovine pestiviruses isolated from the farm, 
revealed no titre difference between viruses of greater than 
fourfold for any serum (Table 3.7). Sera collected at the 
farm also had very similar titres to Oregon C24V (BVDV), but 
much lower titres to the BDV-like 87/6 virus.
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Table 3.7 Comparative neutralization of porcine and bovine 
viral isolates.
Test Reciprocal Reciprocal Reciprocal
Sera VN titre VN titre VN titre
(FBI 91/1) (FP1 91/1) (FP2 91/1)
Bovine farm sera
116940 320 320 480
116955 480 480 640
116954 20 20 20
116953 20 15 10
116950 80 80 80
116965 400 150 150
116967 800 800 800
116968 120 120 120
Porcine farm sera
Piglet 6 <5 <5 <5
Piglet 7 <5 <5 <5
Piglet 8 <5 <5 <5
Sow 4 300 400 600
Sow 2 2400 4800 6400
Piglet 9 400 800 800
Piglet TO 1600 3200 2400
Experimental
reference sera*
6130 7 60 7
2147 30 120 20
2154 10 15 5
2149 5 10 5
2148 480 160 480
2185 640 240 320
2186 240 120 240
2187 £960 480 £960
2188 320 320 £960
2189 480 480 640
FBI virus = bovine pestivirus isolate at 32 TCID50/well. FP1 
& FP2 virus = porcine pestivirus isolates at 100 & 32
TCID50/well respectively. All titres expressed as reciprocal 
dilutions of sera able to neutralise 50% of virus.
* Antisera to an antigenically diverse panel of ruminant 
pestiviruses, all with high titres to their homologous 
viruses (Chapter 2).
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3.5 DISCUSSION
The data in this chapter strongly indicate that BVDV 
infection of pigs occurred on Farm "X". Porcine virus 
isolates were clearly BVDV-like, on the basis of mAb 
recognition and neutralization by polyclonal antisera. 
Furthermore, sera collected from some of the pigs had high 
neutralizing antibody titres to BVDV, but low or negative 
titres to HCV. An opportunity for porcine BVDV infection was 
provided by the unusually close contact between pigs and 
cattle, whilst other avenues of infection were not apparent. 
An apparently normal, persistently viraemic calf was 
identified in an open-fronted pen facing onto a yard crossed 
by both pigs and cattle. Such persistently infected cattle 
are known to shed large amounts of virus in many bodily 
secretions, including oronasal fluids, urine and faeces 
(Baker, 1987) and this calf, which had a high serum virus
titre was considered a likely source of infection for the 
other animals, including the pigs. It has been shown that 
cattle persistently infected with BVDV can infect pigs by 
contact transmission (French and Snowdon, 1977) and indirect 
transmission from this particular calf to pigs was later 
demonstrated experimentally (Chapter 4). The calf was 
brought onto the farm about four months before the dam of 
the affected piglets was served. The finding that all but 
one of the other cattle tested were BVDV seropositive, some 
to high titre, confirmed that BVDV had been circulating on 
the farm.
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The repeated isolation of BVDV from some piglets suggested 
that these* animals were persistently viraemic, most likely, 
as a result of congenital infection. The fact that they 
failed to grow normally is also suggestive of persistent 
infection, since stunting is a common symptom of this type 
of infection in cattle (Boeder and others, 1986).
Experimentally induced infections of pregnant sows with BDV 
(Paton, unpublished results) suggested that fetal infection 
was associated with very high maternal antibody titres. The 
dam of the affected litter on Farm "X", Sow 2, also had a 
very high antibody titre, compared to that of the other 
seropositive sow (Sow 4: Table 3.3). It was not possible to 
establish at what time transplacental infection would have 
occurred or whether the two seropositive survivors were 
infected in utero. However, the high level of antibody 
detected in piglet 10 at one month old, suggests active 
seroconversion rather than passive acquisition of maternal 
antibody. Congenital infections of pigs with ruminant 
pestiviruses have been described previously. In some cases, 
the source of the infection was thought to be cattle contact 
(Terpstra and Wensvoort, 1988), whilst in others it was 
traced to the use in pregnancy of live vaccines 
contaminated with ruminant pestiviruses (Vannier and others, 
1988; Wensvoort and Terpstra, 1988).
Comparison of porcine and bovine isolates made from the farm 
showed both similarities and differences. Their cell culture 
preferences were different, but they showed very similar
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degrees of neutralization by a variety of pestivirus 
antisera. With mAbs, they showed reactivity patterns typical 
of BVDV, but not identical to one another. The mixed 
reactions seen between some BVDV mAbs and the porcine 
isolates in particular, suggested antigenic variation within 
each isolate. It is not uncommon to see only plaques of 
positive cells when individual mAbs are used to stain 
uncloned pestivirus isolates. Wensvoort and Terpstra (1986) 
reported the identification by mAbs of five epitopic 
variants of HCV isolated from a single blood sample. There 
is always a possibility that differences detected between 
isolates following in vitro culture may have been selected 
by the culture system used, especially if cells from a 
different species are used to replicate the virus. Serial 
passage of several isolates in PK15 and CT cells induced 
some differences in intensity of PLA staining with mAbs, 
comparing passage levels two and six, and CTs and PK15s. 
However, the key epitopic differences discriminating between 
the bovine and porcine strains, were apparent regardless of 
passage history. If the pigs on this farm had been 
infected, in utero, with a virus very like the bovine 
isolate, then by the time of the first blood sampling, 
several months and many thousands of virus generation times 
later, small antigenic changes could well have been selected 
for. Ultimately, the similarity of these bovine and 
porcine isolates would be best assessed by genomic 
comparison (Chapter 6) . The antigenic diversity of 
pestiviruses suggests that variants readily arise in vivo,
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and Kreeft and others (1990) detected extensive epitopic 
variation amongst BVDV isolates made from different cattle 
all of which had probably been infected by the same BVDV 
contaminated vaccine.
The symptoms and age of the affected pigs, along with the 
confinement of illness to a single litter, were similar to 
previously recorded features of BVD in pigs (Terpstra and 
Wensvoort, 1988). The infection of only two sows, compared 
to almost all of the cattle suggested that the 
susceptibility of pigs to this particular strain of BVDV was 
low and this was consistent with the failure of the bovine 
isolate to grow in a porcine cell line. Lamont (1977) 
reported previously that even on farms where cattle and pigs 
were both kept, the prevalence of BVDV antibodies in pigs 
was low.
Unlike the situation in cattle, it has not been shown that 
pigs develop a mucosal disease-like syndrome (associated 
with cytopathogenic biotypes. of pestivirus). However, late 
onset disease is a well recognised feature of prenatal 
porcine infection with both low virulent strains of HCV (Van 
Oirschot and Terpstra, 1977) and BVDV (Terpstra and 
Wensvoort, 1988). The trigger for the sudden onset of
disease in these instances, as in the present case (at
between 21 and 50 days of birth) is not known. Acute BVDV
has been associated with thrombocytopenia and haemorrhage in 
calves (Corapi and others, 1989) , but it is not known
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whether thrombocytopenia was involved in the present 
porcine cases of haemorrhage and anaemia. However, the gross 
pathology of the internal organs of piglets 4 and 5 was 
indistinguishable from that typically seen in 
thrombocytopaenic purpura, and it seems likely that these 
animals were at least suffering from a thrombocytopaenia.
3.6 CONCLUSIONS
Deaths within a litter of sucking pigs led to a suspicion of 
hog cholera, but pestiviruses isolated from both dead and 
live piglets were typed as BVDV. Persistent viraemia with 
BVDV-like virus was demonstrated in living littermates and 
also in a bought-in calf, housed in a nearby pen on the same 
farm. Ultimately, only two of the littermates survived, both 
of which had been virus negative and seropositive from the 
outset of testing. Porcine and bovine virus isolates grew 
well in CT cells and were neutralized equally by sera 
collected at the farm of origin from both cattle and pigs. 
However, comparison by means of their reactivity to mAbs 
showed similarity, but not identity, whilst only the porcine 
isolates grew well in a porcine kidney cell line. It was 
considered likely that the persistently infected calf had 
initiated an outbreak of acute BVD. Spread to a pregnant sow 
probably resulted in congenital infections, with subsequent 
postnatal disease. The differences demonstrated between the 
porcine and bovine isolates could have been selected for, by
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many weeks of virus multiplication in the persistently 
infected pigs. The reason for the late onset of illness in 
the piglets is unknown.
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4:1 INTRODUCTION
An outbreak of BVDV in pigs has been described in Chapter 3. 
It was surmised that cattle to pig virus transmission could 
have occurred by indirect contact and that disease was most 
likely a consequence of congenital porcine infections. 
Despite epitopic differences between bovine and porcine 
virus isolates; it was considered that all of the isolates 
were closely related and that the porcine viruses might have 
diverged from the bovine one through passage in pigs. A 
number of experimental animal studies were designed to test 
some of these hypotheses.
The calf that was persistently infected with BVDV 91/1 was 
brought to the laboratory from Farm 11X” and placed in 
indirect contact with BVD seronegative pigs. .Serum from the 
calf was also used to infect pregnant sows in an attempt to 
establish congenital porcine infections. The purposes of 
these experiments were: 1) To establish whether or not
indirect calf/pig contact was sufficient for bovine to 
porcine spread of BVDV. 2) To establish the pathogenicity of 
the calf virus for pigs and to compare any disease with that 
seen in pigs on Farm "X". 3) To see whether or not the
bovine virus isolate would mutate on pig passage and 
subsequently become more like the viruses isolated from Farm 
"X" pigs.
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4 2  MATERIALS AND METHODS
I) Animals, animal inoculations and animal monitoring:
The persistently infected calf identified on Farm "X" was 
purchased, brought to the laboratory and housed in a pen 
next to three ten-week-old pigs. The pigs were from the 
laboratory's own specific-pathogen-free (SPF) herd and were 
seronegative to BVDV. The pigs and the calf were rotated 
between three strawed pens. Each day, the calf moved into a 
clean pen, whilst the pigs were moved into the calf's old 
pen, which was not cleaned out. After a week, the pigs were 
removed to separate accomodation and after a further three 
weeks, they were bled for BVDV serology.
Two sows (PF272 and PF273) from the institute's SPF herd 
were each inoculated intranasally with 2ml of serum taken 
from the persistently infected calf. This serum had a BVDV 
titre of IQ5-5 TCIDgoml-1 in CT cells. Both sows were 
previously BVDV seronegative and both were 27 days pregnant, 
pregnancy having been confirmed by vaginal biopsy. At 
intervals after challenge, blood samples were collected to 
monitor.seroconversion to BVDV, whilst a single blood sample 
was taken at 83 or 90 days post-service to monitor 
pregnancy. The pregnancy test performed was an oestrone 
sulphate estimation and was carried out by a commercial 
laboratory. To induce farrowing at a time suitable for 
observation, sow PF273 was injected with 184 micrograms of 
Cloprostenol Sodium (Planate) at 113 days post-service. At
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birth, all piglets were weighed and a precolostral blood 
sample was collected from the umbilical cord of each animal. 
All piglets received iron injections and had their teeth 
clipped at 2 days old. The progress of the piglets was 
monitored by clinical observation, and by periodic weighing 
and blood collection. Weight differences between pigs born 
viraemic and non-viraemic were compared for statistical 
significance by t-test, using the software package Minitab. 
Pigs were weaned at 5 weeks of age and most were retained 
until 10-11 months old. Postmortem examinations were 
conducted on most of the pigs after death or slaughter. 
Blood and organ samples were collected for virus isolation, 
serology and histopathology as shown in Table 4.1.
ii) Serology:
Virus neutralization tests (VNT) were carried out as 
described in Chapter 2, using PK15 cells. The test virus was 
an isolate made from pig 6 on Farm "X” (FP1 91/1: see
Chapter 3) previously passaged four times in PK15 cells.
iii) Virus isolation:
PK15 cells were used for attempted in vitro virus isolation 
from all sera and tissues. Later, CT cells were compared to 
PK15 cells for virus isolation from selected frozen sera and 
tissues. The methods used have been described in Chapter 2. 
Ten microlitres of each serum sample was inoculated into 
each of four microtitre plate culture wells at the time of 
seeding with cells. After four days incubation, the cells
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Table 4.1 Postmortem collection of tissues for virus 
isolation and histopathology from litter of PF273.
No. death
(days)
stances 
of death1
For Virus 
Isolation2
For Histo­
pathology3
PF394 320 S NO NO
PF395 292 S YES NO
PF396* 313 S YES NO
PF397* 313 S NO NO
PF398 83 D YES YES
PF399 320 S NO NO
PF400 54 H NO YES
PF401 292 S YES YES
PF402* 320 S NO NO
PF403 320 S YES NO
PF404 194 H YES YES
* = gilts . All others were boars.
1 S = slaughter at end of experiment, D = died during 
experiment, H = humane destruction beause of illness, during 
experiment.
2 Samples collected were: tonsil, submandibular lymph node, 
lung, liver, spleen, kidney, testis or ovary, ileum, 
mesenteric lymph node. Brain also collected from 398/404.
3 Samples collected were: 400 - skin, tonsil, submandibular 
and inguinal lymph nodes, lung, heart, thymus, liver, 
kidney, adrenal, spleen, pancreas, bladder, ileum; 398/404 - 
as 400, plus costo-chondral cartilage, brain and spinal 
cord; 401 - ileum, mesenteric lymph node.
NB Blood for serology and virus isolation was collected from 
all animals except 398.
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were fixed and immunostained with a pestivirus-specific mAb. 
One millilitre of tissue homogenate from each organ sample 
was inoculated onto nearly confluent cells in 25cm2 culture 
flasks. After four days incubation, the cultures were 
subpassaged into microtitre plates, incubated for a further 
three days and stained as above.
iv) Antigen detection by ELISA:
The method used was similar to that of Fenton and others 
(1990) as modified by Drew and others (1992) . Heparinised 
blood samples were examined for pestivirus antigen using a 
double antibody sandwich ELISA employing a pair of 
pan-pestivirus reactive mAbs (Paton and others, 1991a).
v) Typing of virus isolates with monoclonal antibodies:
Viruses isolated from precolostral sera or postmortem 
tissues were typed with mAbs and compared with the bovine 
challenge virus and the porcine viruses isolated from Farm 
"X”. The viruses were stained with mAbs at either the second 
passage in CT cells, or the third passage in PK15s, as 
described in Chapter 3.
vi) Comparative neutralization of viruses isolated from the same pig, before and 
after the development of neutralizing antibody:
A serum-virus neutralization test was used to compare a 
virus isolated from postmortem tissues collected from a 320 
day old pig, with an isolate made earlier from the same 
animal's serum. When the first isolate was recovered, the
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pig had been seronegative, whereas, when the second isolate 
was made the pig had been seropositive for several months. 
The comparative neutralization tests were performed to see 
whether or not the virus had persisted by becoming 
antibody-neutralization resistant. A stock of each virus was 
prepared by two serial passages in PK15 cells. Ten-fold 
dilutions of each stock were incubated in microtitre plate 
wells with an equal volume of replicates of either medium or 
serial dilutions of the pig's own serum, collected at 
slaughter, when the pig was 320 days old. After an hour at 
37°C a PK15 cell suspension was added and the test completed 
as for a standard VNT. For each virus, the reduction in 
titre in the presence of serum was plotted against the serum 
dilution, and the two profiles were compared.
43  RESULTS
i) Indirect contact transmission study:
All three pigs involved in the laboratory transmission study 
seroconverted to BVDV. The bloods collected from them three 
weeks after the end of the transmission study contained 
neutralizing antibody titres of 1 in 960, 1 in 480 and 1 in 
120. Throughout the whole period of the experiment, these 
pigs showed no loss of appetite or other grossly observable 
signs of illness.
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ii) Monitoring of pregnant sows:
The intranasally inoculated sows showed no grossly 
observable signs of illness. However, both animals 
seroconverted to BVDV (Fig 4.1). One sow (PF273) showed a 
biphasic antibody response, with a secondary rise in 
antibody between 48 and 83 days post challenge. A low blood 
oestrone sulphate level at 90 days post service suggested 
that PF272 was no longer pregnant, and this sow failed to 
farrow. PF273 farrowed eleven liveborn piglets under 
observation, commencing 23 hours after induction with 
Planate.
iii) Monitoring of litter born to PF273:
Serology and virus isolation from serum
Serological and virological findings for blood samples 
obtained from the litter of PF273 up to 248 days of age are 
summarised in Table 4.2. The ELISA detected virus in the 
blood of some pigs, when it was missed by virus isolation. 
At birth, five out of eleven siblings were virus positive 
and seronegative, whilst the remaining six piglets were 
virus and antibody negative. One of the eleven precolostral 
sera was only virus positive when CT cells rather than PK15 
cells were used.
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Fig 4.1 Seroconversion of sows after intranasal inoculation 
with BVDV
Reciprocal log antibody titre = log10 of the reciprocal 
serum dilution able to neutralize 50% of virus replicates 
containing 100 TCID50 of FP1 91/1. Doubling dilutions of 
serum were tested starting from 1 in 5 (reciprocal logi0 = 
0.7). Titres of <0.7 are marked on graph as 0 . Days post 
challenge = days after intranasal BVDV infection (FBI 91/1). 
PF272 = sow that failed to farrow. PF273 = sow that gave 
birth to congenitally infected piglets.
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Table 4.2 Serological and virological findings for blood 
samples taken from the litter of PF273 between birth and 248 
days of age
Age of pig in days
Pig
No.
0
v/s*
21
v/s
52
V/s
140
v/s
248
V/S
PF394 -/- —/960 —/120 -/40 -/40
PF395 -/- -/480 -/80 —/60 —/15
PF396 +/- —/960 ~/^4O96O ~/^4O96O -/10240
PF397 -/- —/640 —/160 -/60 -/30
PF398 +/- -/80 (+)/- nt nt
PF399 -/- -/160 -/80 “/15 ”/5
PF400 +/- -/- +/- nt nt
PF401 -/- -/640 —/120 -/30 -/10
PF402 -/- -/960 —/60 -/10 -/5
PF403 +/- ( + )/- +/~ -/80 -/3840
PF404 +/- -/30 +/-' +/7.5 nt
* v /s :  v = virus detection / s = serology. Virus detection 
was by cell culture virus isolation and in some cases also 
by ELISA; + = positive by virus isolation, (+) = positive 
only by antigen ELISA. Serology was by VNT; reciprocal 
antibody titres are given, whilst - = reciprocal titre of 
less than 5. nt = not tested, as no longer alive.
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Fig 4. 2a shows the changing antibody status of the six 
piglets born virus negative and antibody negative. They were 
all seropositive at 3 weeks old, and therafter titres waned 
slowly. In most cases residual antibody could still be 
detected at the end of the experiment, when the pigs were 
10-11 months old. Virus was never isolated from any sera 
collected from these 6 pigs.
The five pigs born viraemic and seronegative, could be split 
into two subgroups, on the basis of subsequent serological 
and virological results. Three pigs (Fig 4.2b) became 
non-viraemic at 3 weeks old, with low or undetectable levels 
of antibody (PF400 = <10, PF404 = 30, PF398 = 80). By 7
weeks old all three were again viraemic and seronegative. 
The other two pigs (PF396, PF403: Fig 4.2c) developed very 
high antibody titres, associated with clearance of serum 
virus. They differed in that PF396 seroconverted soon after 
birth, whereas for PF403 seroconversion/loss of serum 
viraemia was first detected at 140 days of age.
Virus isolation from postmortem tissues
Virus isolation results for postmortem tissues collected 
from the pigs are shown in Table 4.3. No virus was isolated 
from two pigs (PF395, PF401) examined from the group born 
non-viraemic. Of the three pigs that died during the 
experiment, two had samples taken for virus isolation after 
death. Virus was isolated from most organs sampled in both 
pigs (PF398 and PF404). PF396 and PF403 were the two pigs
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Fig4.2 Serum antibody profiles of littermates born to PF273
a) Piglets born non-viraemic, all of which survived to the 
end of the experiment.
b) Piglets born viraemic that became ill and did not survive
to the end of the experiment.
c) Piglets born viraemic that survived to the end of the
experiment.
Reciprocal log antibody titre = log10 of the reciprocal 
serum dilution able to neutralize 50% of virus replicates 
containing 100 TCID50 of FP1 91/1. Doubling dilutions of 
serum were tested starting from 1 in 5 (reciprocal log10 = 
0.7). Titres of <0.7 are marked on graph as 0. Day 0 = day 
of precolostral sampling.
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Table 43 Virus isolation from postmortem tissues collected
from litter of PF273.
Tissue PF395 PF396 PF398 PF401 PF403 PF404
Tonsil - - — + - (+) + .
Spleen - - + - - +
SMLN - - nt - (+) +
MLN - - + - - +
Kidney - - + - - +
Lung - - nt - - +
Testis - nt nt ■ — + +
Ovary nt - nt nt nt nt
Liver - - nt - - +
Ileum - - + - + +
Brain nt nt nt nt nt —
SMLN = submandibular lymph node 
MLN = mesenteric lymph node 
-/+ = negative/positive by virus isolation 
(+) = plaques of infected cells only, after two culture 
passages 
nt = not tested
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that had seroconverted and cleared virus from their serum 
(see above). At death, virus could not be isolated from 
PF396, which had been seropositive longest, but virus was 
recovered from testis, ileum, spleen and tonsil from PF403. 
Virus isolation from tissue homogenates collected from PF398 
was attempted in both CT cells and PK15 cells. A difference 
was detected for only one tissue (spleen) , from which virus 
was isolated in CTs but not PK15s.
Health and growth
At birth, the eleven piglets farrowed by PF273 were 
vigorous, and most appeared normal, although a single animal 
(PF398) showed oedema of the ear pinnae (Fig 4.3a). All of 
the pigs survived the perinatal period and were weaned and 
split into groups of three or four animals at 5 weeks old. 
Boars were not castrated, but were housed separately from 
gilts.
A single pig (PF398) died suddenly at 83 days old, whilst 
two other stunted pigs (PF400 and PF404) had to be destroyed 
on humane grounds at 53 and 196 days old respectively. The 
remainder of the litter remained healthy, until killed at 
between 10 and 11 months of age. PF400 was killed at 54 days 
old, when it weighed only 17.5kg, being the smallest pig in 
the litter. Despite a normal body temperature, it had become 
listless and anorexic, was unwilling to rise and was being 
bullied by its pen mates. PF398 died suddenly at 83 days old, 
weighing 20.5kg. It was markedly stunted compared to other
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Fig 4 3  Physical abnormalities in congenitally infected pigs
a) Day old congenitally infected piglet showing oedema of 
the ear pinnae.
b) Stunted (PF404) and relatively normal (PF403) pigs at 180 
days old .
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litter-mates, but otherwise appeared externally normal. 
PF404 was killed on humane grounds because it had difficulty 
walking, after becoming progressively weak on its hind legs. 
It had also developed a more acute lameness of the left 
foreleg. The animal was stunted and weighed only 42.5kg at 
death.
Growth curves for the litter over the full duration of the 
experiment are shown in Fig 4.4. Differences in growth are 
most apparent in the first two months, before several of the 
unthrifty pigs died, and this period is shown in greater 
detail in Fig 4.5. Pigs born viraemic (Fig 4.4a) were mostly 
lighter than their litter-mat es at both 21 and 52 days old. 
PF396, although born viraemic, seroconverted soon after 
birth, and showed a growth pattern similar to the 
non-viraemic group. Since there was no evidence of a group 
difference in birth weight, or of a relationship between 
birth weight and subsequent growth, a statistical comparison 
was made of absolute weights at 21 and 52 days, comparing 
those pigs born viraemic (plus or minus PF396) with those 
not. Table 4.4 shows the raw data compared and Table 4.5 the 
probabilities that differences were significant. Whether or 
not PF396 was included, the mean weights at 21 and 52 days 
were significantly lower for the viraemic-at-birth group. 
Fig 4.3b shows a stunted pig compared to one that was 
growing normally.
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Fig4.4 Growth curves of littermates born to PF273 from birth
to the end of the experiment
a) Piglets born viraemic
b) Piglets born non-viraemic
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Fig 4.5 Growth curves of littermates born to PF273 during
their first two months of age
a) Piglets born viraemic
b) Piglets born non-viraemic
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Table 4.4 Weights at days 0, 21 and 52 for pigs born viraemic 
or non-viraemic.
WEIGHT (kg)
0 DAYS 21 DAYS 52 DAYS
Non-viraemic (n=6) MEAN 1.38 6.19 27.5
s.d. 0.21 0.71 4.6
Viraemic (n=5) MEAN 1.25 5.36 20.2
s.d. 0.23 0.23 4.1
Viraemic (n=4) MEAN 1.20 5.30 18.38
omitting PF396 s.d. 0.23 0.22 0.75
s.d. = standard deviation
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Table 4.5 Stastical significance of weight differences 
between pigs born viraemic or non-viraemic at 21 and 52 days 
old.
WEIGHT (kg) 
DIFFERENCE
MEAN s.e. t-VALUE SIGNIFICANCE
PROBABILITY
Non-viraemic 21 days 0.83 0.31 2.71 0.035*
vs viraemic 52 days 7.30 2.63 2.78 0.024*
Non-viraemic 21 days 0.89 0.31 2.89 0.028*
vs viraemic 52 days 9.13 1.90 4.80 0.005**
(minus PF396)
s.e. = standard error
* = significant at 5% level 
** = significant at 1% level
118
Gross and histopatholoaical postmortem findings 
PF400 The carcase was pale and the blood was thin and 
watery. All lymph nodes examined were enlarged and 
haemorrhagic. The testes were retained within the abdomen. 
Histopathology confirmed haemorrhage within lymph nodes, 
kidney and liver. Widespread deposition of haemosiderin and 
increased splenic haemopoiesis indicated that this 
haemorrhage had been of a chronic nature. Other findings 
included oedema and lymphocyte depletion within lymph nodes, 
villous atrophy of the small intestine, Peyerz s patch 
hyperplasia and abscessation of tonsillar crypts.
PF398 The carcase was pale, watery and oedematous, oedema 
being particularly notable in the submandibular region. All 
lymph nodes examined were very enlarged and haemorrhagic. 
The thymus was also haemorrhagic, with an appearance close 
to clotted blood. Haemorrhagic streaks were detected on the 
epicardium and punctate haemorrhages could be observed on 
the surface of the cerebellum. Histopathology showed a 
rather similar picture to PF400, with in addition, evidence 
of haemorrhage in the cerebellum and spleen and of a 
myocarditis.
PF404 Necropsy findings were almost normal. Submandibular, 
mesenteric and iliac lymph nodes were all enlarged (eg 
submandibular lymph nodes measured 4cm by 3cm) with a firm, 
rubbery texture and a blotchy, pinkish—red discolouration. 
There was a septic bursitis of the left shoulder. 
Histopathology showed haemorrhage and oedema of the 
submandibular lymph node.
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PF395. PF396 No abnormalities detected.
PF401.____PF403 Grossly thickened terminal ileum.
Histopathological examination of this organ from PF401 
confirmed a diagnosis of porcine intestinal adenomatosis. 
PF397. PF397. PF399. PF402 No postmortem examinations
undertaken.
iv) Monoclonal antibody typing;
Using mAbs, viruses isolated from the precolostral sera of 
PF398 and PF404 (EP1 91/1 and EP2 91/1 respectively) were 
compared with viruses isolated from a calf (FBI 91/1) , and 
two pigs from Farm "X" (FP1 91/1 and FP2 91/1) and with the 
virus used to inoculate the piglets' dam (a later isolate 
from the same calf ; FBlb 91/1). All the viruses were 
compared at the second passage in CT cells. The results are 
summarised in Table 4.6. The two viruses isolated from the 
persistently infected calf at an interval of 3 months 
appeared identical. As had previously been found (Chapter 3) 
the two viruses isolated from pigs on Farm "X" were slightly 
different from the calf virus. Only minor differences in the 
character of staining were observed, compared to the 
previous test. The new pig isolates derived from the 
precolostral sera of the experimentally infected pigs 
appeared identical to the calf viruses.
Two viruses isolated from PF403 at different times were 
compared for mAb reactivity after three PK15 passages. The 
results are shown in Table 4.6. The first isolate (EP3 91/1)
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Table 4.6 Comparison of viruses by monoclonal antibodies 
using PLA.
Virus isolates
Monoclonal
Antibody
FBI
91/1
FP1
91/1
FP2
91/1
FBlb
91/1
EPl+2
91/1
EP3+4
91/1
Anti-cro53
fBVDV)
WB115C + + + +
WB158n - - - - - nt
WB162C + + ++ ++ + + ++ nt
WB163C ++ . .+ + ++ ++ ++
WB165C - - - - - nt
WB166n ++ ++ ++ ++ ++ ++
WB170n - - - - - nt
WB214n + + (++) ( + + ) + + + + 4-4-
WB215C + + ( +  ) ( + ) * - + + 4-4-
CA1 +  ' ( + + ) (++) + + -
CA36 + + - - + + + + 4-4-
CA39 + C++) (++) + + nt
CA82 ++ —* ( + ) ++ ++ 4-4-
Anti-oS0 
fBVDV) 
WB160n ++ ++ ++ ++ ++ nt
WB212n ++ ++ ++ ++ ++ nt
FBI 91/1 = original bovine isolate from Farm X; FBlb 91/1 = 
isolate from same calf made 3 months later; FP1-2 91/1 = 
porcine isolates from pigs 6 and 7 from Farm X; EP1+2 91/1 = 
isolates from precolostral sera from pigs PF404 and PF398; 
EP3+4 91/1 = isolates from precolostral serum and testis of 
PF403. All viruses stained at second CT cell passage, except 
EP3+4 91/1, which were stained at third PK15 cell passage.
nt = not tested, - No staining, + Staining, ++ Strong 
staining, () = <50% of infected cells stained, * The
proportion of cells stained was the same at all virus 
dilutions except for those marked *, where only wells 
infected with virus stock at 1 in 10 showed staining.
121
had been made from a precolostral serum sample, collected at 
birth, whilst the second isolate (EP4 91/1) was made 320 
days later, from a testicular tissue sample collected at 
postmortem. No differences were detected comparing these two 
isolates with one another or with EP1-2 91/1.
v) Comparative neutralization of viruses isolated from PF4 03 :
Fig 4.6 shows the comparative neutralization of two virus 
isolates (EP3 91/1 and EP4 91/1) made from the same pig, 
before and after seroconversion. The isolates were made at 
an interval of 11 months; the first, when the pig was 
seronegative and serum-virus positive and the second after 
the pig had been seropositive and serum-virus negative for 
at least 6 months. The serum used in the test was collected 
at the time of the later virus isolation, and had been heat 
inactivated. Complete neutralization of 104-5 TCID5o of EP4 
91/1 was seen at serum dilutions up to 1/1280, whilst 
complete neutralization of 104 TCIDgo of EP3 91/1 occurred 
at serum dilutions up to 1/5120. Furthermore, the rate of 
reduction in virus titre for the two viruses at serum 
dilutions beyond 1/1280 or 1/5120 was nearly parallel. This 
suggested that the small end-point differences for 
neutralization of the two viruses were probably due to 
differences in the titre of each virus and not differences 
in their neutralization properties. There was therefore no 
evidence that EP4 91/1 had persisted in the pig by means of 
an acquired resistance to antibody mediated neutralization.
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Fig 4.6 Comparative neutralization of two viruses isolated 
from PF403, before and after seroconversion
Log reduction in virus titre and log reciprocal serum 
dilution are both Log10. Both viruses were tested against a 
single serum, collected at postmortem. Virus 1 was isolated 
from precolostral serum; virus 2 was isolated from 
postmortem tissues collected 320 days later.
123
54.5 - A-- ■A
CD
4 —
c/)
2  3.5 
>
C
c
o 3 -
O
I d 2.5
»
2 -
1.5 -
 1----- 1----1-----1---- 1---- 1----- 1----
2.6 2.8 3 3.2 3.4 3.6 3.8 4 4.2
Log of reciprocal serum dilution
Virus 1 Virus 2 
— O —  - - A -
124
4.4 DISCUSSION
In Chapter 3, a naturally occurring outbreak of BVD was 
described affecting both cattle and pigs on a single, mixed 
farm. A bought-in, persistently infected calf was considered 
a likely source of subsequent bovine and porcine infections. 
Although virtually all of the cattle on the farm had shown 
signs of infection, only two of six adult pigs had 
seroconverted, indicating that the virus might be less 
infectious for pigs than cattle. In vitro passage of the 
calf virus also suggested more efficient replication in 
bovine rather than porcine cells. To test whether or not the 
persistently infected calf could have been the source of the 
porcine infections, it was brought to the laboratory and 
used as a source of virus for two pig transmission studies.
The results showed that the BVDV replicating in the 
persistently infected calf had the potential to infect pigs, 
even through indirect contact. All three pigs placed in a 
pen recently vacated by this calf seroconverted to BVDV, as 
did two sows directly inoculated with serum from the calf. 
One of the two sows infected in early pregnancy gave birth 
to infected piglets indicating that there had been 
transplacental transmission of virus, most likely as a 
sequel to viraemia. The incomplete infection of the litter 
did however suggest that the virus replicated less 
efficiently in pigs than some other pestiviruses. HCVs 
usually infect the entire litter following transplacental
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spread (Terpstra, personal communication). The biphasic 
pattern of seroconversion of PF273 indicated a secondary 
virus challenge and this was probably due to a 
transplacental transmission in the reverse direction, from 
the fetuses to the dam. This probably explains the very high 
antibody titres found in the dams of congenitally infected 
pigs (Chapter 3.5).
The next question to be addressed was whether or not the 
calf virus was pathogenic for pigs, and if so, did the 
disease produced under experimentally controlled conditions 
match that seen in the naturally occurring outbreak on Farm 
"X". There are no reports of ruminant pestiviruses causing 
experimentally induced postnatal disease in pigs. The 
findings of this study were no different in this respect, 
since none of the postnatally infected pigs showed any 
grossly observable illness. However, the deaths observed in 
the affected pigs on Farm "X" all involved young piglets, 
from the same litter, suggesting that the disease might have 
been a late sequel to congenital infection. The persistently 
infected calf had been brought onto the farm about 4 months 
before the dam of the affected piglets was served, but the 
timing of the dam's infection with relation to pregnancy was 
not known. Previous experimental studies have, however, 
shown that the birth of apparently normal, but viraemic pigs 
is most likely following infection with ruminant 
pestiviruses in early gestation. For instance, direct 
inoculation of pig fetuses with BDV at 37 days of gestation
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produced just such a result (Paton, unpublished results). 
Estimating that development of viraemia and transplacental 
transmission of virus would take approximately 10 days, an 
intranasal challenge was given on the 27th day of gestation. 
Selection of the correct challenge time is probably crucial, 
since the outcome of congenital pestivirus infections is 
highly dependent on the stage of gestation at which 
infection occurs (Vannier and others, 1988).
One of the sows challenged in pregnancy was barren when 
tested at 90 days of gestation. In another experiment, where 
two sows were inoculated intranasally with BDV at days 42 
and 44 of gestation, again, only one sow subsequently 
farrowed (Paton, unpublished results). Although ruminant 
pestiviruses have been recognised as a cause of infertility 
in both ruminants and pigs, their role in the pregnancy 
terminations described above was not proven.
Of the eleven piglets born to PF273, five had been infected 
in utero and six had not. When bled again at three weeks of 
age, nine of the piglets were seropositive and only one was 
detectably viraemic. In most of the piglets, the changes in 
virus and antibody status probably resulted from ingestion 
of colostrum and absorption of maternally derived anti-BVDV 
antibodies. However, PF396 had a very much higher level of 
antibody than any of its littermates and the titre did not 
decline significantly in the next 10 months. This suggested 
that the pig had actively seroconverted. Piglet 10 from Farm
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"X" also had a very high antibody titre (Table 3.3), which 
might have resulted from recovery from congenital infection. 
At seven weeks of age, the four remaining pigs that had been 
born infected had all become seronegative and viraemic once 
again, their antibody titres having declined more rapidly 
than those of their previously uninfected littermates. Rapid 
loss of colostral antibody is a common feature of neonates 
born persistently infected with pestiviruses (van Oirschot 
and Terpstra, 1977; Plateau and others, 1980; Meyling and
Jensen 1988). Three of the four remained viraemic until 
their deaths, although a low level of antibody was detected 
in PF404, indicating that seroconversion had occurred. The 
fourth pig, PF403 seroconverted and became serum-virus 
negative by 20 weeks of age. The six piglets born uninfected 
showed a gradual loss of antibody, and none subsequently 
seroconverted. Their apparent failure to be infected by 
their viraemic littermates was probably because of 
protection derived from colostral antibodies. Virus was 
isolated from many tissues collected from pigs PF398 and 
PF404 that had died or been killed because of illness. Virus 
was also isolated from a more restricted range of tissues 
collected from PF403, six months after this pig had 
seroconverted and become non-viraemic. Terpstra and 
Wensvoort (1992) have also reported spontaneous 
seroconversion in a pig previously persistently BVDV 
viraemic. In a previous experiment (Paton, unpublished 
results), most pigs congenitally infected with BDV actively 
seroconverted and became non-viraemic in postnatal life.
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Some of these pigs also continued to harbour BDV in tissues 
long after seroconversion and clearance of serum virus had 
occurred. The detection of virus in tissues but not serum, 
after the development of neutralizing serum antibodies, 
suggests virus persistence due to location rather than 
development of resistance to antibody neutralization. It has 
certainly been reported that viral proteins are not 
expressed on the surface of pestivirus-infected cells (cited 
in Moennig and Plagemann, 1992). At any rate, these findings 
suggest that antibodies were either inefficient at clearing 
virus from tissues or else appeared in advance of some other 
mechanism that was in fact responsible. Coria and McClurkin 
(1981) have shown that a non-cytopathogenic BVDV could not 
be cleared from a cell culture by passage in the presence of 
a BVDV-neutra1izing antiserum. The role of antibodies versus 
cell mediated immunity in clearance of pestiviruses is in 
any case not well established (van Oirschot and others, 
1983). These animals developed exceptionally high antibody 
titres, presumably due to continuous stimulation of the 
immune system. Comparative neutralization tests confirmed 
that virus persistence was not due to acquired resistance to 
antibody mediated neutralization. The role of cell mediated 
immunity was not examined, and neither the trigger for, nor 
the mechanism of, the loss of congenitally induced 
immunotolérance was established.
Comparison of the pathological findings for the 
experimentally induced infections with those observed on
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Farm ,,X", revealed many similarities, including poor growth 
and fatal, haemorrhagic disease. Table 4.7 summarizes 
previously recorded clinical features of congenital, 
ruminant pestivirus infection in pigs, and indicates which 
ones were observed on Farm "X" and in the litter of PF273. 
In both Farm ,,X” and experimentally infected pigs, those 
that died youngest showed the most striking postmortem 
lesions, with most evidence of haemorrhages and oedema. 
Those that died later, after a period of ill-thrift and 
runting, showed few grossly observable postmortem lesions. 
The most consistent feature was the presence of enlarged, 
rubbery lymph nodes with a pink-red discolouration. Lesions 
of porcine intestinal adenomatosis observed in some pigs at 
postmortem examination were considered to be incidental 
findings.
Most of the viruses from the congenitally infected pigs 
could be isolated in either PK15 cells or CT cells, and 
could be maintained in either thereafter. By contrast, the 
parent virus from which they were derived (FBI 91/1) could 
not be maintained in PK15s (Chapter 3). Nevertheless, typing 
of the isolates with mAbs revealed no evidence that passage 
of the calf virus in pigs had resulted in epitope changes. 
This apparent stability of epitopes in the face of 
cross-species infections is reassuring, since mAbs are 
increasingly relied upon for discrimination between HCV and 
ruminant pestivirus infections of pigs (Edwards and others, 
1991b).
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Table 4.7 Previously recorded clinical features of
congenital, ruminant-type pestivirus infection in pigs, as 
well as those observed on Farm "X" and in the litter of 
PF273.
Clinical Previously Farm "X" PF273
feature recorded litter litter
Farrowing failure 1,6 - +
Prenatal mortality 1,3,4,6 - —
Congenital tremor 3 - —
Developmental abnormality 5,6 - —
Preweaning mortality 1,2,3,4,6 + —
Post weaning mortality 2,6 - +
Colonic button ulcers 3 - -
Conjunctivitis 2,4 - -
Gastroenteritis 1,3,4 - -
Polyarthritis 4 - ?
Pallor/anaemia 1,4,6 + +
Retarded growth 2,3,4,6 + +
Pneumonia 4 - -
Haemorrhagic PM lesions 1,2,3,4,6 + +
Oedematous PM lesions 1,2,3,6 + +
Primary postnatal disease -* - -
PM = postmortem
* mild pyrexia has been observed
1 = Vannier and others (1988)
2 = Leforban and others (1990a)
3 = Wensvoort and Terpstra (1988)
4 = Terpstra and Wensvoort (1988)
5 = Wrathall and others (1978)
6 = Paton, unpublished observations on congenital porcine 
infection with BDV.
? = some leg weakness was noted
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4:5 CONCLUSIONS
Seroconversion of pigs placed in indirect contact with the 
persistently viraemic calf demonstrated that it could have 
been the source for BVDV infection of pigs on Farm "X". 
Successful infection of pigs was in contrast to poor growth 
of this strain of BVDV in PK15 cells.
Experimentally induced infections of two pregnant sows with 
the same strain of BVDV led to the birth of congenitally 
infected piglets in one litter. Transplacental transmission 
was inefficient. It was not established whether the failure 
of the other sow to farrow was attributable to BVDV. Some 
congenitally infected pigs grew poorly and some died or were 
killed because of illness. Those that died youngest, showed 
similar postmortem lesions to those that had been observed 
in BVDV infected pigs on Farm "X". These findings were 
consistent with the theory that the deaths on Farm "X" were 
delayed sequelae to congenital BVDV infection and 
demonstrate that the persistently infected calf could have 
been the source of the infection.
Unlike cattle, which remain persistently viraemic following 
early prenatal infection with BVDV (Harkness and Roeder, 
1988), it would appear that congenitally infected pigs may 
subsequently seroconvert, associated with clearance of virus 
from serum, and possibly an improved survival rate. However, 
despite the presence of high neutralizing titres of antibody
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in serum, virus may persist for some time in tissues. This 
virus is fully neutralized by serum antibody in vitro.
MAb binding studies showed that viruses isolated from the 
experimentally infected pigs appeared identical to the calf 
isolates and slightly different from the pig isolates from 
Farm ,,X". However, passage in pigs had altered the ability 
of the virus to replicate in PK15 cells. Thus, support for 
the contention that passage of the calf virus in pigs could 
account for the . differences between the original calf and 
pig isolates was incomplete.
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5.1 INTRODUCTION
Radioimmunoprecipitation (RIP) of cell lysates with 
monoclonal and polyclonal antibodies (mAbs and pAbs) has 
identified many proteins that are associated with BVDV 
infection. Sequence analysis of the virus genome has 
permitted the production of recombinant proteins and 
synthetic peptides to map the genes. Current theory on the 
genomic organization of BVDV suggests that the virus encoded 
proteins are all derived from a single polyprotein by 
succesive cleavages, producing "families" of polypeptides, 
with common but often transient, intermediate precursors 
(Fig 1.1; Collett, 1992). The genes encoding structural 
proteins are located at the 5 ' end of the single open 
reading frame, whilst the remainder of the genome is thought 
to encode non-structural proteins involved in virus 
replication.
The designation of proteins used in this Chapter is 
according to Collett and others, (1991), with modifications 
from Collett (1992). The putative structural proteins: gp53, 
gp48, gp25 and pl4 are thought to be derived from a common 
precursor protein of 140kDa (Prgpl40). This is cleaved to 
the mature virion proteins by a number of steps giving rise 
to further intermediates, PrgpllG, Prgp78 and gp62. PrgpllG 
is the putative precursor of the three envelope 
glycoproteins and is probably cleaved to gp53 and Prgp78, 
whereupon, Prgp78 itself gives rise to gp62 which has been
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considered a likely precursor of gp48 and gp25 (Collett and 
others, 1989). A summary of this information is shown in Fig
1.1. Amongst the non-structural proteins, the best studied 
are pl25 and the related proteins: pBO and p54 (Purchio and 
others, 1984a, Collett and others, 1989). Changes in the 
pattern of cleavage of this group correlates with 
cytopathogenicity (Pocock and others, 1987, Meyers and 
others, 1991a and b) . Non-cytopathogenic strains of BVDV 
produce only pl25, whilst cytopathogenic strains produce two 
smaller proteins: pBO and p54.
Both the structural proteins and pl25/80 (but not p54 : 
Collett, 1992) are immunogenic for cattle and mice. Murine 
mAbs directed against gp53, gp48 and pl25/80 have all been 
described (Moennig and others, 1987; Bolin and others, 1988; 
Donis and others, 1988, Boulanger and others, 1991). MAbs 
with virus neutralizing activity have mostly been anti-gp53, 
although weakly neutralizing anti-gp48 mAbs have also been 
reported (Boulanger and others, 1991). MAbs specific for 
pl25/80 have been shown to recognise a broad spectrum of 
pestiviruses (Moennig and others, 1987), whilst anti-gp53
mAbs are more specific and can be used to discriminate 
between HCV and ruminant pestiviruses (Wensvoort and others, 
1986).
Using mAb competition studies, three to four antigenic 
domains have been described for BVDV gp53 (Moennig and 
others, 1989; Xue and others, 1990) whilst Wensvoort (1989)
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defined four such domains for El of HCV. Van Rijn and 
others, (1992), extending the work of Wensvoort (1989), have 
indicated that most El epitopes are situated in the 
N-terminal half of the protein, although their precise 
locations were not demonstrated.
The aim of this work was to determine the viral protein 
specificity of 17 anti-BVDV mAbs and to find out whether 
their epitopes were overlapping or spatially distinct. 
Protein specificity was determined by
radioimmunoprecipitation (RIP), whilst overlap of epitopes 
was assessed by competitive binding assays. By comparing 
these results with the already established viral strain 
specificity of the mAbs, it was hoped to identify sites of 
antigenic variation and conservation amongst pestiviruses 
and to divide them on this basis into antigenic subgroups. 
The effect of different methods of antigen preparation on 
the binding of the mAbs was also examined because of its 
importance for the development of diagnostic assays and its 
potential to give information on the conformational 
dependence of the antibody combining sites.
53  MATERIALS AND METHODS
i) Monoclonal antibodies:
MAbs were previously prepared against two laboratory strains 
of BVDV, namely NADL and Oregon C24V. Both these viruses are
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cytopathogenic (Fig 1.2), and both originated from the USA 
(Gutekunst and Malmquist, 1963; Gillespie and others, 1960). 
Production of the mAbs has been described (Edwards and 
others, 1988; Chapter 2). The immunoglobulin class of each 
mAb and its neutralizing effect on the parental strains of 
BVDV are shown in Table 2.2.
ii) Viruses and cells:
The viruses were stored at -70°C and were grown in calf 
testis cells (CT) at passage level 4-9, or in a bovine 
turbinate cell line (BT) as described in Chapter 2. A single 
stock of second passage CT cells were frozen in liquid 
nitrogen and aliquots were removed and thawed to produce the 
third passage generation. The Oregon C24V strain of BVDV 
(Gillespie and others, 1960) was biologically cloned by 
three cycles of limiting dilution and then passaged once 
more prior to use (a total of 67 in vitro passages). The 
NADL strain of BVDV (Gutekunst and Malmquist, 1963) had been 
twice plaque purified and then passaged 7 times before use 
(a total of 12 in vitro passages) . Both strains of BVDV 
produced a cytopathic effect in the two cell culture systems 
used. A non-cytopathogenic BVDV field isolate (ncpl44800: 
Chapter 2) had been biologically cloned by three cycles of 
limiting dilution and was used at passage 8.
iii) Radioimmunoprecipitation:
Preparation of radiolabelled cell Ivsates. NADL, Oregon C24V 
and ncpl44800 viruses were grown in third passage CTs. These
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cells were seeded into 25 cm2 plastic flasks and were 
infected with virus two days later, just as they became 
confluent. A multiplicity of infection of approximately 10 
was used and after one hour of viral adsorption, 9mls of 
growth medium (MEM) containing 10% PCS was added. Mock 
infected cultures were processed concomitantly. Cultures 
were incubated at 37°C until approximately 4 hours before 
the appearance of viral cytopathic effect (16 hours for NADL 
and 22 hours for Oregon C24V) or for 18 hours (ncp!44800). 
At this time all the medium was removed and after three 
washes with PBS, it was replaced with methionine deficient 
MEM without serum. This was then incubated a further two 
hours at 37 °C. Again the medium was discarded and the 
cultures washed three times with PBS. One millilitre of 
methionine deficient MEM was then added, containing 
50-100jL/Ci of radioactive L-[35S]-methionine (Amersham, UK) . 
After 4 hours further incubation at 37°C, the radioactive 
medium was discarded, the cells were washed three times with 
ice cold PBS and 1ml of lysis buffer was added per flask. 
After overnight storage at -2p°C, the flasks were thawed and 
the viscous contents were scraped into a microfuge tube, 
aspirated repeatedly through a 25 gauge needle and then 
clarified by centrifugation at 4°C and 12000g for 10 
minutes. The supernatant was retained in aliquots at -70°C 
until thawed for.RIP use. Radiolabelling was also performed 
with D-[3H]-glucosamine (Amersham, UL). The timing of the 
radiolabelling and the level of radioisotope activity were 
as above. However, PBS was used in place of methionine
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deficient medium.
Preparation of immunosorbent complex. Protein G sepharose 
beads (PGS, Pharmacia) were washed and resuspended in lysis 
buffer. A 20% suspension of PGS beads was incubated with 
mixing, at room temperature, with either antiserum or 
ascitic fluid containing mAb, in proportions of 50/Jl PGS 
beads to 4fJl antiserum/ascitic fluid. The hyperimmune BVDV 
antiserum used (pAb 7145) had been prepared by repeated 
inoculation of a gnotobiotic calf with a pool of BDV strains 
(Lucas, personal communication). After an hour, the PGS 
beads were pelleted (30 seconds centrifugation at 12000g), 
washed with 1ml of lysis buffer and resuspended in lysis 
buffer to give a 20% suspension. This was used as 
immunosorbent for immunoprécipitation.
Immunoprécipitation protocol. Cell lysates were thawed and 
mixed with Staphylococcal protein A (Sigma) pellets, 
previously washed in lysis buffer, at a ratio by volume of 
10:1, cell lysate to protein A. After one hour of mixing at 
room temperature, the protein A was removed by 30 seconds 
centrifugation at 12000g. A 5O-lOOpl volume of clarified 
lysate was then incubated overnight at 4°C with lO-5Opl of 
PGS/antibody immunosorbent. Next morning, incubation was 
continued at room temperature but with shaking for one hour. 
Immunosorbent-antigen complexes were then washed in four 1ml 
volumes of lysis buffer. After each wash step, the 
immunosorbent-antigen complex was pelleted by 30 seconds
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centrifugation at 12000g and the supernatant was discarded. 
The final pellet was mixed with 20-50pl of sample buffer 
and immersed in boiling water for 4 minutes. The fluid phase 
was removed and either loaded immediately for polyacrylamide 
gel electrophoresis or temporarily stored at -70°C.
RIP was attempted from L-[35S]-methionine labelled antigens 
of both NADL and Oregon C24V using the pAb 7145 and mAbs 
which bound to the appropriate virus in PLA. Only Oregon 
C24V was labelled with D-[3H]-glucosamine and RIPs were 
attempted from this antigen only with pAb 7145 and mAbs 
WB112C, WB163C and WB210C.
Polyacrylamide gel electroohoressis. Gels of 1.0mm thickness 
were cast with a 10% separating gel below a 4% stacking gel. 
Each lane was loaded with 20-50pl of sample buffer 
containing either eluted immunoprecipitate or 2-6pl of a 14C 
labelled mixture of molecular weight markers (Amersham, UK). 
RIPs were always loaded as pairs, including a mock-infected 
control antigen. Immediately after loading, power was 
applied at a constant current of 16mA/gel, until the 
bromophenol blue dye front had reached the start of the 
separating gel. At this point the current was increased to 
25mA/gel and electrophoresis was continued until the dye 
front had migrated to within 1cm from the bottom of the gel.
Autoradiography. After fixation, by overnight immersion in 
40% methanol and 10% acetic acid, gels were placed on filter
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papers and dried under vacuum at 80°C for 2 hours. They were 
then placed against the emulsion side of photographic films 
for exposure at -70°C. Hyperfilm Bmax (Amersham, UK) was 
used for L-[35S] methionine labelled gels and Hyperfilm 3H 
(Amersham, UK) for D-[3H] glucosamine labelled gels. After a 
variable period of exposure (3-14 days) the films were
developed and fixed. Films were then photographed with a 
Polaroid camera to produce prints'' that could be cut,
labelled and mounted. These mounts were rephotographed to 
produce the final figures.
Estimation of molecular weights. PAGE results for RIPs were 
interpreted by comparing bands present in lanes of virus
containing antigens with those from adjacent lanes 
containing mock-infected antigens precipitated by the same 
antibody. Only bands specific to the virus infected antigen 
lanes were considered to be representative of virus-specific 
proteins. The distance of migration for each band (B) was 
measured from the start of the separating gel, using a pair 
of electronic callipers giving an automatic digital 
read-out. The total distance from the start of the
separating gel to the most distal band (T) was also 
measured. The migration of each band relative to the total 
run length was then calculated (B/T) . For each gel, a 
callibration curve was constructed from the migration of the 
molecular weight marker proteins. The log10 value of the 
known molecular weight of each protein was plotted against 
its relative migration (B/T) in the gel. Apparent molecular
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weights for all other bands on the gel were calculated by 
extrapolation from this standard curve.
iv) Effect of antigen preparation on the binding of mAbs:
Binding of mAbs to a number of different cell lysate 
antigens in ELISAs was compared to their binding to acetone 
fixed cell monolayers (PLA). Antigens used were all prepared 
from the NADL or Oregon C24V strains 'bf BVDV.
ELI SA procedures. The binding of mAbs to different cell 
lysate antigen preparations was tested by indirect ELISA and 
the results obtained were compared with those from the PLA.
Antigen preparation. CT cells were grown in pairs of roller 
bottle cultures of 850cm2 surface area. When almost 
confluent, the medium was discarded and one bottle was 
infected with BVDV (NADL or Oregon C24V) at a multiplicity 
of infection of approximately one in ten. The other bottle 
was mock-infected with growth medium. After incubation for 
one hour at 37°C, the monolayers were overlain with serum 
free medium and incubated at 37°C for 48 hours. All further 
manipulations were done on ice or at 4°C using pre-chilled 
liquid reagents. The cells were washed three times with 
0.01M PBS pH 7.2 and then scraped into 20ml of serum free 
medium with a rubber policeman. Cell suspension was 
centrifuged at 3000g for 10 minutes and supernatants were 
discarded and replaced by 5ml lysis buffer (Appendix). After 
a freeze/thaw cycle, the lysis buffer antigen (detergent
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extracted antigen) was aspirated repeatedly through a 25 
gauge needle, clarified by 5 minutes centrifugation at 
12000g and then stored in aliquots at -70°C.
ELI SA orotoco1. 96 well ELISA plates (Falcon) were coated
for 48 hours at 4°C, with lOOpl of optimal dilutions of cell 
lysate antigens in 0.05M carbonate buffer pH 9.6. Positive 
(virus infected) lysate wells alternated (odd numbered 
columns) with negative (mock-infected) lysate (even numbered 
columns). After coating, the plates were shaken empty, 
washed three times, blotted dry and stored in sealed plastic 
bags at -20°C. MAbs in the form of murine ascitic fluids 
were precipitated with ammonium sulphate, redissolved at 
2.5mgml"l in 0.05M PBS pH 7.6 containing 50% glycerol and 
stored at -20°C. Serial fourfold dilutions of the mAbs were 
prepared in PLA dilution fluid at a starting concentration 
of 6.25/L/gml'1. Fifty microlitre volumes of each dilution of 
each mAb were added to replicate positive and negative 
antigen wells and incubated for an hour at 37°C. All wells 
were then washed 3 times before addition of 50pl of a rabbit 
anti-mouse, horse-radish-peroxidase-conjugated serum (RAM) 
diluted 1 in 1000 in PLA diluent. After a further one hour 
at 37°C, the plates were washed 4 times before addition of 
50pl of substrate (tetra-methyl benzidine: TMB) to all
wells. All washes were as for the PLA (ie all with PLA wash 
fluid, except for the one before addition of substrate, 
which was with water). After 10 minutes, colour development 
was stopped by addition of 50pl of 2M sulphuric acid and
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colour intensity was recorded by spectrophotometer at a 
wavelength of 450nm. Net optical densities were calculated 
from the difference between the values for infected and 
mock-infected antigens.
To check the affinity of the RAM conjugate for the mAbs, 
each mAb was titrated in carbonate buffer and coated onto 
ELISA plates. After washing, a fixed" dilution of conjugate 
was added to all wells and the test completed as above.
Denatured antigens. Detergent extracted antigens were heat 
treated for 5 minutes in a hot block (Biometra) before 
dilution in chilled carbonate buffer, coating to plates, and 
testing In ELISA as above. Temperatures employed were 25°C, 
50°C, 75°C and 100°C.
Peroxidase linked assay (PLA). The PLA was carried out as 
described in Chapter 2, using CT (passage 4-9) or BT cells 
infected at the time of seeding, with NADL or Oregon C24V 
viruses. Virus was added . at a fixed concentration, 
equivalent to lOOOTCIDgo/microtitre plate well. Plates were 
fixed and stained after three days incubation at 37°C. MAbs 
in the form of concentrated tissue culture supernatants and 
RAM conjugate, were used at previously determined optimal 
dilutions (Sands, personal communication).
v) Competitive binding assays:
Two types of competitive binding assay were used: a
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qualitative test based on the PLA and a quantitative ELISA 
format.
Competition PLA. Competition was assessed between
biotinylated mAbs and unconjugated ascitic fluids for 
binding to infected and mock-infected BT cells fixed to 
microtitre plates, using alternate columns of wells for 
infected and mock-infected cells. Cells were infected with 
NADL or Oregon C24V viruses at a multiplicity of 
approximately 1 and after 48 hours incubation, were fixed in 
situ with PLA fixation fluid. These plates were stored in 
sealed plastic bags at -20°C. The plates were thawed and 
rehydrated with PBS immediately prior to use.
MAbs in the form of ammonium sulphate precipitated ascitic 
fluids were biotinylated using the biotin ester 
N-hydroxysuccinimidobiotin (BNHS from Sigma). After ammonium 
sulphate precipitation, mAbs were redissolved in 0.01M PBS 
pH 7.6 to give a final concentration of lOmgml'1. The biotin 
ester was prepared freshly at a concentration of 22mgml'1 in 
dimethyl sulphoxide. To 1ml of mAb was added:
- 0.1ml 0.5M carbonate buffer
- 0.0125ml BNHS solution (added dropwise with 
stirring)
The mixture was stirred at room temperature for 4 hours and 
then dialysed overnight against 0.01M PBS pH 7.6 to remove 
unbound biotin. Biotinylated mAbs were stored in 50% 
glycerol at -20°C.
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Equal volumes (50/ul) of unbiotinylated and biotinylated mAbs 
were added to antigen containing wells sequentially and 
incubated for 15 minutes at 37°C. After three washes with 
PBST, binding of biotinylated mAbs was detected by 15 
minutes incubation at 37°C with 50pl of a 1 in 400 dilution 
of streptavidin-biotinylated horse radish peroxidase complex 
(Amersham, UK) . Each biotinylated mAb was titrated on its 
own and then used in competition tests at twice the 
concentration at which staining intensity began to decline. 
After three washes with PBST, followed by a final wash in 
distilled water, the bound peroxidase complex was detected 
by 15 minutes incubation at 37°C with
diamino-ethyl-carbazole (DAEC), which stains the monolayer 
red-brown. The reaction was stopped by a further wash in 
PBST and the result assessed by visual microscopical 
observation of cell staining. Staining of infected cells was 
assessed by comparison with staining of uninfected cells, 
and was scored either positive or negative. The effect of 
competitor mAbs at a range of dilutions between 1/50 and 
1/7250 was compared to that of PLA diluent and competition 
at a dilution of >1/100 was considered significant.
Competition ELISA. Some mAbs were reassessed using a 
competitive binding assay modified to give quantitative 
results. Fixed cell monolayers were prepared as before, 
except that a higher multiplicity of infection was used 
(approximately 100) in combination with a shorter incubation
148
prior to fixation (24-36 hours). This was necessary to 
achieve a more uniform infection of the cell sheet, before 
the onset of viral cytopathic effect. Binding of mAbs was 
assessed quantitatively by spectrophotometer. This was 
achieved by substituting TMB for DAEC as substrate. Whereas 
DAEC, produces an insoluble reaction product that stains the 
cell monolayer, TMB is converted to a soluble product, that 
colours the liquid phase of the microtitre well. After the 
enzyme reaction has been stopped with 2M sulphuric acid, 
this colour is yellow and can be measured by absorbance of 
light at 450nm. The percentage inhibition of binding was 
calculated from the ratio of the net optical density 
(positive antigen value minus negative antigen value) when 
biotinylated mAb competed with either an irrelevant 
unlabelled mAb (mAb 3C1, which is transmissible 
gastroenteritis virus specific) or serial dilutions of 
unlabelled pestivirus mAbs. Unlabelled mAbs were in the form 
of ammonium sulphate precipitated ascitic fluids redissolved 
in PBS pH 7.6.
vi) Epitope conservation:
The specificity of the mAbs for 187 different pestiviruses 
was determined by Sands and Edwards (Edwards and others, 
1987; Edwards and Sands, 1988; Sands, personal 
communication), using the PLA and testing each mAb at a 
single predetermined dilution. The viruses examined were a 
mixture of laboratory strains and field isolates that 
differed considerably in their degree of culture passage and
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characterization. For the PLA, HCVs were grown in PK15 
cells, whilst BVDVs and BDVs were grown in bovine turbinate 
cells. Laboratory strains came from a number of different 
countries, whereas most low passage field isolates were from 
Britain. Ninety-two viruses had been isolated from cattle, 
65 from pigs and 30 fom sheep. PLA Staining was scored as 
negative, weak positive, positive or strong positive. 
Staining of less than 20% of the cell sheet (plaques) was 
also noted. For the purpose of correlating the viral strain 
specificty of the mAbs with their protein specificity, all 
positive staining reactions including weak positives and 
plaques were grouped together.
53  RESULTS
i) Radioimmunoprecipitation:
Figures 5.1-5.4 are autoradiographs from polyacrylamide gels 
that have been used to separate immunoprecipitated, 
radiolabelled BVDV antigens. Arrows indicate the positions 
of virus-specific proteins. Fig 5.1 shows RIPs of 
L-[35s]-methionine labelled NADL antigens with most of the 
mAbs and with a hyperimmune pestivirus antiserum (pAb 7145). 
Table 5.1 summarizes which virus-specific bands were 
precipitated by which antibodies from the NADL antigens. The 
polyclonal antibody precipitated eight different sized 
proteins of variable labelling intensity, some showing only 
very faintly. Most of the mAbs gave one of two types of
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Fig 5.1 Autoradiograph of radioimmunoprecipitations from
L-[35S] methionine labelled NADL antigens.
Odd numbered lanes = precipitations from virus infected cell 
lysates; even numbered lanes = precipitations from 
mock-infected cell lysates, m = molecular weight markers. 
Numbers beside arrow heads = estimated molecular weight of 
protein bands (xl03kDa).
Precipitating antibodies
a) Lanes: 1 & 2 = WB170n; 3 & 4 = WB212n; 5 & 6 = WB210c; 7
& 8 = 160n; 9 & 10 = pAb 7145; 11 & 12 = WB214n; 13 & 14 =
WB166n; 15 & 16 = WB158n.
b) Lanes : 1 & 2 = WB106c; 3 & 4 = WB109c; 5 & 6 = WB215c; 7
& 8 = WBlOSc; 9 & 10 = WB112c; 11 & 12 = WB103c; 13 & 14 =
WB163C.
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Table 5.1 Virus-specific bands associated with antibodies
following RIP of L-[35S]-methionine labelled NADL antigens
(from Fig 5.1).
M.Wt. Intensity mAbs precititating this band
kDa. (pAb 7145)
122 + WB160n, WB212n, 
WBlOSc, WB109C,
WB103C, WB112C, 
WB106C, *
108 (+) (WB215C), (WB163C), (WB166n)
77 ++ WB160n. WB212n. 
WBlOSc. WB109C.
WB103C. WB112C. 
WB106C
60 ++
53 ++ WB158n. WB166n. WB214n. WB210C
50 ++ WB170n. WB163C. WB215C
43 (+) (WB210C) •
26 + WB158n, WB166n, 
WB170n, WB163C,
WB214n, WB210C, 
WB215C
Intensity of band for pAb 7145: (+) = barely discernible, +
= weak, but clearly visible, ++ = strong band. Bracketed 
mAbs indicate very weak band only. * = all other mAbs gave 
weak signal also. Underlined mAb indicates major band(s). 
MAbs: WB165c, WB115c and WB162c do not recognise BVDV strain 
NADL in PLA and were not tested against NADL antigens by 
RIP.
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reaction pattern. Six mAbs precipitated a protein with 
anestimated molecular weight of 77kDa and all seven other 
mAbs precipitated three proteins equally. These three 
proteins were estimated to be 60kDa, 53kDa and 50kDa. All 
thirteen mAbs showed variable but weak precipitation of 
other virus-specific proteins. One of the mAbs (WB210c) that 
precipitated the 60kDa, 53kDa and SOkDa proteins, showed 
very weak precipitation of a 43kDa protein, that was also 
precipitated weakly by the polyclonal antibody.
Fig 5.2 shows RIPs of L- [35 S ] -methionine labelled Oregon 
C24V antigens with most of the mAbs and with the pAb 7145. 
The photograph in Fig 5.2a is of an 8% acrylamide gel, 
rather than the 10% gels shown in the other figures. Tables 
5.2-5.4 show which virus-specific bands were precipitated by 
which antibodies from these figures. Nine virus-specific 
bands were precipitated by the polyclonal antibody (Fig
5.2.b). The molecular weights of these proteins were mostly 
similar to those precipitated by the same antibody from NADL 
antigens (Table 5.5a). MAbs again could be divided into 
three reactivity groups. Three mAbs strongly precipitated a 
protein of 78kDa and five precipitated three proteins of 
approximately 62kDa, 53kDa and SlkDa. The relative 
intensities of the bands representing these proteins varied 
somewhat between gels, but the 53kDa band was usually the 
strongest (Fig5.2a). As with NADL antigen, a ninth mAb 
(WB210c), precipitated proteins of 62kDa and 51-53kDa, but 
also a protein of 48kDa. With Oregon C24V antigen the band
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Fig 5.2 Autoradiograph of radioimmunoprecipitations from
L-[35S] methionine labelled Oregon C24V antigens.
Odd numbered lanes = precipitations from virus infected cell 
lysates; even numbered lanes = precipitations from 
mock-infected cell lysates, m = molecular weight markers. 
Numbers beside arrow heads = estimated molecular weight of 
protein bands (xl03kDa).
Precipitating antibodies
a) Lanes: 1 & 2 = WB115c; 3 & 4 = WB162c; 5 & 6 = WB210c; 7
& 8 = 165c; 9 & 10 = WB160n; 11 & 12 = WB163c.
b) Lanes: 1 & 2 = pAb 7145; 3 & 4 = WB215c; 5 & 6 = WBlOSc.
c) Lanes: 1 & 2 = WB103c; 3 & 4 = WB166n; 6 & 7 = WB112C.
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Table 5.2 Virus specific bands associated with antibodies
following RIP of L- [3 5 S]-methionine labelled Oregon C24V
antigens (from Fig 5.2a).
M.Wt. Intensity mAbs precititating this band
kDa. of band
115/95 + WB115c,
WB160n,
WB162C,
WB163C
WB210C, WB165C
78 ++ WB160n
71 + WB160n
67 (+) WB160n
62 - ++ WB115C,
WB163C
WB162C, WB210C, WB165C
56 (+) WB160n
53-51 ++ WB115C,
WB163C
WB162C, WB210C, WB165C
48 4-4- WB210C
28 4- WB115C,
WB163C
WB162C, WB210C, WB165C
Intensity of band: (+) = barely discernible, + = weak, but
clearly visible, ++ = strong band.
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Table 53  Virus specific bands associated with antibodies
following RIP of L- [35S]-methionine labelled Oregon C24V
antigens (from Fig 5.2b).
M.Wt.
kDa.
Intensity 
(pAb: 7145)
mAbs precititating 
this band
115 + WB215C, WB105C
95 (+) WB215C
78 ++ WB105C
67 (+) WB105C
62 ++ WB215C
53 . ++ WB215C
51 ++ WB215C
48 ++
23 + WB215C
Intensity of band for pAb 7145: (+) = barely discernible, +
= weak, but clearly visible, ++ = strong band. Underlined 
mAb indicates major band(s).
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Table 5.4 Virus specific bands associated with antibodies
following RIP of L-[35S]-methionine labelled Oregon C24V
antigens (from Fig 5.2c).
M.Wt. Intensity mAbs precititating
kDa. this band /
+ WB103C, WB112C
++ WB103C, WB112C
+ WB112C
Intensity of band: + = weak, but clearly visible,
strong band.
115
78
57
++ =
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Table 5.5 Comparison of apparent molecular weights of proteins 
precipitated from NADL and Oregon C24V antigens labelled 
with L-[35S]-methionine.
a) Proteins precipitated by pAb 7145:
Virus Apparent molecular weight in kDa
NADL 122 108 77 60 53 50 43 26
Oregon C24V 115 95 78 71 67 62 56 53 51 48 23
Colletta ? ? pBO ? ? gp62 ? gp53 gp48
I
b) Principal13 proteins precipitated by mAbs:
Virus Apparent molecular weight in kDa
NADL 77 60 53 50 43
Oregon C24V 78 62 53 51 48
Colletta pBO gp62 gp53 gp48
a likely designation of proteins according to Collett and 
others (1988b); ? = uncertain. b Principal protein = one
that showed up as a strong band (++) by autoradiography for 
at least one of the two virus antigens.
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representing this 48kDa protein was much stronger than with 
NADL. As with the polyclonal antibody, proteins of similar 
apparent molecular weights were in most cases precipitated 
from either viral antigen by the same mAb (Table 5.5b).
Some of the proteins were precipitated rather weakly and the 
major mAb precipitations had apparent molecular weights of: 
77/78kDa, 62/62kDa, 53/54kDA, 52/50kDa and (43)/48kDa. All
of these are similar to previously reported apparent 
molecular weights for BVDV proteins (Table 5.5b). The 43kDa 
protein in NADL lysates was largely obscured by a prominent 
cell protein, whilst mAb WB166n in combination with Oregon 
C24V, precipitated no virus-specific proteins. All other 
mAb/virus combinations produced virus-specific
autoradigraphic bands following PAGE separations. Three 
basic patterns of reactivity were observed, and the mAbs 
were grouped on this basis. Group 1 mAbs precipitated a 
polypeptide of approximately 78kDa and this was always by 
far the strongest band. A weaker band was consistently 
present at approximately 115kDa whilst less consistent weak 
bands were seen at 95kDa, 71kDa, 67kDa and 57kDa. Group 2 
mAbs precipitated three different molecular weight proteins 
all of which appeared on autoradiographs with almost equal 
intensity: 62kDa, 53kDa and SlkDa. A further weak band was 
discernible in most cases at about 25kDa. Additional, weaker 
bands that were less consistently present had apparent 
molecular weights of approximately 115kDa, and 95kDa. A 
single group 3 mAb WB210c showed a similar reactivity to
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that of the group 2 mAbs except that an additional band was 
present at 43/48kDa, particularly with Oregon C24V antigen. 
These results are summarized in Table 5.6.
Fig 5.3a shows RIPs of D-[3H]-glucosamine labelled Oregon 
C24V antigens with a hyperimmune pestivirus antiserum (pAb: 
7145) and with one each of the mAbs from groups 1, 2 and 3
(mAbs WB163c, WB210c and WB112c).^ Table 5.7 shows the
apparent molecular weights of the virus-specific bands 
precipitated by the antibodies from this figure. The pattern 
of bands precipitated from D-[3H] glucosamine labelled 
lysates was similar to that observed with L-[35S] methionine 
labelling. The principal product precipitated by the group 
1 mAb, WB112c, was again at 78kDa. A very weak band was 
discernible at llSkDa, but this was also present for the 
other mAbs. A group 2 (WB163c) and a group 3 (WB210c) mAb
produced very similar results as with L-[35S] methionine
labelling except that an additional weak band was observed 
at 133kDa. To confirm that the same protein was being 
precipitated from both L-[35S]-methionine labelled and 
D-[3H]-glucosamine labelled Oregon C24V antigens by WB112c, 
the two products were run side by side on the same gel (Fig 
5.3b). The major virus-specific band precipitated from the 
L-[35 S ]-methionine labelled antigen is at 78kDa and this 
lines up exactly with the only visible band precipitated 
from the D-[3H]-glucosamine labelled antigen. This indicated 
that the 78kDa protein is glycosylated.
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Table 5.6 Classification of mAbs by RIP patterns
Group 1 Group 2 Group 3
Major band(s) (kDa) 78 62,53,51 62,53,51,(43)/48
Likely specificity p80 gp'Ss gp48
Oregon C24V 
mAbs
103,105,
106,109,
112
115,162,
165,215,
210
NADL
mAbs
160,212 158.166.
214,170
mAbs = virus neutralizing
Abbreviated mAb designation used without WB prefix or c/n 
ending. ______
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Fig S3 Autoradiograph of radioimmunoprecipitations from a) 
D-[3H] glucosamine labelled Oregon C24V antigens or b) 
D-[3H] glucosamine and L-[35S] methionine labelled Oregon 
C24V antigens.
m = molecular weight markers. Numbers beside arrow heads = 
estimated molecular weight of protein bands (xl03kDa).
Precipitating antibodies
a) Even numbered lanes = precipitations from virus infected 
cell lysates; odd numbered lanes = precipitations from 
mock-infected cell lysates. Lanes: 1 & 2 = pAb 7145; 3 & 4 = 
WB163c; 5 & 6 = WB210c; 7 & 8 = 112c.
b) Lanes : 1 & 2 = WB112c/L- [35S] methionine labelled Oregon 
C24V antigens (lane 1 = mock-infected cell lysate, lane 2 = 
virus infected lysate). Lanes 3 & 4 = WB112c/D-[3H]
glucosamine labelled Oregon C24V antigens (lane 3 = virus 
infected lysate, lane 4 = mock-infected lysate).
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Table 5.7 Virus specific bands associated with antibodies
following RIP of D- [3H]-glucosamine labelled Oregon C24V
antigens (from Fig 5.3a).
M.Wt. Intensity mAbs precititating this band
kDa. (pAb: 7145)
(WB163C), (WB210C)
(WB163C), (WB210C), (WB112c)
WB112C
WB163C, WB210C 
WB163C, WB210C 
WB210C, (WB163C)
WB163C
Intensity of band: (+) = barely discernible, + = weak, but
clearly visible. Bracketed mAbs indicate very weak band 
precipitated.
133 (+)
115 (+)
78 +
62 (+)
51 +
48 +
25 +
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Fig 5.4 Autoradiograph of radioimmunoprecipitations from 
L-[35S] methionine labelled non-cytopathogenic BVDV 
(144800).
Even numbered lanes = precipitations from virus infected 
cell lysates; odd numbered lanes = precipitations from 
mock-infected cell lysates, m = molecular weight markers. 
Numbers beside arrow heads = estimated molecular weight of 
protein bands (xl03kDa).
Precipitating antibodies
Lanes: 1 & 2 = WB112c; 3 & 4 = pAb 7145
167
1 2  3 4
1 1 3K
168
Fig 5.4 shows the result of RIPs with a non-cytopathogenic 
strain of BVDV (ncpl44800) and both the group 1 mAb: WB112c 
and pAb 7145. Virus-specific bands are arrowed, indicating 
their apparent molecular weights. Although the level of 
background binding is high, making discrimination of 
virus-specific bands difficult, mAb WB112c clearly 
precipitates a protein of approximately 113kDa.
ii)  Effect of antigen preparation on the binding of mAbs:
Graphs of optical density, versus mAb concentration coated 
to ELISA plates, indicated that the rabbit anti-mouse 
conjugate bound well to all of the mAbs, giving a plateau 
optical density of between 1.3 and 1.8 in all cases.
The cell lysate antigen concentration which gave the maximum 
ELISA signal was generally about four times less for group 2 
or 3 mAbs compared to group 1 mAbs. Fig 5.5 shows the 
respective dose response curves for the binding of a group 1 
(WB112c), group 2 (WB163c) and group 3 mAb (WB210c) to
different ELISA antigens, prepared from the homologous 
strain of virus (ie that against which the mAbs were 
raised). Table 5.8 compares plateau optical densities in 
ELISA using detergent extracted antigens with binding of 
mAbs in PLA. Table 5.9 summarizes the effects of heat 
treatments on the binding of mAbs to detergent extracted 
antigens.
Some of the mAbs bound strongly to detergent extracted
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Fig 5.5 Dose response curves for binding of mAbs to detergent 
extracted antigens in ELISA.
a) MAb WB112c (group 1)
b) MAb WB163c (group 2)
c) MAb WB210c (group 3)
Different lines represent binding of mAbs to Oregon C24V 
cell lysate antigen heat treated for 5 minutes prior to 
coating: 25°C (solid lines/boxes); 50°C (dashed
lines/triangles); 75°C (dotted lines/circles); 100°C
(long-dashed lines/asterices).
170
o5 o5
S»
1
<
It
wo
&
8*
(tuuosfr) Aysuap iBOjido ibn
o§
■o D)
<
O
ëo
I 4
8*
(oiuost) Aysuep (eoiido 19N
(0
sss
m D)
:i
8
« SI
o
= o
ëo
8+
(luuosfr) ^ isu ep  iBOjido jbn
171
Table 5.8 Comparison of mAb binding to BVDV NADL and Oregon 
C24V antigens in ELISA and in PLA
PLA ELISA
NADL Oregon C24V NADL Oregon C24V
Oregon C24V mAbs
WB103C (gi) ++ ++ 4-4- 4-4-
WB105C (gi) ++ ++ 4-4- 4-4-
WB106C (gi) ++ ++ 4-4- 4-4-
WB109C (gi) ++ ++ 4-4- 4-4-
WB112C (gi) ++ ++ 4-4- 4-4-
WB115C (g2) — 4-4-
WB162C (g2) - 4-4- 4-4-
WB163C (g2) ++ 4-4- 4- 4-4-
WB165C (g2) — 4-4-
WB215C (g2) + 4-4- 4-4-
WB210C (g3) ++ 4-4- - 4-
NADL mAbs 
WB160n (gl) ++ 4-4- 4-4- 4—H
WB212n (gi) ++ 4-4- 4-4- 4-4-
WB158n (g2) ++ — 4-4-
WB166n (g2) ++ 4-4- 4-4-
WB170n (g2) ++ — 4-4-
WB214n (g2) ++ 4-4- 4-4- 4-4-
PLA antigens prepared from acetone fixed infected and mock 
infected CTs. ELISA antigen prepared from detergent 
extracted infected and mock-infected cell lysates. For PLA: 
— no virus—specific staining, + = virus—specific staining, 
++ = strong virus-specific staining. For ELISA: - = plateau 
net optical density = <0.2, + = plateau net optical density 
= 0.2 to 0.5, ++ = plateau net optical density = >0.5. gl-3 
= radioimmunoprecipitation groups 1-3 .
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Table 5.9 Binding of mAbs to heat treated antigens in ELISA
Percentage recognition 
of heat treated antigena
Oregon C24V antigen 
WB103C (gl)
WB105C (gl)
WB106C (gl)
WB109C (gl)
WB112C (gl)
WB160n (gl)
WB162C (g2)
WB163C (g2)
WB215C (g2)
WB210C (g3)
NADL antigen 
WB160n (gl)
WB212n (gl)
WB158n (g2)
WB166n (g2)
WB214n (g2)
50°C
0
4
0
21
0
33
24
28
14
49
5
2
18
23
27
75°C
0
0-
0
17
0
25
1
0
2
15
100°C
1
0
3
25
0
34
0
1
3
12
a = ELISA signal (net plateau optical density) obtained for 
heat treated antigen divided by ELISA signal for antigen 
treated at 25°C X 100 (ie all values are relative to 100% 
recognition at 25°C). gl-3 = radioimmunoprecipitation 
groups 1-3
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antigens (Fig 5.5 and Table 5.8). Comparing binding of the 
mAbs to detergent extracted antigens with binding to acetone 
fixed cell monolayers (PLA) revealed major differences. All 
mAbs that reacted in ELISA also reacted in PLA, but the 
converse was not true (Table 5.8). In PLA, all mAbs reacted 
strongly with the parental strain of virus against which 
they had been raised, whilst some reacted to both BVDV 
strains NADL and Oregon C24V. In ELISA, several group 2 
mAbs gave ELISA signals of <0.2 with the homologous virus 
(WB165c, WB115C, WB170n) and others that reacted to both
NADL and Oregon C24V in PLA again had plateau ELISA signals 
<0.2 to the heterologous strain (WB166n, WB215c). The
ability of group 2 mAbs to neutralize NADL and Oregon C24V 
correlated better with their binding to these viruses in 
ELISA than with their binding in PLA (Table 5.10). The three 
mAbs (WB165c, WB115c, WB170n) that did not neutralize their 
parent virus, also did not recognise this virus in ELISA. 
MAbs that neutralized only their parent virus, for the most 
part only recognised parent virus in ELISA: WB166n, WB215C, 
WB158n, WB162C. The only exception was WB163C, which did
give a weak ELISA signal (plateau optical density of 0.3) 
with the heterologous virus. WB214n which neutralized both 
NADL and Oregon C24V viruses also reacted strongly (plateau 
optical densities of 1.0 and 0.9) with both in ELISA.
The group 2 mAbs all reacted similarly with heat treated, 
detergent extracted antigens (Fig 5.5b and Table 5.9). They 
showed a much reduced recognition of antigen that had been
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Table 5.10 Comparison between mAb neutralization and binding 
to ELISA or PLA antigen for group 2 mAbs.
NADL Oregon C24V
PLA NEUT ELISA PLA NEUT ELISA
Oregon C24V mAbs 
WB115C 
WB162C 
WB163C 
WB165C 
WB215C
+
+
+
+
+
+
+
+
+
+
+
NADL mAbs 
WB158n 
WB166n 
WB170n 
WB214n
+
+
+
+
+
+
+
+
PLA: - = no virus-specific staining, + = virus-specific
staining. Neut = virus neutralizing effect of mAb: - = no 
neutralization of IOOTCID50 of virus by 1/50 dilution of mAb 
ascites. ELISA: - = net plateau optical density of <0.2, + = 
net plateau optical density of >0 .2 .
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heated at 50oC, and failed to show significant binding, 
where heat treatment was at 75°C or 100°C. This was in 
contrast to the reactivity seen with mAbs directed towards 
other BVDV proteins. Most group 1 mAbs did not recognise 
antigen treated at 50°C or above (Fig 5.5a and Table 5.9). 
However, WB109c and WB160n showed approximately 25% of 
binding at all heat treatments compared to 25°C. The single 
group 3 mAb (WB210c) showed a unique^pattern of recognition 
of heat treated antigens (Fig 5.5c and Table 5.9).
iii) Competitive binding assays:
PLA. MAbs WB166n and WB170n were not successfully 
biotinylated and so were only tested as unbiotinylated 
blockers. All the mAbs were assessed for competition between 
one another using the modified PLA and no competition was 
detected between mAbs in different RIP groups. Amongst Group 
1 mAbs all competition involved reciprocal blocking of 
^1/250 and where both Oregon C24V and NADL virus antigens 
were examined an identical pattern of blocking was obtained. 
On this basis, four competition subgroups were defined (Fig 
5.6). There was a more complex relationship between Group 2 
mAbs, with both one and two way blocking, and with all mAbs 
showing at least some degree of one way blocking activity 
against one or more other mAbs in the group (Table 5.11). 
With certain mAb combinations the presence of unbiotinylated 
mAb resulted in a partial block, characterised by an altered 
and usually weakened pattern of staining. In such cases, 
full blocking was not observed even at high concentrations
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Fig 5.6 Competitive binding amongst group 1 mAbs.
Mab = unbiotinylated blocker. B'Mab = biotinylated mAb. c = 
tested against Oregon C24V antigen. % = tested against NADL 
antigen. MAbs abbreviated to numerical code only eg 105 = 
WB105C.
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B’Màl
Reciprocal blocking (A-D =  competition group)
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Table 5.11 C om p etitive  b in d in g  betw een group 2 (a n ti-g p 5 3 )  
mAbs
NADL virus
Blocking
mAb
Biotinylated mAb
WB214n WB166n WB215C WB163C WB170n WB158n
WB214n +/88 nt +/100 -/37 nt - / 3 7
WB166n +/82 nt +/100 -155' nt —/18
WB215C -/15 nt +/87 ~/38 nt -/38
WB163C - / 8 nt +/94 +/98 nt -/27
WB170n -/18 nt +/60 —/60 nt —/16
WB158n "/5 nt +/90 -/38 nt +/100
WB115C, WB162c, WB165c do not recognise NADL
Oregon C24V virus
Blocking Biotinylated mAb
mAb_____ _______________
WB214n WB115C WB162C WB215C WB166n WB163C WB165C
WB214n +/100 +/100 +/100 +/100 nt -/ll +/100
WB115C +/58 +/94 +/87 +/51 nt -/38 —/13
WB162C +/97 +/90 +/98 +/92 nt -122 —/—54
WB215C +/98 +/95 +/100 +/100 nt +/80 -/23
WB166n +/45 +/75 +/80 —/53 nt -/20 +/100
WB163C —/—6 +/100 +/100 +/78 nt +/92 +/100
WB165C —/—4 —/—4 -122 -/ll nt -/20 +/100
WB158n, WB170n do not recognise Oregon C24V
+ or - = positive or negative for competition in PLA 
numerical value = percentage competition in ELISA 
nt = not tested because unable to biotinylate mAb
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of unbiotinylated mAb. Because of the difficulty of 
assessing this type of change objectively it was discounted 
when scoring the plates. However, this phenomenon was the 
main reason for repeating the competitive binding assay 
using an ELISA format.
ELISA. Plateau inhibition levels for competition between 
mAbs were established from graphs ^ such as Fig 5.7 and 
overall results are summarised in Table 5.11. The findings 
were similar to those obtained by modified PLA, but some 
weak competition detected by ELISA appeared to have been 
missed in the other assay. All of the mAbs, except WB165c, 
blocked the binding of at least one other biotinylated mAb. 
Furthermore, each biotinylated mAb except for WB158n, was 
blocked by at least one other unbiotinylated mAb. Reciprocal 
competition of >45% between mAbs is shown in Fig. 5.8. One 
way blocking data for WB166n and WB170n was also included in 
this figure as the possibility of reciprocal block could not 
be excluded for these mAbs. If reciprocal blocking is taken 
as an indication of spatial proximity, then for both 
viruses, it can be seen (Fig 5.8) that many of the epitopes 
appeared to cluster within a single domain, and only those 
of WB158n, and possibly WB165c, were distinct. The four 
epitopes present on both viruses (those of WB166n, WB214n, 
WB215c and WB163c) showed similar, but not identical inter 
relationships whichever virus was used as antigen. A single 
mAb combination showed evidence of binding synergism in that 
WB162c increased the binding of biotinylated WB165c by 54%.
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Fig 5.7 Competitive binding curves.
Figure shows competitive binding between unbiotinylated 
group 2 mAbs and biotinylated WB214n. The percentage of 
blocking was calculated from the ratio of the net optical 
density when biotinylated mAb competed with an irrelevant 
unlabelled mAb or with an unlabelled pestivirus mAb.
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' D • - "O ' — •
WB162C WB163C WB165c WB215C
Fig 5.8 Epitope maps for group 2 mAbs.
Epitope maps of the gp53 proteins of BVDV strains NADL and 
Oregon C24V. Each circle represents the epitope of a single 
mAb, except for WB162c and WBllSc, which behaved in the same 
way and are displayed jointly. Overlap of circles indicates 
reciprocal block of >45% for binding of relevant mAbs in 
competitive binding assay. MAbs defining epitopes 
represented by circles with dotted outlines could not be 
biotinylated. Hence, although tested only by one-way 
blocking, possibility of reciprocal block not excluded. Blue 
circles represent relatively conserved epitopes (identified 
in >30% of BVDVs by PLA), whilst red circles represent 
relatively strain-specific epitopes (identified in <10% of 
BVDVs by PLA). * = neutralizing mAb.
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WB158n 
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WB214n
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WB215C
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iv) Epitope conservation:
Fig 5.9 shows the viral strain specificity of the mAbs in 
relation to their protein specifities. Ruminant viruses were 
designated BVDV if from cattle or BDV if from sheep. HCV 
designation was only given to the 58 isolates from pigs that 
were recognised by HCV specific mAbs (these mAbs did not 
recognise any of the viruses isolated from ruminants). 
Results for seven porcine isolates not recognised by HCV 
specific mAbs are shown separately (Table 5.12). These seven 
isolates are not considered to be HCVs, not only on the 
basis of mAb reactivity, but also because of their low 
virulence for pigs and their pattern of cross-neutralization 
by reference antisera (Wensvoort and others, 1989a). The 
Wisman and P2 91/1 viruses appeared BVDV-like, but none of 
the others reacted with more than two anti-gp53 BVDV mAbs.
The group 1 mAbs tended to be broadly reactive, whilst most 
of the group 2 and group 3 mAbs bound to many BVDVs, a 
lesser proportion of BDVs but not HCVs. There was a striking 
difference between the binding of mAbs WB160n and WB109c in 
terms of viral strain specifity, even though they showed 
reciprocal blocking in competition testing with Oregon C24V. 
Whereas WB109C was panreactive, WB160n bound to just one HCV 
and only a proportion of BVDVs and BDVs. When HCV strain 
Baker A was used as antigen instead of Oregon C24V in 
competition testing, then WB160n no longer blocked the 
binding of WB109c.
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Fig5.9 Viral strain specificity of mAbs.
Figure shows apparent conservation of 17 epitopes amongst 
180 pestiviruses. MAb reactivity determined by PLA (Sands, 
personal communication). BVDV = bovine pestivirus isolate; 
HCV = porcine pestivirus isolates recognised by HCV-specific 
mAbs; BDV = ovine pestivirus isolate. A,B,C,D = competitive 
binding groups (domains) for p80 mAbs.
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Table 5.12 Recognition of atypical porcine pestiviruses from 
different countries by BVDV mAbs
mAb
Holland Germany France Italy Britain
Wisman Rutter V725 Vosges D4942 87/6 P291/1
Groun 1 *
WB103C + + + + + + nt
WB112C + + + + + + nt
WB105C + ' + + + / + + +
WB106C + + + + + + nt
WB212n + + + + + + nt
WB109C + + nt + + + nt
WB160n + + + + + + +
Grouo 2
WB215C + - — — + — +
WB214n + - + + — — +
WB162C + - — — — — +
WB163C + + - — — — +
WBllSc + - — — — + —
WB166n + + + + — + +
WB165C — - — — — — —
WB158n - -  . - — — — —
WB170n - - — — — — —
Grouo 3
WB210C + + + — +
+/- = positive/negative staining in PLA 
nt = not tested
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From Fig 5.9 it can be seen that WB160n and WB166n 
recognised a very similar proportion of BVDVs and BDVs, even 
though these mAbs are specific for different virus proteins. 
A somewhat lower proportion of ruminant viruses were also 
recognised by the group 3 mAb WB210c and several group 2 
mAbs (WB215c, WB162c and WB214n). Fig ,5.10 shows which of 
the 30 BDV isolates were recognised by which of these 6 
mAbs. It can be seen that all isolates that bound WB160n 
also bound WB166n. The smaller proportion of viruses 
recognised by the other 3 mAbs were always a subset of the 
ones recognised by WB166n and WB160n. A similar pattern was 
seen with BVDVs, in which the more highly conserved WB160n 
and WB166n epitopes tended to be missing from the same 
isolates, most of which also lacked the epitopes for the 
other 3 mAbs. Of the seven porcine isolates previously 
considered to be non-HCV pestiviruses, two were clearly 
BVDV-like, whilst the remaining five were difficult to 
classify, mostly binding WB160n, WB166n and one other 
discriminatory BVDV mAb.
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Fig5.10 Border disease virus specificity of mAbs.
Figure shows reactivity of six discriminatory mAbs for ovine 
pestivirus isolates by PLA (Sands, personal communication). 
MAbs abbreviated to numerical code only eg 160 = WB160n.
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5.4 DISCUSSION
RIP studies with the seventeen NADL and Oregon C24V mAbs 
revealed three basic patterns of reactivity. For seven Group 
1 mAbs, a polypeptide of approximately 78kDa was always the 
predominant precipitation product ("band") from the two 
cytopathogenic viruses Oregon C24V and NADL. This probably 
represents the p80/l25 non-strudtural viral protein 
associated with biotype specificity, since one of the group 
1 mAbs (WB112c) precipitated a polypeptide of approximately 
113kDa from antigen prepared from a non-cytopathogenic 
virus. Less prominent bands were also observed at 115kDa, 
95kDa, 7IkDa, 67kDa and 56kDa. It is not clear whether these 
represent other members of the pl25/p80/p54 
post-translational cleavage family or unrelated 
coprecipitants. Deregt and others (1991) have used RIPs to 
study the protein specificity of three pBO mAbs using a 
combination of pulse chase experiments, partial proteolysis 
and different reducing conditions. They concluded that both 
p80 and p!25 are cleaved directly from a common precursor 
(pl75), rather than one from the other. Furthermore they 
demonstrated that p80 existed in a number of different 
conformations dependent on a differing extent of disulphide 
bridging. Under less stringent reducing conditions, an 
additional more rapidly migrating band was sometimes 
evident. This could account for the 7IkDa band seen with 
group 1 mAbs in the present study (see for instance WB160n 
in Fig 5.2a).
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Unexpectedly, a 78kDa band was precipitated by a Group 1 mAb 
(WB112c) from D-[3H]-glucosamine labelled Oregon C24V. 
Direct comparison of glucosamine and methionine labelled 
precipitates confirmed that this represented the major 
product recognised by this mAb. This is at variance with 
previous findings for p80/125, which has always been 
considered to be unglycosylated (Pocock and others, 1987,
Collett and others, 1988b). However, / other reports have not 
tested p80/125 mAbs against D-[3H]-glucosamine labelled 
Oregon C24V antigens. It is therefore possible that this 
strain of virus is exceptional in this respect, possibly due 
to inserted cellular sequences. The alternative explanation, 
that the group 1 mAbs recognise a 78kDa product that is not 
related to p80/125 (possibly Prgp78 of Collett and others,
1991), seems most unlikely, in view of their generally 
panreactive pestivirus specificity and the ability of some 
of them to compete for binding with other characterised 
p80/125 mAbs (Greiser-Wilke, personal communication).
Nine other mAbs were placed together in Group 2. These mAbs 
precipitated several strong bands. The predominant one which 
was always between 50kDa and 53kDa, could sometimes be 
resolved into two separate bands. Another band which was 
consistently present represented a protein of between 60kDa 
and 63kDa. Less consistently present were bands at 115kDa 
and 25kDa. Similar bands were present with glucosamine 
labelling. The strong, glycosylated band(s) at 50-53kDa 
probably represent(s) gp53, whilst the 60-63kDa band is
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probably gp62. The weak high molecular weight glycosylated 
bands could be the precursor proteins Prgpl40 and Prgpll6 
(Collett and others, 1991; 1992, as summarised in Table
1.1). These findings taken together with the fact that many 
of the Group 2 mAbs neutralize virus to high titre suggest 
that these mAbs are anti-gp53 (see also chapter 7) . The 
reason for the coprecipitation of gp62 and gp25 is not 
known, but both these proteins may «hare a common carboxy 
terminus, which could remain linked to gp53 after cleavage 
of the latter from PrgpllG.
A single mAb WB210c was placed in a third group (group 3). 
It precipitated a similar group of proteins to the group 2 
mAbs with an additional very strong band at about 48kDa. 
This protein appeared to be glycosylated on the basis of 
radiolabelling with D-[3H] glucosamine. It is presumed that 
this is an anti-gp48 mAb. Deregt and others (1991) , have 
suggested that both gp62 and gp48/gp25 are derived directly 
from Prgp78. Coprecipitation of gp62 and gp48 may therefore 
be due to both proteins possessing the epitope recognised by 
the mAb. If gp62 and gp53 are coprecipitated by anti-gp53 
mAbs, then reciprocal coprecipitation by an anti-gp48 mAb 
that recognised gp62 would not be unexpected.
MAbs could also be subdivided on the basis of ELISA results 
and this was consistent with the classification suggested by 
RIP reactivity. Group 1 mAbs required a different cell 
lysate concentration from those of group 2 and 3, for
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optimal binding in ELISAs; whilst group 2 and 3 mAbs showed 
different patterns of recognition of heat treated antigens. 
An additional subdivision of the group 1 mAbs was possible 
on the basis of antigen recognition after heat treatment, 
since WB160n and WB109c showed a unique level of binding to 
heat treated Oregon C24V antigen. Although the epitopes of 
these two mAbs are also present on NADL, that of WB160n was 
not recognised after heat treatment. ^
There are many possible mechanisms whereby heat treatment of 
a crude cell lysate could interfere with mAb binding to 
epitopes. The overall effect may be a mixture of 
non-specific influences, such as coagulation and 
precipitation of both target and non-target proteins and 
specific alterations in the secondary and/or tertiary 
structure of the target protein. Denaturation/renaturation 
experiments on purified antigens would be a more elegant way 
to study the specific effects on epitopes. Nevertheless, the 
finding that different mAbs reacted differently after heat 
treatment does suggest that some specific influences could 
be detected by the simple method employed and that many of 
the epitopes are comformation sensitive.
Differences in mAb binding between PLA and ELISA might also 
be an indication of conformational sensitivity of epitopes. 
That the mAbs bound well in PLA is no surprise, since this 
was the method used to screen the hybridomas during initial 
selection (Sands, personal communication) . The finding that
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for some mAbs, epitope conservation may be less by ELISA 
than by PLA indicates that there is a danger in 
extrapolating PLA data to predict the specificity of mAbs in 
diagnostic ELISAs. It is very tempting to do this, since PLA 
is a much easier system than ELISA to screen mAbs for 
reactivity against large numbers of viruses. The apparent 
correlation between cross-reactivity of mAbs in ELISA and 
cross-neutralization requires substantiating with data for 
additional strains of virus. A possible explanation for the 
finding would be that only epitopes involved in 
neutralization bound mAbs in either of two conformations. 
This would be consistent with conformational change 
consequent upon antibody binding being a likely mechanism 
for virus neutralization (Outlaw and Dimmock, 1991).
Reciprocal blocking in competitive binding assays is a good 
indicator of epitopic overlap, but one way blocking is more 
difficult to interpret. It may also result from epitopic 
overlap, if one antibody has a much greater affinity for the 
epitope than the other. Alternatively it may be caused by 
distant epitopes interacting with one another through steric 
changes transmitted down the protein, consequent upon 
antibody binding at one of the sites (Cepica and others, 
1990) . This is also a possible mechanism for synergism in 
antibody binding (Lubeck and Gerhard, 1982). Competition 
studies confirmed the RIP groupings in so far as no 
inter-group competition of any kind was observed. Epitopes 
recognised by the Group 1 mAbs could be subdivided into four
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separate domains, on the basis of reciprocal blocking. 
However, the position and functional relevance of these 
domains is unknown.
Competitive binding studies with the group 2 mAbs gave 
similar results using PLA or ELISA. Detection of some weak 
blocking by ELISA only was not unexpected, since partial 
blocking had been noted in the PLA studies. One way 
blocking was observed with several mAb combinations. The 
reason for this is not known, but it was probably not a 
result of greatly differing antibody affinities, since 
saturation of binding to fixed monolayer antigen occurred at 
a similar concentration for all the mAbs (data not shown). 
Only the epitope of WB158n appeared relatively spatially 
distinct, although reciprocal block was not observed between 
WB165c and any other mAb, whilst one way synergism between 
this mAb and WB162c was noted. This suggested that the 
epitope of WB165c was also part of a separate domain. The 
relationship of the epitopes of WB166n and WB17On to the 
rest of the group could not be established with certainty, 
since these mAbs were assessed only as blockers. Comparing 
these results with the viral strain specifity of the mAbs as 
shown in Fig 5.9, it is apparent that all of the epitopes 
that are moderately to highly conserved amongst BVDVs are 
clustered in a single domain, whilst those that are 
relatively strain specific appear to be distinct. A similar 
finding was reported for another group of anti-gp53 mAbs by 
Mateo (1988) and it is likely that the major domain
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identified in both studies is the same. Gunn and others 
(1992) have in fact suggested that some of the mAbs from 
these two separate panels have overlapping epitopes. Further 
data concerning the spatial relationships and locations of 
the epitopes of group 2 mAbs are presented in chapter 7.
All four antigenic domains defined by the Group 1 mAbs 
appeared to be highly conserved /amongst pestiviruses. 
Previous reports have also found a high degree of 
conservation amongst p80 epitopes, consistent with a 
non-structura1 function for this protein (Moennig and 
others, 1987). An unexpected finding was that whilst one 
epitope on domain D (that of WB109c) was highly conserved, 
another (that of WB160n) was absent from virtually all HCVs 
together with some BVDVs and BDVs.
All but one of the Group 2 mAbs (WB166n) did not bind to any 
HCVs in PLA. Similar results have been reported for other 
BVDV mAbs directed against gp53 (Moennig and others, 1987). 
Since the Group 3 mAb also failed to recognise HCVs it 
appears that some antigenic epitopes on at least two 
envelope proteins of HCV and BVDV may be relatively 
distinct. Presumably, however, others are not, since 
polyclonal antibodies raised against BVDV or HCV frequently 
cross-neutralize the heterologous virus (Liess and others, 
1977). Differentiation of HCVs from other pestiviruses is 
most readily achieved by anti-gp55 mAbs raised against HCV 
(Wensvoort and others, 1986). Some of these mAbs appear to
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recognise all strains of HCV, but no ruminant-type 
pestiviruses. Of 187 pestiviruses examined at CVL in PLA, 
these mAbs failed to recognise any viruses from ruminants 
and also a small proportion of pig isolates (Sands, personal 
communication).
Much more difficult, is differentiation of BVDVs from BDVs. 
The majority of bovine pestivirus ^isolates (71/92) were 
homologous with respect to recognition by WB160n, WB166n, 
WB215c and WB210c indicating a high degree of epitope 
conservation at the level of three different proteins. Six 
of the sheep pestivirus isolates showed the same reactivity, 
suggesting that all 77 of these viruses are very closely 
related.'By contrast, 7 cattle and 11 sheep isolates did not 
bind any of these mAbs, suggesting a fairly distant 
relationship to the previous 77. A number of ruminant 
isolates fell between these two extremes (Fig 5.11). The 
division of ruminant pestiviruses into BVDV-like and 
BVDV-unlike (?BDV) groups has been suggested previously 
(Edwards and others, 1988). However, the knowledge that some 
of the homologies and differences that support this 
supposition exist at the level of three different proteins 
makes this classification much more compelling. Similarly, 
two out of seven non-HCV porcine isolates were clearly 
BVDV-like.
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Fig5.11 Subdivision of ruminant pestiviruses by mAbs.
Figure shows a mAb-based subdivision of ruminant pestivirus 
isolates into ?BVDV-like and ?BDV-like strains. A-F indicate 
PLA reaction with mAbs WB160n and WB166n (A,B,C) or MAbs 
WB215c and WB210c (D,E,F). A,D = negative to both mAbs; B,E 
= negative to one mAb; C,F = positive to both mAbs.
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5.4 CONCLUSIONS
Seventeen mAbs raised against BVDV were divided into three 
groups on the basis of radioimmunoprecipitation results, 
supported by data from ELISAs, competitive binding assays 
and epitope conservation studies. Seven mAbs precipitated a 
polypeptide of approximately SOkDa and defined four domains, 
all of which showed considerable cohservation amongst the 
187 pestivirus strains and isolates examined. Domain D was 
unusual in that it comprised two relatively heat resistant 
epitopes one of which (WB160n) showed a more discriminatory 
and potentially useful, virus-strain-specificity. Nine mAbs, 
including six with virus neutralizing activity, precipitated 
glycosylated polypeptides of 62, 53 and 25kDa. These mAbs
are probably directed against the major envelope
glycoprotein (gp53). Most of the epitopes for these nine
mAbs appeared to cluster in a single domain, but those of 
WB158n and possibly WB165c were distinct. The more conserved 
epitopes were present in many ruminant viruses but with one 
exception (WB166n) , not HCVs. A single mAb (WB210c)
precipitated a glycosylated polypeptide of 48kDa, which is 
probably another viral envelope protein (gp48). This epitope 
was also present on many ruminant viruses but not HCVs. Most 
pestiviruses from cattle and some from sheep and pigs shared 
a number of epitopes located on three different proteins 
(gp53, gp48 and p80).
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CHAPTER 6
COMPARISON OF GENE SEQUENCES FOR THE MAJOR 
ENVELOPE PROTEIN (GP53) OF BVDV
6.1 INTRODUCTION 
6 2  MATERIALS AND METHODS
i) Viruses and cells
ii) Monoclonal antibody typing
iii) Nucleotide sequencing 
-preparation of viral RNA 
-preparation of virus-specific cDNA 
-transformation of E. coli with cDNA 
-preparation of single-stranded
insert-specific DNA 
-sequencing protocol 
-sequencing gel electrophoresis
63  RESULTS
i) Monoclonal antibody typing
ii) Amplification of virus-specific RNA
iii) Nucleotide sequences of the gp53 genes of 
BVDV strains Oregon 024V and NADL
iv) Nucleotide sequences of the gp53 genes of 
the BVD91/1 virus isolates
v) Deduced amino acid composition of gp53 
proteins
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6.4 DISCUSSION
6.5 CONCLUSIONS
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6.1 INTRODUCTION
The major envelope glycoprotein of BVDV (gp53), contains 
immunodominant B cell epitopes some of which are involved in 
virus neutralization (Donis and others, 1988). The
equivalent gp55 protein of HCV has been shown to be 
sufficient to elicit a protective immunity against HCV 
challenge (van Zijl and others, 199^; Moormann and others,
1992). The approximate position of the gp53 gene of BVDV has 
been mapped towards the 5' end of the genome (Collett and 
others, 1988b) , as has the gp55 gene of HCV (Stark and 
others, 1990; Moormann and others, 1990). The N-terminus of 
gp53/gp55 is indicated by a putative signalase cleavage site 
in the nucleotide sequence, and the C-terminus by a region 
of hydrophobic amino acids that represent the membrane 
anchoring site (van Zijl and others, 1991). The deduced 
amino acid sequence of gp53 is approximately 370 residues 
long, whilst the apparent molecular weight from RIP is 
between 51 and 58kba, depending in part on glycosylation 
differences (Donis and Dubovi, 1987b). Antigenic variation 
exists between different strains of BVDV (Heuschele, 1975; 
Edwards and others, 1988) and both epitope conservation 
studies with mAbs (Moennig and others, 1987; Paton and
others, 1991b; Chapter 5) and genomic sequence comparisons 
(Moormann and others, 1990, Weiland and others, 1990)
suggest that gp53 is a particularly variable protein.
This chapter describes the molecular cloning and nucleotide
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sequencing of a large part of each of the gp53 genes from 
five different BVDVs. Two of the viruses were the NADL and 
Oregon C24V reference strains. Two others were field 
isolates obtained from a pig and a calf respectively, both 
animals having been infected at the same time and on the 
same farm (Chapter 3) . The fifth virus was obtained by 
experimentally induced passage of a bovine field isolate in 
pigs (Chapter 4). The sequences obtained are compared with 
one another and with already published sequence data. The 
sequences for NADL and Oregon C24V were obtained as a 
prelude to the characterization of anti-gp53 mAb 
neutralization escape mutants (Chapter 7). The three related 
field isolates were sequenced in order to study their 
genetic .similarity to one another, to examine the effect on 
gp53 of heterologous host passage and to try to relate any 
deduced amino acid differences found to epitopic differences 
detected by mAbs.
6 2  MATERIALS AND METHODS
i) Viruses and cells:
All of the viruses have been described in previous chapters. 
The Oregon C24V strain of BVDV (Gillespie and others, 1960) 
had been biologically cloned by three cycles of limiting 
dilution and then passaged once more prior to use (a total 
of 67 in vitro passages) . The NADL strain of BVDV (Gutekunst 
and Malmquist, 1963) had been twice plaque purified and then
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passaged 7 times before use (a total of 12 in vitro 
passages). Both strains of BVDV produced a cytopathic effect 
in the two cell culture systems used (Figl.2) . The three 
other strains of BVDV were non-cytopathogenic and all 
originated from a suspected case of hog cholera investigated 
in January 1991. They are referred to collectively as 
BVD91/1 viruses. The field bovine isolate (FBI 91/1) and 
field porcine isolate (FP1 91/1) were isolated from sera 
collected on the same day from a calf and a pig on a single 
farm (Farm "X” : Chapter 3). The experimental pig isolate
(EP1 91/1) was isolated from a precolostral serum collected 
from a piglet (PF404: Chapter 4) born viraemic, after
challenge of its dam with FBI 91/1.
Bovine isolates (NADL, Oregon C24V and FBI 91/1) were grown 
in calf testis cells (CT) at passage level 4-9, whilst 
porcine isolates (FP1 91/1 and EP1 91/1) were grown in 
either CTs, or in a semi-continuous porcine kidney cell line 
(PK15). The BVD91/1 viruses were sequenced after two 
separate cycles of molecular cloning, once before and once 
after biological cloning (three cycles of limiting 
dilution). Biologically uncloned BVD91/1 viruses are given 
the prefix u: uFBl 91/1, uFPl 91/1 and uEPl 91/1, whilst 
biologically cloned versions are prefixed c: cFBl 91/1, cFPl 
91/1 and cEPl 91/1. Fig 6.1 shows the passage histories of 
each of these viruses in relation to both sequencing and 
immunocharacterization with mAbs.
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Fig 6.1 Passage histories of BVD91/1 viruses used for mAb 
staining and biological and molecular cloning.
pl-6 = number of culture passages in calf testis cells (CT) 
or in a semicontiuous pig kidney cell line (PK15) . Dates 
given = day of sample collection or culture inoculation (MAb 
stains repeated on different dates - Chapters 3 & 4 - so 
dates not given).
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ii) Monoclonal antibody typing:
Biologically cloned virus stocks were typed exactly as 
described for the uncloned stocks whose
immunocharacterization has been reported in Chapters 3 and 
4. Briefly, this involved titrating the viruses in tenfold 
steps in either CT or PK15 cell cultures, followed by 
acetone fixation of monolayers and subsequent PLA staining 
with mAbs. The intensity and the proportion of the monolayer 
stained was recorded in each case.
iii) Nucleotide sequencing:
Because of uncertainty over the exact genomic position of 
gp53, all BVDV nucleotide and amino acid numbering is 
respectively from the start of the genome and the beginning 
of the open reading frame (ORF, as described by Collett and 
others, 1988a and b, for BVDV strain NADL). The predicted 
N-terminus of gp53 is at ORF amino acid residue 693 
(nucleotides 2462-2465), immediately after a signalase site 
(Moormann and others, 1990) which probably induces cleavage 
by a host proteinase (Collett, 1992). The likely position of 
amino acids from the N-terminus of gp53 will therefore be 
given in parenthesis after the ORF position.
Virus-specific, complementary DNA (cDNA) was synthesized by 
reverse transcription (RT) and amplified by the polymerase 
chain reaction (PCR). RT-PCR derived cDNA was ligated into 
phagemid vectors and these were used to transform E. coli. 
Single-stranded, insert-specific DNA was isolated with a
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helper phage and sequenced by the dideoxy chain termination 
method (Sanger and others, 1977). Sequence data was analysed 
using the GCG software package (Devereux and others, 1984) 
via the Daresbury Laboratory of the Science and Engineering 
Research Council. The similarity of deduced amino acid 
sequences was compared using the method of Gribskov and 
Burgess (1986) to weight differences. Dendrographic analysis 
relied on the UPGMA strategy (unweighted pair-group using 
arithmetic averages) as described by Sneath and Sokal 
(1973).
Preparation of viral RNA. Viral RNA was prepared in CT or 
PK15 cells infected at a multiplicity of between 0.1 and 
0.01. The BVD91/1 viruses were used before and after 
biological cloning at in vitro passage levels of 3 and 7 
respectively (Fig 6.1). Total cellular RNA was extracted 
from BVDV-infected or mock-infected CT or PK15 cells 2-3 
days after infection, as described by Sambrook and others 
(1989b) . The final RNA pellet was dissolved in 200jL/l of TE 
buffer pH 8.0 (Sambrook and others, 1989c), and 4pl was 
examined by electrophoresis through 1% agarose followed by 
ethidium bromide staining. RNA samples were stored in 
aliquots at -70°C.
Preparation of virus-specific cDNA. Virus-specific cDNA was 
synthesized using moloney murine leukaemia virus reverse 
transcriptase and amplified by the PCR using Tag DNA 
polymerase. Oligonucleotide primers for cDNA synthesis and
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amplification were derived from published BVDV sequence data 
(Renard and others, 1987; Dale and others, 1987; Collett and 
others, 1988a), some having been previously described (Roehe 
and Woodward, 1991). They were synthesized on an Applied 
Biosystems 381A DNA synthesizer. The same primers were not 
equally effective with all viruses, and different 
combinations were ultimately selected. Reverse transcription 
was performed as described by Sambrook and others (1989b), 
using one of three primers. For NADL and Oregon C24V 
viruses, the reverse primer R3485-3466 was used, whilst for 
NADL, only, an additional reverse primer R2874-2855 was also 
employed. For the BVD91/1 viruses the reverse primer used 
was R3305-3284. The sequences of the primers and the 
strategy, for their use are shown in Table 6.1 and Fig 6.2 
respectively. Single fragments of Oregon C24V and BVD91/1 
cDNA were amplified with the PCR forward/reverse (F/R) 
primer combinations of F2336-2356/R3486-3467 and 
F2442—2460/R3305-3284 respectively. NADL virus was
amplified as two fragments with two pairs of primers: 
F2336—2356/R2874—2855 and F2855-2874/R3485-3466. Each primer 
began with an additional 9-10 nucleotides of non-viral 
sequence, encoding a specific endonuclease restriction site 
(Table 6.1). The reaction mixtures were formulated as 
recomended by Sambrook and others (1989b). The PCR reaction 
was performed in one of two thermal cycling instruments 
(Hybaid and Biometra) and the cycling conditions used are 
shown in Table 6.2.
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Table 6.1 RT-PCR primers.
Position Nucleotide sequence (5'-S') GC Melt
Site
F2336-2356 TTTGTÇGAÇAGAGATTTAACACGCATTTGG 38% 58°C
Sail
F2442—2460 TTTGAATTCTGATAACAGGGGTACAAGG 47% 56°C
EcoRI
F2855—2874 TTTGTÇGAÇTATAGGATGGACAGGAACTGT 43% 58°C
Sail
R3485—3466 AAAGAATTCATCAGCGAAGTAATCCCGGTG 52% 62°C
EcoRI
R3305-3284 TTTGTCGACCATATGGTCTGCAAGGCATAGG 50% 68°C
Sail
R2874-2855 AAAGGATÇÇAACAGTTCCTGTCCATCCTAT 43% 58°C
BamHI
Position: F = forward primer, R — reverse primer, numbers = 
location with respect to NADL strain of BVDV (Collett and 
others, 1988a).
Nucleotide sequence: underlined = restriction endonuclease
site, bold = complimentary to BVDV.
GC: percentage GC content.
Melt: dénaturation temperature in °C
Site: restriction endonuclease site included in sequence.
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Fig6.2 Strategy for amplification of virus-specific cDNA.
Schematic overview of RT-PCR strategy, 
as Fl-3 and Rl-3: FI = F2336-2356; F2
F2442-2460; RI = R2874-2855; R2 =
R3305-3284 (Table 6.1).
Primers abbreviated 
= F2855-2874; F3 = 
R3485-3466; R3 =
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Table6.2 PCR cycling conditions.
Oregon C24V/NADL
Dénaturation 95°C-linin
Annealing 45°C-2min
Elongation 72°C-2min
N° of cycles 30
BVD-91/1
95°C-45sec
50°C-lmin
72 0C-2min
Transformation of E, coli with cDNA. PCR—derived cDNA was 
purified by low melting-point agarose gel electrophoresis, 
extracted with a silica matrix (Prepagene™, Biorad), cut by 
appropriate restriction endonucleases to give cohesive ends 
and ligated into similarly digested, calf alkaline 
phosphatase treated phagemid vectors (pBluescript™ II 
KS+/-, Stratagene) according to the supplier's instructions. 
The E. coli strain XLl-Blue (Stratâgene) was transformed 
with the phagemid construct using the CaCl2 method (Sambrook 
and others, 1989a) and transformed bacteria were selected by 
overnight growth at 37 °C on LB agar plates containing 
SOjjgml-1 ampicillin, la.Spgml-1 tetracycline, SOpgml"1 X-gal 
and 20mM IPTG. Colonies with phagemids containing inserts 
were picked by blue/white colour selection. The strategy is 
summarized in Fig 6.3.
Preparation of single-stranded, insert-specific DNA. Single 
stranded DNA (ssDNA) was isolated using the helper phage 
VCSM13 (see Fig 6.3) and the Stratagene protocol (based on 
the method of Vieira and Messing, 1987). A single bacterial 
colony was inoculated into 2X YT broth (Sambrook and others, 
1989c) containing SOpgml-1 ampicillin and VCSM13 at 107-108 
pfuml'i. After 90 minutes shaking at 37°C, kanamycin was 
added to 70pgml'1, in order to select for phage infected 
bacteria. After 16 hours further growth, the bacteria were 
removed by centrifugation and helper phage ssDNA was 
extracted from clarified supernatant fluids. One millilitre 
of supernatant yielded enough DNA for approximately six
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Fig 63 Stategy for production of insert-specific ssDNA.
Cut = digested with specific restriction endonuclease 
enzymes to produce cohesive ended DNA. Ligate = overnight 
ligation with T4 ligase. Transform = transformation of E. 
coli, strain XL1 Blue. Selective growth = overnight growth 
on LB agar (Sambrook and others, 1989c) in presence of
ampicillin (to select for transformed bacteria) and 
tetracycline (to select for F' episome, necessary for later 
infection with helper phage)• Colour selection = selection 
of white colonies which indicate the presence of an 
insertion into the lacZ gene, disrupting B-galactosidase 
production. Infection with helper phage: kanamycin added to 
kill non-infected bacteria. ssDNA extracted from 
precipitated helper phage with phenol/chloroform (Sambrook 
and others, 1989c).
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Bluescript Vector
RT-PCR Product
Cut
Y Cut
E. coli
Selective Growth
+ Ampicillin 
1 + Tetracycline Helper Phage
Single White 
Colony
Agar Plate 
Colour 
Selection
Infect Transformed E. coli 
With Helper Phage
+ Kanamycin
Helper Phage 
+ insert
ssDNA
2 1 9
sequencing reactions. The presence of an insert in the 
phage DNA was assessed by electrophoresis in a 1% agarose 
gel, comparing the migration with that of phage DNA without 
an insert.
Sequencing protocol. The single-stranded DNA was sequenced 
using 35S ATP (Amersham UK), the enzyme "Sequenase" and 
oligonucleotide primers derived frpm Bluescript or BVDV 
sequence data (Table 6.3). The method was that of dideoxy 
termination, according to the Sequenase™ (United States 
Biochemical) protocol. All genes were sequenced in both 
directions using a total of three to eight clones per virus; 
increased numbers of clones being sequenced across regions 
where differences between viruses were detected.
Sequencing gel electrophoresis. A more detailed account is 
given in Chapter 2. Sequencing reactions were separated into 
component oligonucleotides on an SII sequencing tank (Gibco 
BRL) using 6% polyacrylamide-urea gels. After 
electrophoresis # gels were dried under vacuum, 
autoradiographed and read by eye. Data was fed into a 
computer and aligned and compared with existing sequences 
using the GCG software package (Devereux and others, 1984) 
via the Daresbury Laboratory of the Science and Engineering 
Research Council.
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Table 63  Sequencing primers. 
H13 PRIMERS:
T3 5'ATTAACCCTCACTAAAG3z
-20 5'6TAAAAC6AC66CCA6T3'
BVDV PRIMERS:
F2576—2592 5'CT66AA6ACACAAT66T3' 
F2785-2801 5'CAACCCCATA6TAA6A63' 
F3122-3138 5'TACCCCATTGGCAAGTG3' 
R3132-3116 5'CCAATGGGGTAGTGTGG3' 
R2924-2928 5'TCCGTACTACTGCTGTG3' 
R2799-2783 5'CTTACTATGGGCCTGGC3' 
R2685-2701 5'GAATACCACACTGGTCG3'
F = forward primers for sequencing positive sense ssDNA 
R = reverse primers for sequencing negative sense ssDNA 
Numbers relate to nucleotide position of NADL according to 
Collett and others (1988a).
PCR primers were also used as sequencing primers
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63  RESULTS
i) Monoclonal antibody typing:
Table 6.4 shows PLA results for all five stocks of cloned 
viruses. Table 6.5 compares results for cloned and uncloned 
stocks of BVD91/1 viruses. Results for FP1 91/1 were 
different after cloning, with a number of epitopes being 
lost, and the uncloned virus appearing more similar to the 
other BVD91/1 viruses. FBI 91/1 and its descendant EP1 91/1, 
were unchanged following cloning and appeared identical to 
one another by mAb typing. This was despite differences in 
in vivo and in vitro host passage, and despite differences 
in in vitro host cell preference (only the latter would grow 
in both' CT and PK15 cells: Chapters 3 and 4). In mAb
reactivity, cFBl and cEPl 91/1 viruses appeared more similar 
to Oregon C24V than to NADL, whilst cFPl 91/1 had lost most 
epitopes specific to discriminatory mAbs (Chapter 4).
ii) Amplification of virus-specific RNA:
Figs 6.4-6.5 show the appearance of nucleic acids after 
agarose gel electrophoresis and ethidium bromide staining. 
Fig 6.4 shows cDNA prepared by PCR and Fig 6.5 shows ssDNA 
prior to sequencing. Both NADL and Oregon C24V could be 
amplified using the primer combination of 
F2336-2356/R3485-3466, but this combination was unsuitable 
for the molecular cloning of NADL because of an internal 
EcoRI in the gp53 sequence. For this reason, NADL cDNA was 
amplified in two fragments.
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Table 6.4 MAb typing of cloned virus stocks.
MAb C24V NADL FBI 91/1* FP1 91/1* EP1 91/1*
Anti-cro53
(BVDV)
WB115C ++ — + - . +
WB158n - ++ — — —
WB162C ++ - ++ ^ ++ ++
WB163C ++ ++ + — ++
WB165C ++ - — — -
WB166n ++ ++ ++ ++ ++
WB170n - ++ — — -
WB214n ++ ++ ++ ++
WB215C ++ ++ ++ ++
CA36 + - ++ — ++
CAB 2 ++ ++ + +
Anti-oBO
(BVDV)
WB105C ++ ++ + + +
C24V = Oregon C24V strain of BVDV; NADL = NADL starin of 
BVDV; FBI 91/1 = original bovine isolate from Farm X; FP1 
91/1 = porcine isolate from pig 6 from Farm X; EP1 91/1 = 
isolate from precolostral serum from pig PF404, whose dam 
was infected with B1 91/1.
*Two separately cloned stocks of each of these viruses gave 
identical reaction patterns.
Staining was by PLA:
- = no staining, + = positive staining, ++ = strong 
staining. No plaques of positive staining observed, except 
at titration end-points.
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Table 6.5 Comparative mAb typing: biologically cloned versus 
uncloned BVD91/1 viruses.
Virus isolate
FBI FP1 EP1
91/1 91/1 91/1
u c u c u c
Anti-cm53
(BVDV)
WB115C + 4- - — 4- 4-
WB163C ++ 4-4- 4- — 4-4- 4-4-
WB166n 4-4- 4-4- 4-4- 4-4- 4-4- 4-4-
WB214n 4-4- 4-4- (++) - 4-4- 4-4-
WB215C 4-4* 4-4- ( + ) - 4-4- 4-4-
CA36 4-4- 4-4- - 4-4- 4-4-
CAB 2 4-4- 4- - - 4-4- 4-
Anti-oBO
(BVDV)
WB105C 4-4- 4-4- 4-4- 4-4- 4-4- 4-4-
B1 91/1 = original bovine isolate from Farm X; PI 91/1 = 
porcine isolate from pig 6 from Farm X; P5 91/1 = isolate 
from precolostral serum from pig PF404.
U = uncloned virus at passage 2 in CT cells (Table 4.6)
C = biologically cloned virus at passage 6 in CT cells (FBI) 
or PK15 cells (EP1/FP1)
- = no staining () = <50% of infected
+ = positive staining cells stained
++ = strong staining
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Fig6.4 RT-PCR products.
Figures show ethidium bromide stained agarose gels after 
electrophoresis of lOpl of RT-PCR product. Arrowed numbers 
refer to base pairs of virus-specific RT-PCR products; m = 
molecular weight markers.
a) BVDV NADL and BVDV Oregon C24V. Lanes 1-4 show use of 
F2336-2356/R3485-3466 primers (1150 base pair product): 
Lane 1 = Oregon C24V; Lane 2 = uninfected CT control for 
lane 1; Lane 3 = NADL; Lane 4 = uninfected CT control for 
Lane 3. Lanes 5 & 6 show use of F2336-2356/R2874-2855
primers (539 base pair product) : Lane 5 = NADL; Lane 6 = 
uninfected CT control for lane 5. Lanes 7 & 8 show use of 
F2855-2874/R3485-3466 primers (631 base pair product): Lane
7 = NADL; Lane 8 = uninfected CT control for lane 7.
b) BVD91/1 viruses amplified with F2442-2460/R3305-3284 
primers. Lane 1 = uFBl 91/1. Lane 2 = uFPl 91/1. Lane 3 = 
uEPl 91/1. Lane 4 = uninfected CT control for lanes 1-3. 
Lane 5 - uninfected CT control for lane 6. Lane 6 = cFBl 
91/1. Lane 7 = uninfected PK15 control for lanes 8 & 9. Lane
8 = cFPl 91/1. Lane 9 = cEPl 91/1. Arrow indicates 864 base 
pair fragment of virus-specific DNA.
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a) m  1 2 3 4 5  6 7  8 m
1150 ► 
539 ►
b) m  1 2 3 4 5 6 7 8 9
864 ►
# # # # *
«4631
m
22 6
111 II 1 1
Fig 6.5 Single stranded DNA preparations.
Lane 1 = ssDNA from helper phage lacking insert. Lane 2 = 
phage DNA with 539 base insert. Lane 3 = phage DNA with 631 
base insert. Lane 4 = phage DNA with 864 base insert. Lane 
5 = phage DNA with 1150 base insert, m = molecular weight 
markers.
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iii) Nucleotide sequences of the gp53 genes of BVDV strains Oregon C24V and 
NADL:
Using ssDNA as "templates for sequencing generally gave good 
results and a single wedge gel separation usually permitted 
unambiguous reading of 250-350 nucleotide bases. Part of a 
sequencing gel autoradiograph is shown in Fig 6.6. Since PCR 
products inevitably have 3'and 5' ends that are exactly 
homologous to the primers used in their synthesis (and not 
necessarily the DNA being amplified) , the reliable sequence 
obtained was:- Oregon C24V and variants: nucleotides
2357-3465 and NADL and variants: nucleotides 2357-2854 plus 
2875-3465. The gp53 NADL sequence determined in this study 
differed from that obtained by Collett and others (1988a) 
for the same strain by four nucleotide changes. The 
nucleotide sequence for gp53 of Oregon C24V is shown in Fig 
6.7, aligned to that of CVL-NADL. Comparison of the Oregon 
C24V nucleotide sequence from bases 2357-3465, with 
published data for the homologous regions of other BVDV 
strains (NADL: Collett and others, 1988a, Osloss: Renard and 
others, 1987 and Singer, nucleotides 2357-3112: Dale and
others, 1987) showed nucleotide homologies of between 74 and 
86%, compared to 60% homology for comparison with either HCV 
strain Alfort (Meyers and others, 1989) or Brescia (Moormann 
and others, 1990) . The greatest similarity was to BVDV NADL 
(Paton and others, 1992b).
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Fig 6.6 Sequencing gel autoradiograph.
Part of an autoradiograph to show sequencing reactions 
initiated by T3 primer for FP1 91/1-specific (1) and EP1 
91/1-specific (2) ssDNA after PAGE separation and 
autoradiography. G = reaction stopped with dideoxy-guanosine 
triphosphate. A = reaction stopped with dideoxy-adenosine 
triphosphate. C = reaction stopped with dideoxy-cytosine 
triphosphate. T = reaction stopped with dideoxy-thymidine 
triphosphate. Dashes indicate sequence differences.
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iv) Nucleotide sequences of the gp53 genes of the BVD91/1 virus isolates:
The nucleotide sequences of the three biologically cloned 
viruses (cFBl 91/1, cFPl 91/1 and cEPl 91/1) are shown in 
Fig 6.7 and sequence differences are summarized in Table 
6.6. The sequences obtained for FBI 91/1 and EP1 91/1 were 
18 nucleotides shorter than those obtained for FP1 91/1. 
This was because of an internal EcoRI site just downstream 
of that introduced into the cDNA by/the F2336-2356 primer. 
Sequence differences between cloned and uncloned BVD91/1 
viruses are shown in Table 6.7. The uncloned FBI 91/1 and 
EP1 91/1 were almost identical to the cloned stocks. The 
only difference was a single nucleotide change (G to C at 
position 2479) in uEPl 91/1 compared to cEPl 91/1. Even this 
difference was only found in two out of four ssDNA clones 
sequenced. The uFPl 91/1 virus isolate showed six nucleotide 
changes compared to the biologically cloned version (cFPl 
91/1) . The change at position 2780 was present in only two 
out of four ssDNA clones sequenced. cFBl 91/1 and cEPl 91/1 
were very similar, with only 3 nucleotide differences and 
both were much less similar to cFPl 91/1. Table 6.8 shows 
the nucleotide homologies of the BVD 91/1 viruses to one 
another and to other pestiviruses.
v) Deduced amino acid compositions of gp53 proteins:
Of four nucleotide differences found between CVL-NADL and 
the NADL virus of Collett and others (1988a), two encoded 
amino acid changes: leucine to phenylalanine and valine to 
glutamic acid at residues 745(53) and 771(79) respectively.
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Fig 6.7 Alignment of gp53 nucleotide sequences for the BVDV 
reference strains NADL and Oregon C24V and for the three 
BVD91/1 viruses.
EP1, FBI and FP1 = BVD91/1 viruses. C24V = BVDV Oregon C24V. 
NADL = CVL strain of BVDV NADL. Numbering is from 5' end of 
genome, according to Collett and others (1988a) for BVDV 
NADL. Dots indicate absence of deduced sequence. * = 
predicted start of gp53 gene (after signalase site).
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2357 2406
EPI .......................................................
FBI ..... ................................... ..............
C24V AACGCTGCCA CGACTACTGC ATTCCTAGTA TGCCTTGTTA AGATGGTCAG
NADL AACGCTGCAA CAACTACTGC TTTTTTAGTA TGCCTTGTTA AGATAGTCAG
FP1 ..  ......  .........  ..... ...........................
2407 2456
EPI ............. . .  ................... .... .....
FBI ................................ ......... . ...... ...
C24V GGGCCAGATG GTACAGGGCA TCCTATGGCT ACTACTGATA ACAGGAGTGC
NADL GGGCCAGATG GTACAGGGCA TTCTGTGGCT ACTATTGATA ACAGGGGTAC
FP1 ....  .............. . .................................
2457 * / 2506
EPI   GGAATTCA CATATGCCAT AGCCAAAGAT
FBI      GGAATTCA CATATGCCAT AGCCAAAGAT
C24V AGGGGCACCT AGACTGCAAA CCTGAATACT CATATGCCAT AGCCAAGAGT
NADL AAGGGCACTT GGATTGCAAA CCTGAATTCT CGTATGCCAT AGCAAAGGAC
FP1 ....GAACCT AGACTGCAAA CCCGAACACT TATATGCTAT AGCTAAGAAT
2507 2556
EPI GAAAGAATTG GCCCACTAGG GGCCGAAGGC CTCACCACCA CATGGAAAGA
FBI GAAAGAATTG GCCCACTAGG GGCCGAAGGC CTCACCACCA CATGGAAAGA
C24V GATAGAATTG GCCTACAAGG AGCTGAAGAC CTTACTACTG TTTGGAAGGA
NADL GAAAGAATTG GTCAACTGGG GGCTGAAGGC CTTACCACCA CTTGGAAGGA
FP1 GAGAATATTG GCCCACTTGG AGCTGAAGGC CTTACTACTG TTTGGAAGGA
2557 2606
EPI TTACTCGCAT GAAATGATTC TGGAAGACAC AATGGTTATA GCTTGGTGCA
FBI TTACTCGCAT GAAATGATTC TGGAAGACAC AATGGTTATA GCTTGGTGCA
C24V TTACTCACAT GGAATGACAC TGGAAGACAC AATGGTCATA GCATGGTGCA
NADL ATACTCGCCT GGAATGAAGC TGGAAGACAC AATGGTCATT GCTTGGTGCG
FP1 TTATTCACAT GAAATGATGC TGGAAGACAC AATGGTCATA GTTTGGTGCA
2607 2656
EPI AAGATGGAAA GTTTACATAC CTCCCAAGGT GCACAAGAGA AACCAGATAT
FBI AAGATGGAAA GTTTACATAC CTCCCAAGGT GCACAAGAGA AACCAGATAT
C24V AAGATGGTAA GTTAACATAT TATGCAAGGT GCACTAGGGA AACCAGATAT
NADL AAGATGGGAA GTTTATGTAC CTCCAAAGAT GCACGAGAGA AACCAGATAT
FP1 AAGGTGGTGA GATCAAATAC TTCTCAAGGT GCACAAGAGA AACCAGATAT
2657 2706
EPI CTCGCAATCT TGCATTCAAG AGCTTTACCA ACCAGTGTGG TGTTCAAAAA
FBI CTCGCAATCT TGCATTCAAG AGCTTTACCA ACCAGTGTGG TGTTCAAAAA
C24V CTTGCAATTT TGCATTCAAG AGCCTTACCG ACCAGTGTGG TATTCAAAAA
NADL CTCGCAATCT TGCATACAAG AGCCTTGCCG ACCAGTGTGG AATTCAAAAA
FP1 CTCGCAATCT TGCATTCGAG GGCCTTACCA ACCAGTGTGG TGTTCAAGAA
2707 2756
EPI ACTTTTTGAT GGCCGAAGGC AAGAGGACGA AGTCGAAATG GACGATAACT
FBI ACTTTTTGAT GGCCGAAGGC AAGAGGACGA AGTCGAAATG GACGATAACT
C24V ACTTTTCGAG GGGCAAGGGC AAGAGGACAC AGTCGAAATG GATGACAACT
NADL ACTCTTTGAT GGGCGAAAGC AAGAGGATGT AGTCGAAATG AACGACAACT
FP1 ACTTTTCGAT GGGCGAAAGC AAGAGGATAC AGTCGAAATG GACGACCACT
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2757 2806
EPI TTGAGTTTGG ACTTTGCCCA TGCTATGCCA GGCCCATAGT AAGGGGGAAA
FBI TTGAGTTTGG ACTTTGCCCA TGCGATGCCA GGCCCATAGT AAGGGGGAAA
C24V TTGAATTTGG ACTCTGCCCA TGCGATGCCA AACCCATAGT AAGAGGGACT
NADL TTGAATTTGG ACTCTGCCCA TGTGATGCCA AACCCATAGT AAGAGGGAAG
FP1 TTGAAGCTGG ACTTTGCCCA TGTGACGCCA AACCAATAGT AAGAGGGAAA
2807 2856
EPI TTCAACACAA CACTGCTAAA TGGACCAGCC TTCCAGATGG TATGCCCTAT
FBI TTCAACACAA CACTGCTAAA TGGACCAGCC TTCCAGATGG TATGCCCTAT
C24V TACAATACAA CACTGCTAAA CGGACCAGCC TTCCAGATGG TATGCCCCAT
NADL TTCAATACAA CGCTGCTGAA CGGACCGGCC TTCCAGATGG TATGCCCC..
FP1 TTCAGTACAA CACTGCTAAA TGGTCCGGCC TTCCAGATGG TGTGCCCCAT
2857 / 2906
EPI AGGGTGGACA GGGACTGTAA GCTGTATGCT AGCTAATAGG GATACCCTAA
FBI AGGGTGGACA GGGACTGTAA GCTGTATGCT AGCTAATAGG GATACCCTAA
C24V AGGTTGGACA GGGACTGTGA GCTGTATGTT AGCTAATAGA GACACCCTAG
NADL .............. AA GCTGTACGTC ATTCAATATG GACACCTTAG
FP1 AGGATGGACA GGGACTGTGA GTTGTTTGCT AGCTAATAGG GATACCTTAG
2907 2956
EPI GCACGGTAGT GGTACGGACG TACAGGAGGT CCGTTCCATT TCCTTACAGA
FBI GCACGGTAGT GGTACGGACG TACAGGAGGT CCGTTCCATT TCCTTACAGA
C24V ACACAGCAGT AGTACGGACG TATAGAAGGT CCAGACCATT CCCTTATAGG
NADL CCACAACTGT GGTACGGACA TATAGAAGGT CTAAACCATT CCCTCATAGG
FP1 ACACTACAGT TGTTCGGACG TATACGAGGT ATAAACCATT CCCTTACAGG
2957 3006
EPI CAAGGCTGTA TCATCCAGAA AACCCTGGGG GAGGATCTCT ATAGCTGTGT
FBI CAAGGCTGTA TCATCCAGAA AACCCTGGGG GAGGATCTCT ATAGCTGTGT
C24V CAAGGCTGTA TTACCCAAAA GACCCTGGGG GAGGATCTCT ATGACTGTAT
NADL CAAGGCTGTA TCACCCAAAA GAATCTGGGG GAGGATCTCC ATAACTGCAT
FP1 CAGGGCTGTA TCACCCAAAA AACCCTGGGG GAGGATCTCT ATGACTGTGC
3007 3056
EPI CCTTGGAGGA AATTGGACTT GTGTGACTGG AGACATGCTA CGGTACACAG
FBI CCTTGGAGGA AATTGGACTT GTGTGACTGG AGACATGCTA CGGTACACAG
C24V TCTTGGAGGA AACTGGACTT GTGTAACTGG GGACCAACTA CAATACACAG
NADL CCTTGGAGGA AATTGGACTT GTGTGCCTGG AGACCAACTA CTATACAAAG
FP1 CCTTGGGGGA AATTGGACTT GTGTGACTGG TGACCAACTA CAATACACAG
3057 3106
EPI GGGGCTCTAT TGAATCCTGC AAGTGGTGTG GTTTTAAATT TCAAAAAAGT
FBI GGGGCTCTAT TGAATCCTGC AAGTGGTGTG GTTTTAAATT TCAAAAAAGT
C24V GAGGCTCTGT TGAATCTTGC AAGTGGTGTG GTTTTAAATT CCAAAAAAGT
NADL GGGGCTCTAT TGAATCTTGC AAGTGGTGTG GCTATCAATT TAAAGAGAGT
FP1 GGGGCCCTGT TGAATCCTGC AAGTGGTGTG GTTATAAATT TAAAAAAAAC
3107 3156
EPI GAGGGACTAC CACACTACCC CATTGGTAAG TGTAGATTGG AGAATGAGAC
FBI GAGGGACTAC CACACTACCC CATTGGTAAG TGTAGATTGG AGAATGAGAC
C24V GAGGGACTAC CACACTACCC CATTGGCAAG TGTAGGTTGA AGAACGAGAC
NADL GAGGGACTAC CACACTACCC CATTGGCAAG TGTAAATTGG AGAACGAGAC
FP1 GAGGGATTAC CACACTACCC CATTGGCAAG TGTAGGTTAG AGAACGAGAC
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EP1
FBI
C24V
NADL
FP1
3157
TGGCTATAGA
TGGCTATAGA
TGGCTACAGA
TGGTTACAGG
TGGCTACAGG
TTAGTAGATG
TTAGTAGATG
TTCGTGGATG
CTAGTAGACA
TTGGTAGATG
ACACC C CTTG 
ACACCTCTTG 
GTACCTCTTG 
GTACCTCTTG 
ACACCTCTTG
CAACAGGGAA
CAACAGGGAA
CAACAGAGAA
CAATAGAGAA
CAATGTAGAA
3206
GGTGTGGCCA
GGTGTGGCCA
GGTGTGGCCA
GGTGTGGCCA
GGTGTGGCCA
EP1
FBI
C24V
NADL
FP1
3207
TAGTACCACA
TAGTACCACA
TAGTGCCACA
TAGTACCACA
TAGTACCAGG
TGGGACAGTA
TGGGACAGTA
AGGACTGGTA
AGGGACATTA
AGGGCCGGTA
AAGTGCAAGA
AAGTGCAAGA
AAGTGTAAGA
AAGTGCAAGA
AAGTGTAAGA
TAGGAGACAC
TAGGAGACAC
TAGGAGACAC
TAGGAAAAAC
TAGGAGACAC
3256
AATTGTACAG
AATTGTACAG
AATTGTACAG
AACTGTACAG
AATTGTACAG
EP1
FBI
C24V
NADL
FP1
3257
GTTGTAGCTA
GTTATAGCTA
GTCATAGCTC
GTCATAGCTA
GTCGCAGCTA
TGGACACTAA
TGGACACTAA
TTGACACCAA
TGGATACCAA
TGGACACTAG
ACTTGGC... 
ACTTGGC... 
ACTTGGGCCT 
ACTCGGGCCT 
ACTAGGA...
ATGCCTTGCA
ATGCCTTGCA
3306
AGCCATATGA
GACCATATGA
EP1
3307 3356
FBI
C24V
NADL
FP1
GATCATACCA
AATCATATCA
AGCGAGGGGC
AGTGAGGGGC
CTGTGGAAAA
CTGTAGAAAA
GACGGCGTGC
GACAGCGTGT
ACCTTCAACT
ACTTTCAACT
EP1
3357 3406
FBI
C24V
NADL
FP1
ACACAAGGAC
ACACTAAGAC
ATTGAAAAAT
ATTAAAAAAT
AAATATTTTG
AAGTATTTTG
AGCCCAGAGA
AGCCCAGAGA
CAGTTACTTC
CAGCTACTTT
EP1
3407 3456
FBI
C24V
NADL
FP1
CAACAATATA
CAGCAATACA
TGCTAAAAGG
TGCTAAAAGG
AGAGTATCAA
ÀGÀGTATCAA
TACTGGTTTG
TACTGGTTTG
ACCTGGAGGT
ACCTGGAGGT
EP1
3457 3506
FBI .................... 3' end of.
C24V CACTGACCA......... gp53 gene is.
NADL GACTGACCA ......... at nucleotide
FP1 ...................  3573........
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Table 6.6 Summary of sequence differences between
biologically cloned stocks of BVD91/1 viruses.
Number of differences
Nucleotides Amino acids
-  . —  —
123 / 41
124 43
FBI = cFBl 91/1 virus 
EP1 = cEPl 91/1 virus 
FP1 = cFPl 91/1 virus
FBI v EP1 
FBI v FP1 
FP1 v EP1
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Table 6.7 Nucleotide and amino acid sequence differences
between cloned and uncloned BVD91/1 viruses.
Difference from cloned version of same virus
Nucleotide change Amino acid change^
uFBl 91/1 no changes no changes
uEPl 91/1 2479 G-Cb / none determined
uFPl 91/1 2487 T-C no change
2692 T-C no change
2780 G-Tb 800(107) D-Yb
2811 G-A 810(117) N-S
2882 T-A 834(141) M-L
3106 C-T no change
The table shows the sequences of uncloned viruses, where 
they differ for those of the biologically cloned viruses 
(already shown in full: Figs 6.9 and 6.10).
Prefix u indicates uncloned virus stock, none determined = 
not known whether or not nucleotide change would have 
encoded an amino acid change because substitution was at 
extreme end of determined nucleotide sequence and the rest 
of the codon was not determined. a = position of change is 
given from start of ORF and then in parenthesis, from likely 
start of gp53. b = Changes only present in two out of four 
ssDNA clones sequenced.
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Table 6.8 GP53 sequence homologies for different
pestiviruses.
% AMINO ACID HOMOLOGY
BVDV HCV BDV
NADL SING EPI FBI C24V FP1 Oslo Alfo Bres Mori
NADL 94 85 85 85 '82 81 66 62 65
Sing 92 88 88 85 83 81 64 62 63
EPI 83 84 99 90 87 81 63 62 66
1 FBI 83 84 99 90 87 81 63 62 66
m
C24V 84 83 84 84 87 80 64 64 63
FP1 82 81 83 83 84 81 62 62 63
Oslo 69 68 70 70 70 70 63 62 67
> Alfo 56 54 55 55 54 55 53 89 74
u
Bres 54 54 56 56 55 55 52 80 73
§
m
More 56 55 57 57 55 55 55 63 62
Differences between amino acids are weighted for 
evolutionary significance in the calculation of the above 
homologies (Gribskov and Burgess, 1986).
NADL = BVDV NADL (Collett and others, 1988a) . Sing = BVDV
Singer (Dale and others, 1987). EPI = EP1 91/1 virus. FBI = 
FBI 91/1 virus. C24V = BVDV Oregon C24V. FP1 = FP1 91/1 
virus. Oslo = BVDV Osloss (Renard and others, 1987). Alfo = 
HCV Alfort (Meyers and others, 1989a). Bres = HCV Brescia
(Moormann and others, 1990). More = BDV Moredun (Lowings and 
Paton, 1992),
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All three nucleotide differences between cFBl 91/1 and cEPl 
91/1 encoded amino acid changes and both viruses had many 
disimilarities (41 and 43 respectively) compared to cFPl 
91/1 (Table 6.6). No amino acid differences were determined 
comparing cFBl 91/1 and cEPl 91/1 with their respective 
uncloned stocks. However, three of the five nucleotide 
differences detected between biologically cloned and 
uncloned FP1 91/1 encoded amino adid differences (Table 
6.7) .
Fig. 6.8 shows an alignment of deduced amino acid sequences 
for all the gp53 proteins, whilst Table 6.8 summarizes 
homologies over a 213 residue length, including comparison 
with other published data. Fig 6.9 is a computer-derived 
dendrogram of similarity coefficients for all the 
pestiviruses compared, based on gp53 amino acid homologies 
over the same region {residues 699(7)-911(219)}. All of the 
BVDVs showed at least 80% homology to one another for the 
amino acids compared. EPI 91/1 and FBI 91/1 appeared almost 
identical, whilst the next most similar were BVDV NADL to 
Singer (92% homology) followed by Oregon C24V to EP1/FB1 
91/1 (90% homology) . BVDV Osloss had a lower and more
consistant homology to other BVDVs (80-81%). The Alfort and 
Brescia strains of HCV and BDV Moredun had only 62-66% 
homology to the BVDVs. The homology between HCVs Brescia and 
Alfort for the same region of gp53 was 89%. BDV Moredun was 
more like either strain of HCV than any strain of BVDV. 
Amino acid homologies between the different viruses were
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Fig 6.8 Alignment of deduced amino acid sequences of gp53 
proteins for the BVDV reference strains NADL and Oregon C24V 
and for the three BVD91/1 viruses.
EPI, FBI and FP1 = BVD91/1 viruses. C24V = BVDV Oregon C24V. 
NADL = CVL strain of BVDV NADL. C = consensus sequence which 
indicates where all the above sequences share either the 
same or an evolutionarily very similar amino acid (Gribskov 
and Burgess, 1986) . Numbering is from start of ORF of BVDV 
NADL (Collett and others, 1988b) or from likely start of 
gp53 (in parenthesis). Dots indicate absence of deduced 
sequence. * = predicted start of gp53. = FB1/EP1
differences.
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658(-35) 707(15)
*
EPI  .......... .... .............. ..........  . EFTYAIAKD
FBI .........  .........  ...... ......... .......EFTYAIAKD
FPl         NLDCK PEHLYAIAKN
C24V NAATTTAFLV CLVKMVRGQM VQGILWLLLI TGVQGHLDCK PEYSYAIAKS
NADL NAATTTAFLV CLVKIVRGQM VQGILWLLLI TGVQGHLDCK PEFSYAIAKD
C NAATTTAFLV CLVK-VRGQM VQGILWLLLI TGVQG-LDCK PE— YAIAK-
708(16) 757(65)
EPI ERIGPLGAEG LTTTWKDYSH EMILEDTMVI AWCKDGKFTY LPRCTRETRY
FBI ERIGPLGAEG LTTTWKDYSH EMILEDTMVI AWCKDGKFTY LPRCTRETRY
FPl ENIGPLGAEG LTTVWKDYSH EMMLEDTMVI VWCKGGEIKY FSRCTRETRY
C24V DRIGLQGAED LTTVWKDYSH GMTLEDTMVI AWCKDGKLTY YARCTRETRY
NADL ERIGQLGAEG LTTTWKEYSP GMKLEDTMVI AWCEDGKFMY LQRCTRETRY
C E-IG— GAE- LTT-WKDYS- -M-LEDTMVI -WC— G Y L-RCTRETRY
758(66) 807(115)
▼
EPI LAILHSRALP TSWFKKLFD GRRQEDEVEM DDNFEFGLCP CYARPIVRGK
FBI LAILHSRALP TSWFKKLFD GRRQEDEVEM DDNFEFGLCP CDARPIVRGK
FPl LAILHSRALP TSWFKKLFD GRKQEDTVEM DDHFEAGLCP CDAKPIVRGK
C24V LAILHSRALP TSWFKKLFE GQGQEDTVEM DDNFEFGLCP CDAKPIVRGT
NADL LAILHTRALP TSVEFKKLFD GRKQEDWEM NDNFEFGLCP CDAKPIVRGK
C LAILH-RALP TSV-FKKLFD G— QED-VEM -D-FE-GLCP C-A-PIVRG-
808(116) 857(165)
EPI FNTTLLNGPA FQMVCPIGWT GTVSCMLANR DTLSTVWRT YRRSVPFPYR
FBI FNTTLLNGPA FQMVCPIGWT GTVSCMLANR DTLSTVWRT YRRSVPFPYR
FPl FSTTLLNGPA FQMVCPIGWT GTVSCLLANR DTLDTTWRT YTRYKPFPYR
C24V YNTTLLNGPA FQMVCPIGWT GTVSCMLANR DTLDTAWRT YRRSRPFPYR
NADL FNTTLLNGPA FQMVCPIGWT GTVSCTSFNM DTLATTWRT YRRSKPFPHR
C F-TTLLNGPA FQMVCPIGWT GTVSC N- DTL-T-WRT Y-R— PFP-R
858(166) 907(215)
EPI QGCIIQKTLG EDLYSCVLGG NWTCVTGDML RYTGGSIESC KWCGFKFQKS
FBI QGCIIQKTLG EDLYSCVLGG NWTCVTGDML RYTGGSIESC KWCGFKFQKS
FPl QGCITQKTVG EDLYDCALGG NWTCVTGDQL QYTGGPVESC KWCGYKFKKN
C24V QGCITQKTLG EDLYDCILGG NWTCVTGDQL QYTGGSVESC KWCGFKFQKS
NADL QGCITQKNLG EDLHNCILGG NWTCVPGDQL LYKGGSIESC KWCGYQFKES
C QGCI-QK— G EDL— C-LGG NWTCV-GD-L -Y-GG-IESC KWCGF-F---
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908(216) 957(265)
▼
EPI EGLPHYPIGK CRLENETGYR LVDDTPCNRE GVAIVPHGTV KCKIGDTIVQ
FBI EGLPHYPIGK CRLENETGYR LVDDTSCNRE GVAIVPHGTV KCKIGDTIVQ
FPl EGLPHYPIGK CRLENETGYR LVDDTSCNVE GVAIVPGGPV KCKIGDTIVQ
C24V EGLPHYPIGK CRLKNETGYR FVDGTSCNRE GVAIVPQGLV KCKIGDTIVQ
NADL EGLPHYPIGK CRLENETGYR LVDSTSCNRE GVAIVPQGTL KCKIGKTTVQ
C EGLPHYPIGK C-L-NETGYR LVD-T-CN-E GVAIVP-G—  KCKIG-T-VQ
958(266) 1007(315)
▼
EPI WAMDTKLG. .............................. .............
FBI VIAMDTKLG......    . .................... .....
FPl VAAMDTRLG................. ................  .........
C24V VIALDTKLGP MPCKPYEIIP SEGPVEKTAC TFNYTRTLKN KYFEPRDSYF
NADL VIAMDTKLGP MPCRPYEIIS SEGPVEKTAC TFNYTKTLKN KYFEPRDSYF
C V-AMDT-LG- MPC-PYEII- SEGPVEKTAC TFNYT-YKLN KYFEPRDSYF
1008(316) 1057(365)
firx . . ...... ..........
C24V QQYMLKGEYQ YWFDLEVTDH 
NADL QQYMLKGEYQ YWFDLEVTDH 
C QQYMLKGEYQ YWFDLEVTDH
EPI
FBI
FPl
Approximate
C-terminus
of gp53 is at
amino acid 
1063 (370)
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Fig 6.9 Dendrogram based on comparison of 213 amino acid long 
fragments of the gp53 proteins from 10 pestiviruses.
Computation based on largest fragment size (213 amino acids) 
for which alignable sequence available for all viruses. 
Limiting data at 5' end was that for EP1/FB1 91/1 and at 3' 
end was that for BVDV Singer. Similarity clustering is by 
pairwise alignment and alignment of clusters is based on 
arithmetic average similarity scores of constituents. As 
such, the dendrogram is not a phylogenetic tree, although 
the vertical branch lengths are proportional to the 
similarity between sequences.
NADL = BVDV NADL (Collett and others, 1988a) . Singer = BVDV 
Singer (Dale and others, 1987) . EPI = EPI 91/1 virus. FBI = 
FBI 91/1 virus. Oregon C24V = BVDV Oregon C24V (Paton and 
others, 1992b). FPl = FPl 91/1 virus. Osloss = BVDV Osloss 
(Renard and others, 1987). Alfort = HCV Alfort (Meyers and 
others, 1989a). Brescia = HCV Brescia (Moormann and others, 
1990). Moredun — BDV Moredun (Lowings and Paton, 1992).
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always greater than or equal to nucleotide homologies and 
this difference became greater as increasingly disimilar 
strains were compared. For instance, comparing NADL to all 
other BVDVs except Osloss, the nucleotide and amino acid 
homologies were 82-92% and 82-94% respectively. Comparing 
Osloss to all other BVDVs, the nucleotide and amino acid 
homologies were 68-70% and 80-81% respectively.
/
6.4 DISCUSSION
Use of RT-PCR to amplify RNA for sequencing has already been 
reported for pestiviruses (De Moerlooze and others, 1991;
Roehe, 1991). The region amplified and sequenced for the 
NADL and Oregon C24V viruses extended from nucleotide 2357 
to 3465 (1108 nucleotides). A small region of 20 nucleotides 
within the NADL sequence was not determined because of the 
use of overlapping internal primers to generate cDNA. 
However, the fact that the primers worked, suggests that 
this area is likely to be similar to the primer sequences, 
which were based on the NADL sequence of Collett and others 
(1988a). A shorter region of BVD91/1 viral sequences were 
established, extending from nucleotides 2461 to 3283. The 
genomic regions sequenced in this study probably equate to 
about 90% of the gp53 genes for BVDVs NADL and Oregon C24V 
and about 74% of the gp53 genes for the BVD91/1 viruses. The 
deduced amino acid sequences finish about 35 and 104 
residues short of the likely C-termini of the respective
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gp53 proteins. These calculations are based on an N-terminus 
of gp53 at amino acid residue 693 (1) and a C-terminus at
amino acid residue 1063 (370) . This would place the gp53
gene at between nucleotides 2462 and 3573. The location of 
the N-terminus is based on a signalase site (Moormann and 
others, 1990) and the C-terminus is an estimate of Collett 
and others (1988b) , supported by the data of van Zijl and 
others (1991). The latter, working with the Brescia strain 
of HCV have shown that a 373 amino acid, recombinant gp55 
protein with an N-terminus at the signalase site is both 
membrane anchored and able to induce protective immunity. By 
contrast, a protein that is 33 amino acids shorter at the 
C-terminus is secreted, and induces poor protective 
immunity..
The NADL sequence obtained in this study was very similar to 
that of Collett and others (1988a). Small differences were 
not unexpected, considering inevitable variation in passage 
histories for the viruses in different laboratories and the 
fact that mAb binding studies have previously indicated 
antigenic differences between different laboratory stocks of 
"the same" reference strain of BVDV (Cay and others, 1989) . 
Over the 213 amino acid region compared between all strains, 
the Oregon C24V virus showed a homology of 85% or greater to 
all other BVDVs apart from Osloss (80% homology). Compared 
to NADL or BVD91/1 viruses, there were too many differences 
to make confident predictions as to the likely positions of 
epitopes for mAbs able to discriminate between the strains.
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On the basis of mAb discrimination, the FBI 91/1 and EPI 
91/1 viruses appeared identical to one another and more like 
Oregon C24V than NADL. Limited sequencing confirmed these 
relationships revealing a 99% amino acid homology between 
FBI 91/1 and EPI 91/1 and a homology for either of these two 
viruses to Oregon C24V and NADL of 90% and 85% respectively. 
MAb reactivity detected epitopic variants in uFPl 91/1 but 
not in either of uFBl 91/1 or uEPl 91/1. Again sequence data 
was in agreement, detecting differences between biologically 
cloned or uncloned FPl 91/1, but very little difference 
between equivalent stocks of the other two BVD91/1 viruses. 
FPl 91/1 had appeared antigenically distinct from EPI 91/1 
and FBI 91/1 before and especially after biological cloning. 
Sequencing confirmed that FPl 91/1 was the odd one out of 
the three BVD91/1 viruses and it appeared less similar to 
the other two viruses than did Oregon C24V. It is, however, 
still a possibility that some variants within uFPl 91/1 that 
were not selected for molecular cloning could be much more 
like FBI 91/1 and EPI 91/1. Limited sequence data also 
concurred with mAb typing and cross-neutralization, in 
finding that all three BVD91/1 viruses were clearly 
BVDV-like and not HCV-like. Considering the increasing 
emphasis placed on mAb-based differentiation of pestivirus 
isolates, it is encouraging to have found that this mAb 
panel was in most respects as good as sequencing at 
determining both inter and intra isolate variation. All 
field isolate typing at CVL has been done (at least 
initially) using biologically uncloned stocks of virus. It
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is clear that quite different results may be obtained after 
cloning.
The dendrogram of similarity coefficients (Fig 6.9 ) 
revealed a suprising homogeneity amongst the BVDVs, many of 
which were as similar to one another as was HCV Alfort to 
HCV Brescia. It was particularly striking that a virus 
isolated in the 1960's in North America (Oregon C24V) should 
be as similar to either of two viruses (FBI 91/1 and FPl 
91/1) isolated from the same English farm in 1991 as these 
two were to one another. In Chapter 5, it was shown by mAb 
typing that the majority of BVDV strains and field isolates 
share common epitopes on gp53. Thus both antigenic studies 
and sequencing indicate that most BVDVs form a relatively 
homomgeneous group. Table 6.9 shows the reactivity of the 
anti-gp53 mAbs described in Chapter 5 for most of the 
viruses compared genetically in Fig 6.10 (Sands, personal 
communication). Biologically cloned FPl 91/1 expressed the 
fewest epitopes of this particular mAb panel, even though 
Osloss is the most disimilar BVDV genetically. As reported 
by Lowings and Paton (1992), BDV Moredun appeared 
genetically more like HCV than any of the BVDVs. One of the 
anti-BVDV-gp53 mAbs used in the present studies recognised 
BDV Moredun but not HCVs Alfort and Brescia. However, this 
mAb (WB166n) did recognise some HCVs (Sands, personal 
communication: Fig 5.9). It was noted that for all the BVDVs 
other than Osloss, the amino acid and nucleotide homologies 
were very similar. For HCV Alfort, HCV Brescia, BDV Moredun
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Table 6.9 MAb recognition of pestiviruses for which sequence 
data available.
BVDV BDV HCV
mAbs NADL C24V FBI Osloss FPl Moredun Alfort Brescia
WB158n + - - - - - - -
WB166n + + + + + ' + - -
WB170n + - - - - — - -
WB214n + + + - - - -■ -
WB115C - + + - - - - -
WB162C - + - + - - - -
WB163C + + + - - - - -
WB165C - + - - - - - -
WB215C + + + + — — — —
Data is that of Sands, personal communication:
+ = virus-specific staining in PLA 
- = no virus-specific staining in PLA
All viruses except HCVs were cloned by limiting dilution 
before immunocharacterization. Data on conservation of these 
epitopes in BVDV Singer was not available.
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ctnd especially BVDV Osloss, there was a greater decrease in 
homology if nucleotides were compared. This difference may 
partly reflect codon degeneracy. The low nucleotide homology 
suggests that these viruses are quite distantly related to 
the other BVDVs, whilst the higher amino acid homologies 
probably reflect functional constraints on protein 
diversity.
The contention made in Chapter 3 was that FPl 91/1 was most 
likely a descendant of FBI 91/1 and that any differences 
could be accounted for by passage in a sow and her 
congenitally infected piglet. Although experimental passage 
could not reproduce these changes, prior to sequencing, it 
was still possible to speculate that the epitopic variations 
in FPl 91/1 might have been the result of some specific 
selective pressure leading to rather limited sequence 
changes and that overall the virus would prove to be rather 
similar to the other two. Limited sequence data from this 
study suggests that this is unlikely and it now seems 
probable that two different strains of BVDV were circulating 
on Farm "X". Some uncertainty still remains, however, 
because the dissimilarity of all variants of FPl 91/1 from 
FBI 91/1 is not confirmed, whilst a bovine origin for FPl 
91/1 on Farm ,lXn was not discovered. Since sequence 
differences between FBI 91/1 and FPl 91/1 were widely 
distributed, this did not suggest that recombination between 
FPl 91/1 and another virus was responsible for FBI:FPl 
heterogeneity.
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For those viruses that appeared to have a very close 
similarity on sequencing, the question must arise as to 
whether or not this could have been due to 
cross-contamination between stocks, especially after or 
during PCR-amplification of cDNA. Whilst the possibility can 
never be ruled out absolutely, a number of precautions were 
taken to guard against this mischance. Control negative 
cultures were always maintained concômitantly with infected 
ones, and were always screened for contamination by mAb 
staining or RT-PCR as appropriate. None of these control 
cultures ever showed signs of having become infected. Repeat 
PCR on previously amplified material, which introduces a
particularly high risk of cross-contamination, was never 
performed. For all the BVD91/1 viruses, two separate cycles 
of immunocharacterization and molecular cloning were carried 
out, before and after biological cloning. Such small 
differences in sequence as were detected between EPI 91/1 
and FBI 91/1 viruses were consistent for both of these
cycles. Furthermore, these two viruses were isolated several 
months apart, whilst other independently derived stocks of 
virus obtained from later bleeds of the persistently 
infected calf (source of FBI 91/1) and from littermates of 
PF404 (source of EPI 91/1) were all identical with respect 
to mAb typing.
There were three amino acid differences between FBI 91/1 and 
EPI 91/1 at positions 799 (107) , 933 (241) and 959 (267).
The last of these was immediately adjacent to a predicted
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location for the epitope of mAb WB215c (Chapter 7) . During 
passage of FBI 91/1 in the experimentally infected sow and 
her piglet, selective pressure for change might have been 
exerted by immunological responses made by the pigs. 
However, since the piglet appeared immunotolerant to the 
infecting virus, and since transplacental spread may preceed 
the development of any maternal immunity, it is uncertain 
that any immunological selective pressures would have been 
applied. Non-immunological selective pressures on a virus 
consequent upon passage in a new host might also be 
envisaged. For instance, host-specific virus receptors might 
exert an influence on structural proteins such as gp53. 
Since the viral epitopes of neutralizing antibodies might 
also be involved in receptor binding, it may not be a 
coincidence that one of the changes between FBI 91/1 and EPI 
91/1 coincides with a predicted mAb epitope. A change in the 
intracellular environment consequent upon infection of a new 
host-type might affect non-structura1 proteins. It would 
therefore be interesting to compare other genes for the 
FBI/EPI virus pairs. Without this information, it is not 
possible to say how important were the changes detected in 
gp53. No amino acid difference were confirmed between cEPl 
91/1 and uEPl 91/1. This was in spite of the fact that the 
uncloned virus had been passaged twice in a bovine cell 
culture (CTs), whilst the cloned virus had been passaged in 
PK15s. The apparent lack of influence of these cultural 
differences is hard to assess, because of the small number 
of CT passages and the ambiguity of sequence data derived
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from uncloned virus.
The considerable antigenic diversity amongst pestiviruses 
points to a high rate of mutation and passage between 
animals is a possible method by which different strains 
might arise. Kreeft and others (1990) found antigenic 
variation amongst BVDVs isolated from different cattle after 
presumed infection with the same stock of virus. Gunn and 
others (1992) found that passage of BVDV between cattle and 
sheep selected for rather specific changes in epitope 
expression.
The number of amino acid differences between the 
biologically cloned stocks of the BVD 91/1 viruses were too 
great (FPl 91/1 versus the other two) or too few (FBI 91/1 
versus EP191/1) to make deductions as to the likely site of 
binding of discriminatory mAbs. However, the three amino 
acid differences between FPl 91/1 before and after 
biological cloning might be related to differences in mAb 
reactivity for these viruses. This will be considered in 
Chapter 7.
It would be expected that biological cloning by the method 
of limiting dilution would select the most numerous variant 
from within a given population. Where all variants are 
equally effective at binding RT-PCR primers, the same would 
be predicted for molecular cloning. Prior to biological 
cloning FPl 91/1 showed a mixed immunostaining pattern, with
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epitopic variants occurring at titres close to that of the 
mainstream population (Chapter 3). In this case, molecular 
and biological cloning selected different viruses. 
Presumably this occurred because as well as the differences 
identified between the sequences of cFPl 91/1 and uFPl 91/1, 
an additional difference or differences affected the binding 
of the RT-PCR primers. Whilst it is possible that 
differences in the sequences of uFPl 91/1 and cFPl 91/1 
reflect the influence of the different cell cultures used to 
generate these viruses (CT and PK15 for biologically cloned 
and uncloned respectively), this seems unlikely given the 
lack of influence that this had comparing uEPl 91/1 and cEPl 
91/1.
6.5 CONCLUSIONS
Between 74% and 90% of the gp53 genes of several BVDV 
strains and field isolates were sequenced after RT-PCR 
amplification. The CVL-NADL differed fromthat of Collett 
and others (1988a) by four nucleotides, of which two encoded 
amino acid changes. These small differences probably reflect 
different passage histories of the sequenced viruses.
The nucleotide and amino acid sequences of Oregon C24V and 
the BVD91/1 viruses showed 85—90% homology to one another 
and to most other BVDVs. Similarity to BVDV Osloss was less, 
particularly at the nucleotide level. Nucleotide and amino
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acid similarity to HCV Brescia and Alfort and to BDV Moredun 
was least of all, confirming that the porcine isolate FPl 
91/1 was not HCV.
Sequence data supported the findings of antigenic studies 
that had already suggested that:
1) FBI 91/1 and EPI 91/1 were both homogeneous and similar 
to one another.
2) FPl 91/1 contained a mixed virus population with 
differences from FBI 91/1 and EPI 91/1.
It was concluded that FPl 91/1 was probably not a direct 
descendant of FBI 91/1. Three amino acid differences were 
found between the gp53 proteins of a bovine virus analysed 
before and after passage in preimmune pigs. The significance 
of these changes remains to be established.
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CHAPTER 7
LOCATION OF EPITOPES DEFINED BY ANTI-GP53 
MONOCLONAL ANTIBODIES.
7.1 INTRODUCTION 
1 2  MATERIALS AND METHODS
i) Viruses, cells and mAbs
ii) MAb Neutralization Escape mutants
iii) Molecular cloning and sequencing of gp53 
genes of escape mutant viruses
73  RESULTS
i) MAb Neutralization Escape mutants
ii) Sequencing of escape mutants
iii) Nucleotide and amino acid substitutions in 
escape mutants
7.4 DISCUSSION
7.5 CONCLUSIONS
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7.1 INTRODUCTION
In chapter 5, epitope mapping with nine anti-gp53 mAbs 
defined a major domain in which most of the epitopes 
clustered including all those that showed a moderate to high 
level of conservation amongst ruminant pestiviruses. Less 
highly conserved epitopes, and in particular that recognised 
by mAb WB158n, appeared to be spatially distinct. Mateo 
(1988), who demonstrated four antigenic domains on BVDV gp53 
using mAbs and competitive binding assays, also found 
clustering of conserved epitopes. Van Rijn and others 
(1992), have indicated that most epitopes on the equivalent 
protein of HCV (gp55) are situated in the N-terminal half of 
the protein, although their precise locations were not
demonstrated.
In this chapter, the production and characterization of 
mutant NADL and Oregon C24V viruses are described.
Neutralizing mAbs were used to select for neutralization 
escape mutants and these were compared with the parental 
strains by mAb binding studies and by molecular cloning and 
sequence analyses of gp53 genes. This provided data for the 
location of antigenic domains and also demonstrated that 
they are probably defined by discontinuous sequences of 
amino acids. Re-examination of the sequence data from
Chapter 6, in the light of the information gained from the 
escape mutants provided additional support for some of the 
epitope locations.
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7Jt MATERIALS AND METHODS
i) Viruses, cells and mAbs:
The Oregon C24V and NADL strains of BVDV were as described 
in Chapter 2. CT cells were used as described in Chapter 2. 
Anti-gp53 mAbs were those described in Chapter 5.
ii) MAb Neutralization Escape mutants: /
Using 96 well plates (Nunc) , NADL and Oregon C24V viruses 
that escaped neutralization by mAbs were selected by 
incubating sequential, tenfold virus dilutions with equal 
volumes of mAb at concentrations of between 0.12 and 0.20 
mgml'1. After one hour at 37°C, cell suspension was added 
and incubation continued for a further 3 days. Supernatant 
fluids were retained, whilst monolayers were fixed and 
immunostained using a pan-pestivirus-reactive anti-pBO mAb 
as previously described (Chapter 2). Supernatants from
cultures containing only plaques of stained cells, at virus 
dilutions where 100% infection would have been expected in 
the absence of mAb, were passaged twice without antibody to 
produce stocks of potential escape mutant viruses. These
mutants received one further passage, either for
characterization with mAbs or to extract RNA for molecular 
cloning. Each stock was titrated in tenfold steps and
stained with the selecting mAb and an anti-pBO mAb. Only 
those stocks which were recognised by the anti-pBO mAb and 
not the selecting mAb were retained as escape mutant 
viruses. Escape mutants were titrated in tenfold steps with
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and without the presence of mAbs (final dilution 0.OSmgml'1) 
to test whether they escaped neutralization. They were also 
examined by PLA for recognition by the full panel of 
anti-gp53 mAbs to assess epitopic changes. All escape mutant 
viruses were named after the mAb/virus combination selected 
from (eg A1 214n was selected from NADL with WB214n, whilst 
C3 214c was selected from Oregon C24V with the same mAb) and 
all were derived from separate culture wells.
iii) Molecular cloning and sequencing of gp53 genes of escape mutant viruses:
The procedure used was exactly as described for the parental 
strains of virus (NADL and Oregon C24V) in Chapter 6. 
Sequence data was analysed using the GCG software package 
(Devereux and others, 1984) via the Daresbury Laboratory of 
the Science and Engineering Research Council. As in Chapter 
6, nucleotide numbering is according to that of Collett and 
others (1988a) and amino acid numbering is from the start of 
the large open reading frame according to Collett and others 
(1988b), with the likely position from the N-terminus of 
gp53 given in parenthesis.
73  RESULTS
i) MAb Neutralization Escape mutants:
Mutant viruses, that escaped neutralization by their 
selecting mAb, were obtained for all neutralizing mAb/virus 
combinations except for WB163c/Oregon C24V. The log10
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neutralization of parental virus by the selecting mAbs was 
between 2.5 and 3.75 (Table 7.1). All mutants showed at 
least a two logio reduction in ' neutralization, in the 
presence of the inducing mAb, compared to that seen for the 
parent virus with the same mAb. Some mutants showed a 
similar order of neutralization resistance with additional 
mAbs. Table 7.2 summarizes the pattern of mAb
neutralization resistance of the mutants and also shows 
their loss of binding epitopes. Where multiple binding 
epitopes were lost, this was considered suggestive of 
epitopic overlap. On this basis, NADL epitopes could be 
split into three groups: 1) WB166n and WB215c, 2) WB214n and 
3) WB158n. The WB170n and WB163c epitopes seemed distinct, 
in that they were not lost from any of the NADL mutants, but 
their relationship to one another was not established. For 
Oregon 024V virus, the pattern of epitope loss suggested a 
domain comprising the epitopes of WB214n, WB166n, WB162c, 
WBllSc and WB215C. The WB163c and WB165c epitopes were not 
lost from any of the mutants, but again their relationship 
to one another could not be established. In Fig 7.1, the 
evidence of epitopic overlaps from the shared loss of 
epitopes has been added to the original epitope map from 
Chapter 5 (Fig 5.8).
ii) Sequencing of escape mutants:
RT-PCR products used for molecular cloning and sequencing 
are shown in Fig 7.2.
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Table 7.1 Neutralization indices for parental and escape 
mutant viruses incubated with mAbs.
Loam neutralization of NADL virus and variants
Monoclonal Antibody
Virus
A1 2l4n 
C5 158n 
C2 166n 
C3 166n 
NADL
WB166n WB214n WB158n
3.25 
4.0
1.5
1.25
3.5
0.5
4.0
4.25
2.5
2.5
3.25 
0.75
4.25
3.25
3.25
Loam  neutralization of Oregon C24V virus and variants:
Monoclonal Antibody
Virus
C3 214c 
A2 214c 
G1 215c 
C4 162c 
Oregon C24V
WB214n
0
0.5
3.75 
0
3.75
WB162C
2.0
2.75 
0
0.5
3.75
WB163C
2.75 
3.5
2.75 
3.25 
3.0
WB215C
2.0
2.5
0.75
1.0
2.75
Neutralization indices expressed as log10 neutralization of 
virus following incubation with mAbs (0.OSmgml-1)
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Table 7.2 Characteristics of escape mutant viruses, including 
changes in mAb binding, neutralization, nucleotide sequence 
and deduced amino acid sequence.
Escape mAbs no mAbs with red- Nucleotide Amino acid
mutant longer uced neutral- changeb changeb
virus binding^ izing effecta /position /position
NADL Mutants: /
A1 214n 214n 214n G-A/2676
G-A/2897
R-K/764
D-N/838
(72)
(146)
C5 15 8 n 158n 158n G-A/2579 E-K/732 (40)
C2 166n 166n,215c 166n T-C/2682
A-G/2978
L-S/766 
N—D/865
(74)
(173)
C3 166n 166n,215c 166n T-G/2682 L-W/766 (74)
Oreaon C24V Mutants:
C3 214c ' 214n,166n 214n A-C/2677
A-G/2864
R-S/764
T-A/827
(72)
(135)
A2 214c 214n,166n 214n A-C/2677
A-G/2864
R-S/764
T-A/827
(72)
(135)
G1 215c 215c,115c, 
162c,166n
215c,
162c
T-C/2672
C-T/3273
S-P/763 
T—1/963
(71)
(271)
C4 162c 115c,162c, 
166n,215c
214n,162c, 
215c
A-G/2675
T-C/3006
R-G/764
I-T/874
(72)
(182)
Positions are according to Collett and others (1988a): 
nucleotide positions are from 5' end of genome and amino 
acid positions are either from start of BVDV open reading 
frame (or if in parenthesis are from likely start of gp53) . 
a = compared to binding/neutralization of parental virus. b 
= parent virus nucleotide/amino acid is shown first, 
followed by that of the escape mutant. Designation of mAbs 
abbreviated by ommission of WB prefix.
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Fig 7.1 Epitope maps for anti-gp53 mAbs, showing shared 
epitope loss from escape mutant viruses.
Each circle represents the epitope of a single mAb, except 
for WB162c and WBllSc, which behaved in the same way and are 
displayed jointly. Overlap of circles indicates reciprocal 
block for binding of relevant mAbs in competitive binding 
assay. MAbs defining epitopes represented by circles with 
dotted outlines were tested by one-way blocking only. Blue 
circles represent relatively conserved epitopes (identified 
in >30% of BVDVs by PLA), whilst red circles represent 
relatively strain-specific epitopes (identified in <10% of 
BVDVs by PLA). * = neutralizing mAb. Shaded overlaps have
been confirmed by shared epitope loss from escape mutant 
viruses.
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gp53 epitopes: NADL
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%
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Epitopes absent: 
WB158n 
WB170n
WB214n *
WB166n
WB162c
WB115C
WB215C
WB165C
WB163C
2 6 5
Fig 1 2  RT-PCR products from parental and escape mutant 
viruses used for molecular cloning and sequencing.
Figures show ethidium bromide stained agarose gels after 
electrophoresis of lOpl of RT-PCR product. Arrowed numbers 
refer to base pairs of virus-specific RT-PCR products; m = 
molecular weight markers.
a) RT-PCR of NADL escape mutants using primer combination of 
F2855-2874 and R3485-3466 (631 base pair product). Lane 1 = 
uninfected CT control; Lane 2 = NADL; Lane 3 = C5 158n; Lane 
4 - C2 166n; Lane 5 = C3 166n; Lane 6 - Al 214n.
b) RT-PCR of NADL escape mutants using primer combination of 
F2336-2357 and R2874-2855 (539 base pair product). Lane 1 = 
uninfected CT control; Lane 2 = NADL; Lane 3 = C5 158n; Lane 
4 - C2 166n; Lane 5 = C3 166n; Lane 6 - Al 214n.
c) RT-PCR of Oregon C24V escape mutants using primer 
combination of F2336-2356 and R3485-3466 (1150 base pair
product). Lane 1 = uninfected CT control ; Lane 2 = Oregon 
C24V; Lane 3 = A2 214c; Lane 4 = C3 214c; Lanes 5 = C4 162c; 
Lane 6 - C5 162c; Lane 7 = H8 215c; Lane 8 = G1 215c
No virus-specific band was obtained from mutants C5 162c and 
H8 215c.
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iii) Nucleotide and amino acid substitutions in escape mutants:
Compared with their parental viruses, two escape mutants 
contained single point mutations and six contained double 
point mutations. All of the observed nucleotide changes 
encoded amino acid substitutions, of which only two were 
conservative changes. The changes are detailed in Table 7.2 
and their positions are shown in Figs 7.3 and 7.4. Mutant C5 
158n had a single non-conservative, âmino acid substitution 
at residue 732 (41), 40 amino acids from the predicted
N-terminus of gp53 and at least 31 amino acids upstream of 
all other substitutions. The remaining mutants all had an 
amino acid substitution at residues 763 (71), 764 (72) or
766 (74). These changes were also non-conservative, except
in mutants Al 214n and C3 166n. Amino acids 763-766 (71-74) 
have a moderate antigenicity index, are flanked on either 
side by a hydrophobic region encompassing 6-8 residues, are 
preceded by residues with a predicted B-sheet secondary 
structure and have no predicted adjacent sites of 
glycosylation. Comparison amongst known gp53 sequence for 
different pestiviruses showed that this region of the 
protein is relatively conserved ( F i g 7.3). Amino acid 
homology amongst BVDVs was particularly high, with 
differences only at residue 763 (71) of Oregon C24V and
residue 771 (79) of the CVL-NADL strain (Fig. 7.3). Twelve 
out of fifteen amino acids between residues 756-770 (64-78) 
are also conserved in HCV strains Alfort (Meyers and others, 
1989) and Brescia (Moormann and others, 1990) and in the 
Moredun strain of BDV (Bowings and Paton, 1992).
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Fig 73 Amino acid sequence alignments for regions of the 
gp53 protein identified as possible epitope sites.
Domain A = major domain on both NADL and Oregon C24V, 
comprising epitopes of most anti-gp53 mAbs, including all 
those which are relatively conserved amongst BVDVs. Possible 
locations within primary sequence defined by amino acid 
substitutions (*) in escape mutants derived from NADL or 
Oregon C24V: 2 = Al 214n, C2/3 166n, A2/C3 214c, G1 215c, 04 
162c; 3 = A2/C3 214c, Al 214n; 4 = 04 162c, 02 166n; 5 = G1 
215c.
Domain B = NADL domain defined by relatively strain-specific 
mAb WB158n. Possible location within primary sequence 
defined by amino acid substitutions (*) in escape mutant 
derived from NADL: 1 = 05 158n.
g — predicted site of N-glycosylation in amino acid sequence 
of NADL
NADL = BVDV NADL (Collett and others, 1988a) . Sing = BVDV 
Singer (Dale and others, 1987). EPI = EP1 91/1 virus. FBI = 
FBI 91/1 virus. 024V = BVDV Oregon 024V. FP1 = FP1 91/1 
virus. Oslo = BVDV Osloss (Renard and others, 1987). Alfo = 
HCV Alfort (Meyers and others, 1989a). Bres = HCV Brescia 
(Moormann and others, 1990). More = BDV Moredun (Lowings and 
Paton, 1992). C = consensus sequence.
Numbering is from start of ORF of NADL (Collett and others, 
1988b) with likely position from start of gp53 given in 
parenthesis.
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NADL
Sing
EPI
FBI
C24V
FP1
Oslo
Alfo
Bres
More
C
NADL
Sing
EP1
FBI
C24V
FP1
Oslo
Alfo
Bres
More
C
NADL
Sing
EP1
FBI
C24V
FP1
Oslo
Alfo
Bres
More
C
699(7)
EFSYAIAKDE
EFSYAIARDE
EFTYAIAKDE
EFTYAIAKDE
EYSYAIAKSD
EHLYAIAKNE
GFYYAIAKNN
DYRYAISSTN
DHRYAISTTN
GYRYALAKTN
748(56)
LQRCTRETRY
LPRCTRETRY
LPRCTRETRY
LPRCTRETRY
YARCTRETRY
FSRCTRETRY
LITCEREARY
TALNWSRRY
TALNWSRRY
REHCLIGQRY
RIGQLGAEGL 
RIGQLGAEGL 
RIGPLGAEGL 
RIGPLGAEGL 
RIGLQGAEDL 
NIGPLGAEGL 
EIGPLGATGL 
EIGLLGAEGL 
EIGLHGAEGL 
EIGPLGAESL 
—IG— GA— L
LAILHTRALP 
LAILHTRALP 
LAILHSRALP 
LAILHSRALP 
LAILHSRALP 
LAILHSRALP 
LAILHTRALP 
LASLHKRALP 
LASLHKDALP 
LASLHQRALP 
LA-LH— ALP
TTTWKEYS.P 
TTTWKDYS.P 
TTTWKDYS.H 
TTTWKDYS.H 
TTVWKDYS.H 
TTVWKDYS.H 
TTQWYEYS.D 
TTTWKEYS.H 
TTTWKEYN.H 
TTTWTDYQRN 
TT-W-DY— -
TSWFKKLFD 
TSWFKKLFD 
TSWFKKLFD 
TSWFKKLFD 
TSWFKKLFE 
TSWFKKLFD 
TSWFEKIID 
TSVTFELLFD 
TSVTFELLFD 
TSVTFELIPG 
TSV-F---——
GMKLEDTMVI 
EMKLEDTMVI 
EMILEDTMVI 
EMILEDTMVI 
GMTLEDTMVI 
EMMLEDTMVI 
GMRLQDTGW 
GLQLDDGTVK 
NLQLDDGTVK 
NLKLDDGTVR 
-M-L-D— V-
*
Domain B1
GRKQEDWEM 
GRKQEDWEM 
GRRQEDEVEM 
GRRQEDEVEM 
GQGQEDTVEM 
GRKQEDTVEM 
GKEQEDWEM 
GTNPAIE.EM 
GTSPLTE.EM 
GSTLIKE.EM 
G-------EM
747(55)
AWCEDGKLMY
AWCKDGKFTY
AWCKDGKFTY
AWCKDGKFTY
AWCKDGKLTY
VWCKGGEIKY
VWCKGGEIKY
AVCTAGSFKV
AICMAGSFKV
ATCSRGFFRF
797(105) 
NDNFEFGLCP 
DDNFEFGLCP 
DDNFEFGLCP 
DDNFEFGLCP 
DDNFEFGLCP 
DDHFEAGLCP 
DDNFELGLCP 
DDDFGFGLCP 
GDDFGFGLCP 
GDDFEFGLCP 
-D-F— GLCP
** * 
Domain A2
798 (106')
CDAKPIVRGK
CDAKPIVRGK
CDARPIVRGK
CDARPIVRGK
CDAKPIVRGT
CDAKPIVRGK
CDAKPLVRGK
FDTSPVIKGK
YDTSPWKGK
CDSRPWKGK
CD— P-V-G-
FNTTLLNGPA
FNTTLLNGPA
FNTTLLNGPA
FNTTLLNGPA
YNTTLLNGPA
FSTTLLNGPA
FNTTLLNGPA
YNTTLLNGSA
YNTTLLNGSA
YNTTLLNGSA
F-TTLLNG-A
9
FQMVCPIGWT
FQMVCPIGWT
FQMVCPIGWT
FQMVCPIGWT
FQMVCPIGWT
FQMVCPIGWT
FQMVCPIGWT
FYLVCPIGWT
FYLVCPIGWT
FQLVCPYGWV
F-MVCP-GW-
*
GTVS.CTSFN 
GTVS.CMSFN 
GTVS.CMLAN 
GTVS.CMLAN 
GTVS.CMLAN 
GTVS.CLLAN 
GTVSLCHWSN 
GWE.CTAVS 
GVIE.CTAVS 
GRVE.CTTVS 
q-V— C---
Domain A3
846(154 ) 
MDTLATTWR 
MDTLATTVIR 
RDTLSTVWR 
RDTLSTVWR 
RDTLDTAWR 
RDTLDTTWR 
KDTLAMTWR 
PTTLRTEWK 
PTTLRTEWK 
KDTLVTEWR 
— TL---W -
*
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847 (: )
NADL TYRRSKPFPH RQGCITQKNL GEDLHNCILG
Sing TYRRSKPFPH RQGCITQKTL GEDLHNCILG
EPI TYRRSVPFPY RQGCIIQKTL GEDLYSCVLG
FBI TYRRSVPFPY RQGCIIQKTL GEDLYSCVLG
C24V TYRRSRPFPY RQGCITQKTL GEDLYDCILG
FP1 TYTRYKPFPY RQGCITQKTV GEDLYDCALG
Oslo TYKRHRPFPF RQGCITQKVI GGDLYDCALG
Alfo TFRRDKPFPH RVDCVTTIVE KEDLFHCKLG
Bres TFRREKPFPY RRDCVTTTVE NEDLFYCKWG
More IYKKTKPFPQ RVGCDHTTIH GEDLYHCQMG
C -Y PFP- R— C------ ——DL”*“C“*“G
* *
Domain A4
928(236)
NADL LVDSTSCNRE GVAIVPQGTL KCKIGKTTVQ
Sing .........       .
EPI LVDDTPCNRE GVAIVPHGTV KCKIGDTIVQ...... WAMDTKLG..
FBI LVDDTSCNRE GVAIVPHGTV KCKIGDTIVQ VIAMDTKLG. ....
C24V FVDGTSCNRE GVAIVPQGLV KCKIGDTIVQ VIALDTKLGP MPCKPYEIIP
FP1 LVDDTSCNVE GVAIVPGGPV KCKIGDTIVQ VAAMDTRLG. ....
Oslo QVDETSCNRD GVAIVPTGSV KCKIGDTWQ VIAMDDKLGP MPCRPYEIIP
Alfo WDSTDCNRD GWISTEGEH ECLIGNTTVK VHALDERLGP MPCRPKEIVS
Bres IVDSTDCNRD GWISTEGSH ECLIGNTTVK VHALDERLGP MPCRPKEIVS
More AVDDTSCNRG GWIDRTGNL ECLIGETTVK VFSLDKKLG...........
C -VD-T-CN—  GV-I G—  -C-IG-T-V- V-A-D— LGP MPC-P-EI—
*
Domain A5
896(204) 
GNWTCVPGDQ LLYKGGSIES 
GNWTCVPGDM LLYKGGSIES 
GNWTCVTGDM LRYTGGSIES 
GNWTCVTGDM LRYTGGSIES 
GNWTCVTGDQ LQYTGGSVES 
GNWTCVTGDQ LQYTGGPVES 
GNWTCVPGDI LRYVDGPVES 
NWTCVKGDP VTYKGGQVKQ 
GNWTCVKGEP VTYTGGPVKQ 
GNWTCMRGEP VRYTGGLVKQ 
GNWTC— GD— — Y— G—V—
g
977(285) 
VIAMDTKLGP MPCRPYEIIS
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Fig 7.4 Schematised gp53 showing escape mutant amino acid 
changes.
Schematic scale representation of gp53 protein to show 
^®i^tive positions of amino acid changes in escape mutant 
viruses. Open rectangle represents that part of the protein 
for which the amino acid sequence was deduced, whilst single 
line represents the likely unsequenced region. NH2 = the 
likely amino terminus and COOH = the likely carboxy 
terminus. Positions of amino acid changes are marked as 
asterices. Numbers in boxes = amino acid position of 
mutations counting from the likely amino terminus of gp53. 
Boxes are colour-coded for different mutants, whilst the 
mutant virus designation is given beside each substitution 
site.
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C5 158n 
G1 215c
| 72 | 72 I 72 || 72 |
74 74 C2/C3 166n
135 135 C3/A2 214c
146 A1 214n
173 C2 166n
182 C4 162c
* 271 G1215c
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Six escape mutant viruses were found to have a combination 
of two mutations (Table 7.2), one involving amino acid 
residues at 763—766 (71—74) and the other, a
non-conservative change in one of three regions (Fig 7.4):
1) residues 827 (135) or 836 (146) for mutants C3/A2 214c
and Al 214n respectively.
2) residues 865 (173) or 874 (182) for mutants C2 166n and 
C4 162c respectively. ^
3) residue 963 (271) for mutant G1 215c.
Comparing amino acids for these regions of gp53 amongst BVDV 
strains of known sequence (Fig 7.3), residue 827 (135) is
towards the end of a run of 23 highly conserved, mainly 
hydrophobic, amino acids that begin with a strongly 
predicted glycosylation site at arginine-809 (117). The next 
substitution at residue 836 (146) of mutant Al 214n is in a 
more variable region of mainly hydrophilic residues, whilst 
amino acid conservation is only moderate at substitution 
sites 865 (173) and 874 (182). Residue 874 (182) is four
residues from a predicted glycosylation site at amino acid 
878 (186). Residue 963 (271), is part of a small hydrophilic 
region of three residuessurrounded on either side by highly 
conserved, hydrophobic residues.
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7.4 DISCUSSION
Eight different neutralization-escape mutant viruses were 
prepared using five anti-gp53 mAbs. Four mutants were 
selected from the NADL strain of BVDV and four from the 
Oregon C24V strain. They were compared with their parental 
virus for recognition and neutralization by a panel of nine 
anti-gp53 mAbs. Approximately 90%^ of each gp53 gene, 
including the whole of the N-terminus, was sequenced for all 
eight escape mutants. This sequence was compared with that 
established for the parental viruses in Chapter 6.
All of the mutant viruses were selected on the basis of 
non-recognition by the selecting mAb in PLA. This is a 
convenient method to use, but does eliminate the possibility 
of identifying neutralization-escape mutants that still bind 
the selecting mAb. Such mutants have been described for HCV 
by Wensvoort (1989). Multiple epitope loss and multiple 
neutralization resistance was observed for several mutants 
and this is very suggestive of epitope overlap. The findings 
in this respect, supported the competitionstudies of 
Chapter 5 insofar as multiple epitope loss from mutants 
always involved epitopes previously linked by reciprocal 
blocking (Fig 7.2).
Sequence comparison between neutralization-escape mutants 
and the parental viruses from which they were selected can 
provide information on the possible location of epitopes.
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The necessary assumption is that a mutation at the antibody 
combining site is the most likely mechanism for acquired 
neutralization resistance. However, mutations outside of an 
epitope could also have an influence on antibody binding by 
means of long-distance steric effects (Cepica and others, 
1990). Competitive binding assays had already suggested 
clustering of most epitopes into one domain and sequencing 
of escape, mutants revealed that sevéh out of eight mutants 
had amino acid changes at positions 763, 764 or 766: 71, 72 
or 74 amino acids from the predicted N-terminus of gp53. It 
would therefore seem very likely that this region of gp53 is 
indeed part of an antibody combining site on both BVDV NADL 
and Oregon C24V. Van Rijn and others (1992) have already 
suggested that a major conserved domain on the gp55 protein 
of HCV is located towards the N-terminus, whilst more 
recently Ridpath and Bolin (1992); Wilson and Donis (1992) 
and Piet and others (1992) have all demonstrated escape 
mutant virus mutations in this region for both BVDV and HCV.
Of the seven mutants with an amino acid change in the 
763-766 (71-74) region, six had another amino acid change in 
one of three, more C-terminal regions (Figs 7.3 and 7.4). It 
is possible, that by means of secondary folding of the gp53 
protein, these other amino acids could combine with the 
residues in the 763-766 (71-74) site to form discontinuous 
and conformation-dependent epitopes. However, this 
assumption needs substantiation, because a consideration of 
the possible causes of double mutants reveals that the
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significance of second substitutions may be questionable. 
Double mutations can arise during selection with mAbs, 
especially if the selective pressure is low. Alternatively, 
a second mutation can arise subsequent to selection because 
of instability of the primary point mutant. A third 
possibility is that double mutations are in fact derived 
from multiple single mutants present as a mixture in a 
particular mutant stock. The last two possibilities cannot 
be excluded in the present studies, since the mutant viruses 
were not biologically cloned prior to sequencing and neither 
was their stability established.
There is therefore a possibility that where double mutations 
have occurred, one of the amino acid changes may be 
irrelevantto antibody binding. This would seem most unlikely 
for the 763-766 (71-74) region, because on the one hand, the 
grouping of the substitutions does not suggest a chance 
event, whilst on the other, one of the mutants defining this 
region (mutant C3 166n) had only a single amino acid change. 
Several lines of evidence suggest that the distal mutations 
were at least not random. Firstly, none of the nucleotide 
changes were silent, since all encoded amino acid 
substitutions. Secondly most of the mutations showed some 
clustering rather than a haphazard distribution. In 
particular, three different mutants selected for by mAb 
WB214n, from both NADL and Oregon C24V, all had second 
mutations in the space of 11 amino acids, whilst the two 
Oregon C24V mutants A2/C3 214c had identical proximal and
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distal substitutions.
Further evidence that amino acids outside the 763-766 
(71-74) region are involved in mAb binding can be obtained 
by a re-examination of the sequencing and 
immunocharacterization comparisons from Chapter 6. The amino 
acids at 763-766 (71-74) are at the centre of a run of 15 
residues with considerable homology amongst diverse 
pestiviruses (Fig 7.3), including HCV . and BDV. This was 
unexpected, since anti-gp53 mAbs are mainly BVDV- or 
HCV-specific (Moennig and others, 1987), and in particular, 
none of the BVDV anti-gp53 mAbs used in this study 
recognised either HCV Brescia or HCV Alfort (Chapters 5 and
6) . An obvious explanation would be that the epitopes are 
conformational and that less conserved amino acids from 
another site or sites are also involved. More definite 
evidence that this may be so comes from comparing the amino 
acid sequences of less distantly related pestiviruses. 
Biologically cloned stocks of FP1 91/1 and FBI 91/1, showed 
complete amino acid homology from position 750-779 (58-87)
even though mAbs WB214n and WB215c, both of which selected 
for amino acid changes in the 763-766 (71-74) region, only 
recognised FBI 91/1 (Figs 7.3 and 7.5). This strongly 
suggests that the epitopes are discontinuous. Furthermore, 
the double mutants selected by the two mAbs WB214n and 
WB215c have second amino acid substitutions at 827/838 
(135/146) and 963 (271) respectively. All of these amino
acids are close to the positions of amino acid differences
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Fig 7.5 Schematic representation of gp53 proteins to show 
comparative locations of amino acid differences between 
pairs of viruses that differ with respect to recognition by 
the anti-gp53 mAb WB214n.
Boxes represent positions of amino acids that differ between 
strains compared. C = amino acid differences between gp53 
proteins of biologically cloned FP1 91/1 and FBI 91/1 
viruses. B = amino acid differences between gp53 proteins of 
WB214n escape mutants and parental viruses. A = amino acid 
differences between gp53 proteins of FP1 91/1 and FP1 91/1 
virus before and after biological cloning. Open rectangle 
represents that part of the protein for which the amino acid 
sequence was deduced, whilst single line represents the 
likely unsequenced region. NH2 = the likely amino terminus 
and COOH = the likely carboxy terminus. Positions of amino 
acid changes are all marked to the same scale from the 
N-terminus.
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between FP1 91/1 and FBI 91/1: 833/841 (141/149) and 959/964 
(267/272). However, because there are also many other 
differences between FP1 91/1 and FBI 91/1 (Fig 7.5c), the 
similarities between the escape mutant sites and these 
particular strain-differentiating sites could still be 
coincidental.
The virus FP1 91/1 was sequenced 'and immunostained both 
before and after biological cloning (uFPl 91/1 and cFPl 
91/1). Before biological cloning, there was a mixture of 
epitopic variants, some of which were recognised by both 
WB214n and WB215c. After cloning, cFPl 91/1 was no longer 
recognised by either mAb. Comparing the amino acid sequences 
of uFPl * 91/1 and cFPl 91/1 revealed either two or three 
differences (depending on which of the molecular clones of 
uFPl 91/1 were sequenced : Chapter 6 and Fig 7.5 a) . One of 
the differences conserved between all clones was at 833 
(141), coinciding once again with the 827/838 (135/146)
region specified by the double-point escape mutants (Fig 
7.5b). Finally, Ridpath and Bolin (1992), have also found an 
escape mutant of BVDV Singer with an amino acid substitution 
in this part of gp53 (residue 153 from the N-terminus).
The amino acid substitution at position 963 (271) does not 
appear to be close to any of the other substitutions. 
However, the location of the change does not seem to be 
random, in that passage of FBI 91/1 in pigs produced a 
change very nearby {position 959 (267)}. All the available
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data is therefore compatible with the theory that a major 
domain of gp53 comprises discontinuous epitopes defined by 
amino acids at 763-766 (71-74) and at least one (and
possibly three other) more C-terminally located region(s) of 
amino acids. Amino acids at 827/838 (135/146) seem
particularly likely to be involved in such a domain.
Conformational dependence of these epitopes would be 
consistent with the apparent changes 'in epitope conservation 
that followed upon different antigen processing (Chapter 5). 
Furthermore, it has been shown that other anti-gp53 mAbs do 
not recognise BVDV antigens in Western blots (Ridpath and 
Bolin, 1992) nor do they bind to any of a series of
overlapping peptides encompassing the entire protein
(Greiser-Wilke, personal communication). Epitope mapping of 
foot-and-mouth disease virus has suggested that two 
discontinuous regions can combine spatially to form a single 
epitope (Parry and others, 1985) and this finding has been 
further substantiated by X-ray diffraction studies (Acharya 
and others, 1990). X-ray diffraction studies of 
protein/antibody complexes, for influenza virus
neuraminidase and egg white lysozyme, have suggested that 
two to five discontinuous loops of a protein may be involved 
in an antibody combining site (Laver and others, 1990). The 
complexity of interaction involved in the composition of 
each epitope, along with the difficulty of predicting 
secondary structure for membrane proteins prevents more 
precise deductions as to the nature of the antibody binding 
sites. None the less, the data presented would indicate that
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generation of subunit vaccines for BVDV may have great 
difficulties, due to the conformational structure of gp53 
and the need for correct presentation of epitopes that 
exhibit neutralization. These difficulties are also likely 
to be compounded by the problem of antigenic variation.
From competition studies, the epitope of mAb WB158n appeared 
relatively spatially distinct. Furthermore, escape mutants 
lacking this epitope showed no change in the patterns of 
either neutralization or binding with other mAbs. Sequence 
comparison with the parental virus (NADL) revealed a single 
amino acid substitution at position 732 (40), 31 amino acids 
upstream of the substition site shared by the other mutants. 
Thus all the data on this epitope point to it being in a 
separate domain from the others.
7.5 CONCLUSIONS
Sequencing of escape mutant viruses revealed that a cluster 
of three amino acids in the N-terminal half of gp53, were 
involved in the main antigenic domain shared by both NADL 
and Oregon C24V viruses, whilst an amino acid 31 residues 
further towards the N-terminus was involved in a second site 
present only on the NADL strain. Since other amino acids 
defining the major domain were located at distant positions 
within the gp53 protein, it is likely that it consists of 
composite, conformation-dependent epitopes.
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8.1 PRINCIPAL CONCLUSIONS
1) Naturally occuring disease in a litter of pigs was due to 
infection with BVDV.
2) A steer persistently infected with BVDV could infect pigs 
by indirect pen contact.
3) A bovine, BVDV-like virus could cause congenital porcine 
infection and subsequent disease.
4) Congenital BVDV in pigs may lead to postnatal virus 
persistence. Clinical recovery and clearance of viraemia is 
associated with production of neutralizing antibodies and 
may occur at a variable period after birth. Clearance of 
virus from tissues may be delayed.
5) Typing with anti-gp53 mAbs is an invaluable tool for 
discrimination between BVDV field isolates.
6) Field isolates of BVDV vary in their antigenic 
heterogeneity.
7) Passage of BVDV through pigs via congenital infection did 
not detectably alter the expression of gp53 epitopes, but 
resulted in three changes in the amino acid sequence of that 
protein.
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8) Passage of gp53 through pigs improved the ability of the 
virus to grow in a porcine kidney cell line.
9) A panel of 17 mAbs raised against BVDV were subdivided 
into three groups specific for the p80, gp53 and gp48 
proteins respectively.
10) MAbs defined four domains on p80 >and two on gp53.
11) Apparent epitope conservation was influenced by the 
method of antigen preparation. By PLA, anti-p80 mAbs were 
broadly reactive, whereas anti-gp53 and anti-gp48mAbs had 
more restricted specificities, confined largely to 
pestiviruses isolated from ruminants.
12) Some ovine and porcine pestivirus isolates appeared 
BVDV-like in terms of epitopes expressed on three different 
proteins.
13) Sequencing RT-PCR amplified viral gene fragments was a 
convenient method of comparing viruses.
14) Some likely locations of epitopes on the gp53 protein 
were established.
15) The major domain located on gp53 probably comprises 
epitopes defined by non-linear amino acid sequences.
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8.2 FINAL DISCUSSION
i) Ruminant-type pestivirus infections of pigs:
Although ruminant-type pestivirus infections of pigs have 
been recognised for many years, (Snowdon and French, 1968), 
they are generally considered uncommon and unimportant 
except as a possible cause for misdiagnosis of hog cholera
(Roehe, 1991). Most cases are attributed to either
transmission from ruminants (Terpstra and Wensvoort, 1988) 
or to the use of. contaminated vaccines (Vannier and others, 
1988; Wensvoort and Terpstra, 1988). In the case reported 
upon in Chapter 3 (Baton and others, 1992a), the 
investigation was initiated because of a suspicion of hog 
cholera, but there was ample opportunity for virus
transmission from cattle. Many features of the outbreak were 
similar to previously recorded cases (Terpstra and 
Wensvoort, 1988). There was haemorrhagic disease similar to 
that seen with hog cholera, but it was confined to a single 
litter and appeared to be a delayed sequel to congenital 
infection. The reason for the delayed onset of disease is 
unknown, and cytopathogenic virus biotypes as occur in 
mucosal disease were not isolated. Possibly some other
change in virus virulence might have taken place, or else 
the disease might have resulted from a break-down in 
immunotolérance.
Experimentally, the virus from the persistently infected 
steer readily infected pigs, even though it could not be
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Maintained in vitro in a porcine kidney cell line. Further 
spread between pigs was not demonstrated on this occasion. 
However, Leforban and others (1990a) have shown that pigs 
congenitally infected with BDV can infect others by contact 
transmission in the first few weeks of life and a 19 month 
old pig persistently infected with a BDV-like virus has been 
shown to infect other pigs, by indirect pen contact (Paton, 
unpublished results). On this evidence it would be predicted 
that ruminant-type pestiviruses have the potential to be 
maintained in pigs without continuing ruminant contacts. 
Some features of the experimental infections were similar to 
earlier accounts of BVD/BD in pigs (Chapter 4). For example, 
acute postnatal infections appeared to be asymptomatic. This 
finding does not seem to support the supposition of Moennig 
and Plagemann (1992) that HCV was initially highly virulent 
for swine because it was a poorly host-adapted form of BVDV 
or BDV. The apparent avirulence of a virus experimentally is 
not proof of unimportance in the field. Early reproductive 
effects have not been well studied. In ruminants themselves, 
primary postnatal infections with BVDV or BDV are also 
generally asymptomatic (Nuttal and others 1980) and yet may 
contribute to disease on farms (Richer and others, 1988). 
Congenital porcine infections with ruminant pestiviruses 
have known pathogenicity (Leforban and others, 1990a) and in 
the present study variable disease was observed, even within 
a single litter. This variation might have resulted from 
infection of different fetuses at different stages of 
gestation. Only one pig died suddenly with haemorrhagic
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lesions, but other viraemic animals grew poorly and became 
unthrifty. Stunting is a recognised feature of congenital 
pestivirus infections in ruminants (Boeder and others, 1986) 
and may involve non-specific interference with cell division 
or specific loss of luxury cell functions such as hormone 
production (Sawyer and others, 1991). Only two initially 
viraemic pigs survived to the end of the experiment and both 
of these animals developed neutralizing antibodies. This 
seroconversion appeared to be associated with an immediate 
clearance of virus from serum, but a very delayed clearance 
from tissues. A similar finding was observed in previous 
experiments (Paton, unpublished results). It therefore seems 
that congenital immunotolérance induced by pestiviruses in 
pigs may be somewhat different from that which occurs in 
ruminants, since the latter very rarely eliminate virus in 
later life. Temporary viral persistence along with 
occasional continued tissue persistence in the presence of 
neutralizing antibodies has also been described for 
congenital rubella in man (Rawls, 1974).
ii) Effects of cross-species infections on gp53:
The bovine pestivirus isolated from the persistently 
infected steer was compared first of all with viruses 
isolated from pigs on the same farm (Chapters 3 and 6) and 
later with itself, after experimentally induced passage in 
pigs (Chapters 4 and 6). The bovine isolate grew well in CT 
cells, but not in PK15s, whereas the porcine isolates would
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grow in either cell type. By cross-neutralization tests, the 
bovine and porcine field isolates appeared to be very 
similar, but differences could be detected by 
immunocharacterization with mAbs. By mAb typing, the bovine 
field isolate and the experimental porcine isolates appeared 
identical. The deduced amino acid sequences of part of the 
gp53 proteins of some of these viruses were compared before 
and after biological cloning in Chapter 6. All were 
BVDV-like, but it appeared that the porcine and bovine 
isolates made from the same farm were distinct, and that 
sequence differences between them were not reproduced by 
experimental passage of the bovine virus in pigs. Perhaps 
FP1 91/1 was a different bovine strain that was also 
circulating on the farm at the same time as FBI 91/1. 
Alternatively, considering the heterogeneity of FP1 91/1, it 
might even be speculated that this virus was the end result 
of a mixed porcine infection involving both FBI 91/1 and 
some other unidentified bovine virus. This could account for 
the antigenic similarity of a subpopulation of biologically 
uncloned FP1 91/1 to FBI 91/1. Biological cloning could have 
weeded out the FBI 91/1-like fraction, leaving a virus that 
was both antigenically and genetically distinct. An 
additional complicating factor in a mixed infection would be 
the possibility of viral recombinations. The reason why some 
pestivirus isolates appear far more heterogeneic than 
others, certainly warrants further investigation.
Despite the diversity within the pestivirus group, direct
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evidence of antigenic or genetic instability of pestiviruses 
following in vivo passage has rarely been reported. Gunn and 
others (1992) working with cattle and sheep, found that 
cross-species pestivirus passage could select for epitopic 
variants detectable by anti-gp53 mAbs. Although such changes 
were not detected by experimental passages made in this 
study, three amino acid differences resulting from 
cross-species infection were observed and one of these 
changes was adjacent to a predicted mAb binding site. Such 
changes could have selective advantages in porcine cells, 
for instance through improvements in: viral adsorption and 
uptake, viral release into the cytoplasm or viral maturation 
and cellular exocytosis. It would be desirable to sequence 
more of the genomes of the BVD91/1 viruses, to establish the 
entire sequences of gp53 and to see what effects if any, 
host changes had on other genes. The observed substitutions 
might have been selected by the change in host or by 
immunological pressures. They could also have been merely a 
reflection of a more random genetic drift. Since all the 
nucleotide differences found also encoded amino acid 
differences, this does not suggest that the mutations were 
random. There is doubt as to whether virus passage through 
congenital infection would subject a pestivirus to 
immunological pressure. It might well be that serial, 
postnatal passage of pestiviruses in immunologically mature 
animals would be a more potent selector of viral diversity 
than passage in immunotolerant ones.
291
iii) Epitope mapping:
A panel of BVDV mAbs that included some of those used to 
discriminate between the above and other pestivirus strains 
was characterised with respect to protein specificity 
(Chapter 5). Most of the mAbs recognised either the major 
envelope glycoprotein (gp53) of BVDV or an immunodominant 
non-structural protein (p80). Viral recognition by mAbs was 
influenced by the method of antigen preparation. Competitive 
binding studies were used to localise more precisely the 
epitopes involved. Combining this with already established 
data on the viral strain specificity gave an indication of 
the degree of conservation of different pestivirus epitopes 
(Paton and others, 1991b). Conservation of epitopes was much 
greater for p80 than for gp53. This was not unexpected, 
since although a strong immunogen, p80 is a nonstructural 
protein that is probably not subject to immunological 
selective pressures. By contrast, gp53 is an envelope 
protein found at the surface of the virus (Thiel and others, 
1992) and involved in virus neutralization.
In many respects these findings are similar to already 
reported studies. Epitope mapping of pBO has not been 
previously reported. More precise localization of these 
epitopes may come from studies with synthetic peptides or 
with recombinant p80 proteins. The latter have already been 
examined as potential diagnostic antigens (Lecomte and 
others, 1990). Being immunogenic and also highly conserved, 
p80 is a very suitable antigen for use in serological tests
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where broad specificity is required (Paton and others, 
1991a). The p80 epitope of WB160n reported upon in the 
present study seems to be absent from HCVs and might prove 
useful in discriminatory serology.
Deduced amino acid differences in the sequences of gp53 
proteins for different strains of BVDV were too great to 
correlate directly with mAb binding patterns (Chapter 6). In 
an attempt to identify epitope locations, mAb 
neutralization-escape mutants were produced, and 
characterised with respect to mAb reactivity and gp53 gene 
sequence (Chapter 7). Sequence differences between parental 
and mutant strains indicated the possible location of 
antibody binding sites on gp53 and supported results from 
competitive binding studies which had suggested that most 
epitopes clustered in a single domain. The pattern of amino 
acid differences comparing escape mutant viruses with both 
parental viruses and others of known mAb reactivity 
suggested that epitopes may be non-linear and thus likely to 
be conformation dependent (Paton and others, 1992b,c). The
composite nature of the epitopes would explain why the 
binding of anti-gp53 mAbs was greatly influenced by the 
method of antigen preparation. The finding that the viral 
strain specificity of the anti-gp53 mAbs for ELISA (but not 
PLA) antigen was restricted in a similar manner to their 
spectrum of neutralization needs to be tested by examination 
of a range of virus strains. However, even were it to be 
confirmed, it is difficult to extrapolate from without more
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basic information on what processes are involved in 
antibody-mediated viral neutralization and antigen 
preparation.
Part of the major domain for the epitopes of anti-gp53 mAbs 
was found to be located in a region of relatively conserved 
amino acid sequence amongst diverse pestiviruses. This was 
surprising in view of the narrow virus-strain specificity of 
the mAbs used to define the site. However, it was postulated 
that the epitopes were non-linear and also incorporated 
other regions of less conserved sequence. This could account 
for the narrow specificity of the mAbs. The existence of a 
conserved core region might also explain the ability of some 
polyclonal antisera to cross-neutralize diverse 
pestiviruses. Although mAbs apparently do not recognise 
linear sequences of synthetic peptides derived from the 
sequence of gp53 (Greiser-Wilke, personal communication), 
polyclonal antisera might do so. Suitably designed 
infectious viral clones should be able to show more 
unequivocally the effect of specific sequence changes on 
epitope expression. For instance it would be interesting to 
see what mAbs would bind to a BVDV with various different 
HCV-like sequence substitutions in gp53. Similar techniques 
might be used to assess the significance of amino acid 
changes with respect to host specificity and to map the 
epitopes of non-neutralizing mAbs.
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APPENDIX
General reagents:
Physiological phosphate buffered saline (0.01M PBS)
pH 7.2 pH7.6
Sodium dihydrogen phoshate 0. 3 6g 0.20g
Disodium hydrogen phosphate 1. 37g 1.55g
Sodium chloride 8. 5g 8.5g
Distilled water to 1L to 1L
Cell culture reagents:
Antibiotic supplement
100 IU penicillin, lOOug streptomycin, 20IU mycostatin per 
ml
Minimal essential medium (MEM)
Eagle's minimal essential medium (lOx concentrate, 100ml
Flow laboratories)
Glutamine 0.2M 10ml
Sodium pyruvate 0.1M 10ml
Antibiotic supplement 5ml
Sodium bicarbonate 7.5% 20ml
Sodium hydroxide 0.25M 15ml
Hepes 1.0M 15ml
Lactalbumen hydrolysate 5% 10ml
Sterile deionised water to 1L
PLA reagents:
PLA diluent.
PLA wash fluid with 21 .SgL-1 sodium chloride.
PLA fixation fluid.
20% acetone in 0.01M 
albumen (Sigma).
PBS pH7.6 with 200mgL"1 bovine serum
PLA substrate.
Diamino-ethyl-carbazole (DAEC):
Stock solution: dimethyl formamide 24ml
Working solution:
DAEC (Sigma) 160mg
acetate buffer 10ml
stock DAEC 0. 6ml
20% hydrogen peroxide 5jL/l
0.05M acetate buffer: Distilled water 1L
Sodium acetate 2. 9g
Acetic acid 1ml
PLA wash fluid.
0.01M PBS pH7.6 with 5mlL'1 polyoxyethylene glycol (80) 
sorbitan monolaurate (Tween 80).
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ELISA reagents:
TMB ELISA substrate.
Solution A:
Tetra methyl benzidine (Aldrich) O.lg
Ethanol 100ml
Solution B (Phosphate-citrate buffer pH 5):
Citric acid 20.4g
Na2P04 29.2g
Water to 2L
H202 (0.075%) at 0.25ml per litre
Working Solution:
1 part of solution "A" to 9 parts of Solution "B".
TMB stop solution.
2M H2S04
Radioimmunoprecipitation reagents:
Acrvlamide/Bis (30%T.2.67%C) Stock.
Acrylamide  ^ 146g
N'N'-Bis methylene acrylamide 4g
Distilled water to 0.5L
Filter
Store at 4°C in the dark 
Ammonium Persulphate (10%).
Ammonium persulphate lOOmg
Distilled water iMl
made up fresh daily
Electrode (Running) buffer PH8.3.
5x Stock solution:
Tris base 459
Glycine 216g
SDS 15g
Distilled water to 3L
store at 4°C
warm to 37°C before use if precipitation occurs
300ml of stock diluted with 1.2L distilled water for one
electrophoresis run
Electrophoresis sample buffer
Distilled water 4.0ml
0.5M Tris-HCl pH6.8 1.0ml
Glycerol 0.8ml
10% SDS 1.6ml
2-B-mercaptoethanol 0.4ml
0.05% w/v bromophenol blue 0.2ml
store at room temperature
Lvsis buffer
Sodium chloride
Sodium deoxycholate '
Triton X-100 
SDS
Tris base 
Distilled water
pH adjusted to 7.6 with IN hydrochloric acid 
Distilled water 
Stored at 4°C
4.38g 
5.00g 
5. 0ml 
0.50g 
1.21g 
to 0.3L
to 0.51,
SDS n o % K  
SDS
Distilled water
store at room temperature
10g 
to 100ml
SDS-PAGE 10% Separating gel (0.375M Tris-HCl PH8.8Ï. 
Distilled water 40.0ml
1.5M Tris-HCl pHÇ.8 25,0ml
10% SDS 1.0ml
Acrylamlde/bis stock - degassed at room) 33.0ml
temperature for approximately 5 minutes)
10% Ammonium persulphate 0.5ml
TEMED 0.05ml
Total monomer 100.0ml
Ammonium persulphate and TEMED added last, immediately
before pouring gel.
Separating gel buffer
4x Stock solution (Stored at +4°C):
1.5M TRIS-HCL pH8.8
Tris base 54.45g
Distilled water to 150ml
pH adjusted to 8.8 with IN hydrochloric acid 
Distilled water to 300ml
Stacking gel buffer.
4x Stock solution (Stored at 4°C):
0.5M TRIS-HCL pH6.8 
Tris base 
Distilled water
pH adjusted to 6.8 with IN hydrochloric acid 
Distilled water
6. Og 
to 60ml
to 100ml
SDS-PAGE 4% Stacking gel (0.125M Tris-HCl PH6.8).
Distilled water 6.1ml
0.5M Tris-HCl pH6.8 2.5ml
10% SDS 0.1ml
Acrylamide/bis stock - degassed at room) 1.3ml
temperature for approximately 5 minutes)
10% Ammonium persulphate 0.05ml
TEMED 0.01ml
Total monomer 10.0ml
Ammonium persulphate 
before pouring gel.
and TEMED added last, immediately
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Molecular biological reagents:
Reagents not listed were formulated according to Sambrook 
and others (1989c).
TAE buffer (XSO).
(for agarose gel electrophoresis)
Tris base
Glacial acetic acid 
0,5M EDTA 
Distilled water
TBE buffer (X5).
(for sequencing gel electrophoresis) ^
Tris base 
Boric acid 
0.5M EDTA 
Distilled water
Sequencing gels.
Sequagel™ reagents (National Diagnostics)
Sequagel sequencing concentrate 36ml
Sequagel sequencing buffer 15ml
Sequagel sequencing diluent 99ml
10% Ammonium persulphate 0.9ml
TEMED • 0.15ml
Ammonium persulphate and TEMED added last, immediately 
before pouring gel.
54g 
27.5g 
20ml 
to 1L
242g 
57.1ml 
100 ml 
to 1L
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